Year,Organisation Name,Organisation Code,Category,Measure,Value
2016/17,England,Eng,Total primary care (all BNF),Prescription Items,1098397839.00
2016/17,England,Eng,Total primary care (all BNF),Net Ingredient Cost (£),8962693142.26
2016/17,England,Eng,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,52011677.00
2016/17,England,Eng,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),983715324.06
2016/17,England,Eng,Insulins (BNF 6.1.1) ,Prescription Items,7076970.00
2016/17,England,Eng,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),349122092.60
2016/17,England,Eng,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,2245880.00
2016/17,England,Eng,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),104592186.88
2016/17,England,Eng,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,4831090.00
2016/17,England,Eng,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),244529905.72
2016/17,England,Eng,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,37423493.00
2016/17,England,Eng,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),443666573.12
2016/17,England,Eng,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,8389231.00
2016/17,England,Eng,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),26765356.79
2016/17,England,Eng,Biguanides (BNF 6.1.2.2) ,Prescription Items,20843554.00
2016/17,England,Eng,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),94390078.24
2016/17,England,Eng,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,8190708.00
2016/17,England,Eng,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),322511138.09
2016/17,England,Eng,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,7211297.00
2016/17,England,Eng,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),186972042.38
2016/17,England,Eng,Human analogue insulins ,Prescription Items,5716664.00
2016/17,England,Eng,Human analogue insulins ,Net Ingredient Cost (£),303560067.30
2016/17,England,Eng,Other insulins ,Prescription Items,1360306.00
2016/17,England,Eng,Other insulins ,Net Ingredient Cost (£),45562025.30
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Total primary care (all BNF),Prescription Items,3271863.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Total primary care (all BNF),Net Ingredient Cost (£),29263228.11
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,143558.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2793137.09
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Insulins (BNF 6.1.1) ,Prescription Items,19920.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),991506.84
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5949.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),274793.86
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13971.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),716712.98
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,97678.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1122383.02
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,25933.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),60278.70
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Biguanides (BNF 6.1.2.2) ,Prescription Items,50962.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),266995.81
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,20783.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),795108.51
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,24820.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),667320.87
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Human analogue insulins ,Prescription Items,15623.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Human analogue insulins ,Net Ingredient Cost (£),857359.12
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Other insulins ,Prescription Items,4297.00
2016/17,"Airedale, Wharfedale and Craven CCG",02N,Other insulins ,Net Ingredient Cost (£),134147.72
2016/17,Ashford CCG,09C,Total primary care (all BNF),Prescription Items,2298465.00
2016/17,Ashford CCG,09C,Total primary care (all BNF),Net Ingredient Cost (£),19721558.53
2016/17,Ashford CCG,09C,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,103825.00
2016/17,Ashford CCG,09C,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2259330.83
2016/17,Ashford CCG,09C,Insulins (BNF 6.1.1) ,Prescription Items,17450.00
2016/17,Ashford CCG,09C,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),874737.77
2016/17,Ashford CCG,09C,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5927.00
2016/17,Ashford CCG,09C,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),282751.79
2016/17,Ashford CCG,09C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,11523.00
2016/17,Ashford CCG,09C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),591985.98
2016/17,Ashford CCG,09C,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,70241.00
2016/17,Ashford CCG,09C,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),989077.94
2016/17,Ashford CCG,09C,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,14036.00
2016/17,Ashford CCG,09C,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),43189.25
2016/17,Ashford CCG,09C,Biguanides (BNF 6.1.2.2) ,Prescription Items,37923.00
2016/17,Ashford CCG,09C,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),218780.52
2016/17,Ashford CCG,09C,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,18282.00
2016/17,Ashford CCG,09C,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),727108.17
2016/17,Ashford CCG,09C,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,15267.00
2016/17,Ashford CCG,09C,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),387019.63
2016/17,Ashford CCG,09C,Human analogue insulins ,Prescription Items,14574.00
2016/17,Ashford CCG,09C,Human analogue insulins ,Net Ingredient Cost (£),792078.56
2016/17,Ashford CCG,09C,Other insulins ,Prescription Items,2876.00
2016/17,Ashford CCG,09C,Other insulins ,Net Ingredient Cost (£),82659.21
2016/17,Aylesbury Vale CCG,10Y,Total primary care (all BNF),Prescription Items,3491228.00
2016/17,Aylesbury Vale CCG,10Y,Total primary care (all BNF),Net Ingredient Cost (£),25898339.68
2016/17,Aylesbury Vale CCG,10Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,173777.00
2016/17,Aylesbury Vale CCG,10Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3126324.75
2016/17,Aylesbury Vale CCG,10Y,Insulins (BNF 6.1.1) ,Prescription Items,26855.00
2016/17,Aylesbury Vale CCG,10Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1345724.09
2016/17,Aylesbury Vale CCG,10Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8810.00
2016/17,Aylesbury Vale CCG,10Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),409339.43
2016/17,Aylesbury Vale CCG,10Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,18045.00
2016/17,Aylesbury Vale CCG,10Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),936384.66
2016/17,Aylesbury Vale CCG,10Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,118944.00
2016/17,Aylesbury Vale CCG,10Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1057679.06
2016/17,Aylesbury Vale CCG,10Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,29293.00
2016/17,Aylesbury Vale CCG,10Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),91219.25
2016/17,Aylesbury Vale CCG,10Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,74958.00
2016/17,Aylesbury Vale CCG,10Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),362673.28
2016/17,Aylesbury Vale CCG,10Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,14693.00
2016/17,Aylesbury Vale CCG,10Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),603786.53
2016/17,Aylesbury Vale CCG,10Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,27211.00
2016/17,Aylesbury Vale CCG,10Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),714325.20
2016/17,Aylesbury Vale CCG,10Y,Human analogue insulins ,Prescription Items,22490.00
2016/17,Aylesbury Vale CCG,10Y,Human analogue insulins ,Net Ingredient Cost (£),1209360.57
2016/17,Aylesbury Vale CCG,10Y,Other insulins ,Prescription Items,4365.00
2016/17,Aylesbury Vale CCG,10Y,Other insulins ,Net Ingredient Cost (£),136363.52
2016/17,Barking & Dagenham CCG,07L,Total primary care (all BNF),Prescription Items,3589797.00
2016/17,Barking & Dagenham CCG,07L,Total primary care (all BNF),Net Ingredient Cost (£),27838765.75
2016/17,Barking & Dagenham CCG,07L,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,239726.00
2016/17,Barking & Dagenham CCG,07L,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4269430.73
2016/17,Barking & Dagenham CCG,07L,Insulins (BNF 6.1.1) ,Prescription Items,27665.00
2016/17,Barking & Dagenham CCG,07L,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1230227.82
2016/17,Barking & Dagenham CCG,07L,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8223.00
2016/17,Barking & Dagenham CCG,07L,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),328317.30
2016/17,Barking & Dagenham CCG,07L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19442.00
2016/17,Barking & Dagenham CCG,07L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),901910.52
2016/17,Barking & Dagenham CCG,07L,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,182090.00
2016/17,Barking & Dagenham CCG,07L,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2452460.37
2016/17,Barking & Dagenham CCG,07L,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,26101.00
2016/17,Barking & Dagenham CCG,07L,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),78169.54
2016/17,Barking & Dagenham CCG,07L,Biguanides (BNF 6.1.2.2) ,Prescription Items,99417.00
2016/17,Barking & Dagenham CCG,07L,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),452868.60
2016/17,Barking & Dagenham CCG,07L,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,56572.00
2016/17,Barking & Dagenham CCG,07L,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1921422.23
2016/17,Barking & Dagenham CCG,07L,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,29286.00
2016/17,Barking & Dagenham CCG,07L,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),576573.16
2016/17,Barking & Dagenham CCG,07L,Human analogue insulins ,Prescription Items,24537.00
2016/17,Barking & Dagenham CCG,07L,Human analogue insulins ,Net Ingredient Cost (£),1142058.15
2016/17,Barking & Dagenham CCG,07L,Other insulins ,Prescription Items,3128.00
2016/17,Barking & Dagenham CCG,07L,Other insulins ,Net Ingredient Cost (£),88169.67
2016/17,Barnet CCG,07M,Total primary care (all BNF),Prescription Items,5516164.00
2016/17,Barnet CCG,07M,Total primary care (all BNF),Net Ingredient Cost (£),51742849.71
2016/17,Barnet CCG,07M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,301855.00
2016/17,Barnet CCG,07M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6667306.07
2016/17,Barnet CCG,07M,Insulins (BNF 6.1.1) ,Prescription Items,33974.00
2016/17,Barnet CCG,07M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1818734.74
2016/17,Barnet CCG,07M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10934.00
2016/17,Barnet CCG,07M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),569079.47
2016/17,Barnet CCG,07M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,23040.00
2016/17,Barnet CCG,07M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1249655.27
2016/17,Barnet CCG,07M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,223953.00
2016/17,Barnet CCG,07M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3652698.25
2016/17,Barnet CCG,07M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,48992.00
2016/17,Barnet CCG,07M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),196587.99
2016/17,Barnet CCG,07M,Biguanides (BNF 6.1.2.2) ,Prescription Items,118649.00
2016/17,Barnet CCG,07M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),642237.35
2016/17,Barnet CCG,07M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,56312.00
2016/17,Barnet CCG,07M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2813872.91
2016/17,Barnet CCG,07M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,42612.00
2016/17,Barnet CCG,07M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1179457.68
2016/17,Barnet CCG,07M,Human analogue insulins ,Prescription Items,30383.00
2016/17,Barnet CCG,07M,Human analogue insulins ,Net Ingredient Cost (£),1702331.55
2016/17,Barnet CCG,07M,Other insulins ,Prescription Items,3591.00
2016/17,Barnet CCG,07M,Other insulins ,Net Ingredient Cost (£),116403.19
2016/17,Barnsley CCG,02P,Total primary care (all BNF),Prescription Items,7245814.00
2016/17,Barnsley CCG,02P,Total primary care (all BNF),Net Ingredient Cost (£),51443507.98
2016/17,Barnsley CCG,02P,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,315855.00
2016/17,Barnsley CCG,02P,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5594634.71
2016/17,Barnsley CCG,02P,Insulins (BNF 6.1.1) ,Prescription Items,38356.00
2016/17,Barnsley CCG,02P,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1886566.43
2016/17,Barnsley CCG,02P,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12421.00
2016/17,Barnsley CCG,02P,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),577811.70
2016/17,Barnsley CCG,02P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,25935.00
2016/17,Barnsley CCG,02P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1308754.73
2016/17,Barnsley CCG,02P,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,237642.00
2016/17,Barnsley CCG,02P,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2674650.42
2016/17,Barnsley CCG,02P,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,46374.00
2016/17,Barnsley CCG,02P,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),122141.02
2016/17,Barnsley CCG,02P,Biguanides (BNF 6.1.2.2) ,Prescription Items,131989.00
2016/17,Barnsley CCG,02P,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),478874.73
2016/17,Barnsley CCG,02P,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,59279.00
2016/17,Barnsley CCG,02P,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2073634.67
2016/17,Barnsley CCG,02P,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,37713.00
2016/17,Barnsley CCG,02P,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1004815.00
2016/17,Barnsley CCG,02P,Human analogue insulins ,Prescription Items,35103.00
2016/17,Barnsley CCG,02P,Human analogue insulins ,Net Ingredient Cost (£),1779414.38
2016/17,Barnsley CCG,02P,Other insulins ,Prescription Items,3253.00
2016/17,Barnsley CCG,02P,Other insulins ,Net Ingredient Cost (£),107152.05
2016/17,Basildon and Brentwood CCG,99E,Total primary care (all BNF),Prescription Items,4500919.00
2016/17,Basildon and Brentwood CCG,99E,Total primary care (all BNF),Net Ingredient Cost (£),41689293.23
2016/17,Basildon and Brentwood CCG,99E,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,218365.00
2016/17,Basildon and Brentwood CCG,99E,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4724809.50
2016/17,Basildon and Brentwood CCG,99E,Insulins (BNF 6.1.1) ,Prescription Items,33992.00
2016/17,Basildon and Brentwood CCG,99E,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1718466.00
2016/17,Basildon and Brentwood CCG,99E,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10300.00
2016/17,Basildon and Brentwood CCG,99E,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),482696.61
2016/17,Basildon and Brentwood CCG,99E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,23692.00
2016/17,Basildon and Brentwood CCG,99E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1235769.39
2016/17,Basildon and Brentwood CCG,99E,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,150897.00
2016/17,Basildon and Brentwood CCG,99E,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2201990.60
2016/17,Basildon and Brentwood CCG,99E,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,30695.00
2016/17,Basildon and Brentwood CCG,99E,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),128866.37
2016/17,Basildon and Brentwood CCG,99E,Biguanides (BNF 6.1.2.2) ,Prescription Items,80384.00
2016/17,Basildon and Brentwood CCG,99E,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),451506.57
2016/17,Basildon and Brentwood CCG,99E,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,39818.00
2016/17,Basildon and Brentwood CCG,99E,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1621617.66
2016/17,Basildon and Brentwood CCG,99E,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,32048.00
2016/17,Basildon and Brentwood CCG,99E,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),790243.92
2016/17,Basildon and Brentwood CCG,99E,Human analogue insulins ,Prescription Items,26352.00
2016/17,Basildon and Brentwood CCG,99E,Human analogue insulins ,Net Ingredient Cost (£),1466371.83
2016/17,Basildon and Brentwood CCG,99E,Other insulins ,Prescription Items,7640.00
2016/17,Basildon and Brentwood CCG,99E,Other insulins ,Net Ingredient Cost (£),252094.17
2016/17,Bassetlaw CCG,02Q,Total primary care (all BNF),Prescription Items,2647758.00
2016/17,Bassetlaw CCG,02Q,Total primary care (all BNF),Net Ingredient Cost (£),21572185.67
2016/17,Bassetlaw CCG,02Q,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,120597.00
2016/17,Bassetlaw CCG,02Q,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2542469.98
2016/17,Bassetlaw CCG,02Q,Insulins (BNF 6.1.1) ,Prescription Items,17299.00
2016/17,Bassetlaw CCG,02Q,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),842309.78
2016/17,Bassetlaw CCG,02Q,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5762.00
2016/17,Bassetlaw CCG,02Q,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),251266.98
2016/17,Bassetlaw CCG,02Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,11537.00
2016/17,Bassetlaw CCG,02Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),591042.80
2016/17,Bassetlaw CCG,02Q,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,86091.00
2016/17,Bassetlaw CCG,02Q,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1204546.67
2016/17,Bassetlaw CCG,02Q,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,12753.00
2016/17,Bassetlaw CCG,02Q,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),35727.83
2016/17,Bassetlaw CCG,02Q,Biguanides (BNF 6.1.2.2) ,Prescription Items,48033.00
2016/17,Bassetlaw CCG,02Q,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),224007.41
2016/17,Bassetlaw CCG,02Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,25305.00
2016/17,Bassetlaw CCG,02Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),944811.43
2016/17,Bassetlaw CCG,02Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,16697.00
2016/17,Bassetlaw CCG,02Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),490027.49
2016/17,Bassetlaw CCG,02Q,Human analogue insulins ,Prescription Items,14622.00
2016/17,Bassetlaw CCG,02Q,Human analogue insulins ,Net Ingredient Cost (£),753105.90
2016/17,Bassetlaw CCG,02Q,Other insulins ,Prescription Items,2677.00
2016/17,Bassetlaw CCG,02Q,Other insulins ,Net Ingredient Cost (£),89203.88
2016/17,Bath and North East Somerset CCG,11E,Total primary care (all BNF),Prescription Items,3883677.00
2016/17,Bath and North East Somerset CCG,11E,Total primary care (all BNF),Net Ingredient Cost (£),26693932.72
2016/17,Bath and North East Somerset CCG,11E,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,154975.00
2016/17,Bath and North East Somerset CCG,11E,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2556788.98
2016/17,Bath and North East Somerset CCG,11E,Insulins (BNF 6.1.1) ,Prescription Items,20311.00
2016/17,Bath and North East Somerset CCG,11E,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1025956.63
2016/17,Bath and North East Somerset CCG,11E,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6749.00
2016/17,Bath and North East Somerset CCG,11E,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),347530.38
2016/17,Bath and North East Somerset CCG,11E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13562.00
2016/17,Bath and North East Somerset CCG,11E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),678426.25
2016/17,Bath and North East Somerset CCG,11E,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,111761.00
2016/17,Bath and North East Somerset CCG,11E,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),880665.86
2016/17,Bath and North East Somerset CCG,11E,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,32282.00
2016/17,Bath and North East Somerset CCG,11E,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),85442.29
2016/17,Bath and North East Somerset CCG,11E,Biguanides (BNF 6.1.2.2) ,Prescription Items,60348.00
2016/17,Bath and North East Somerset CCG,11E,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),208101.79
2016/17,Bath and North East Somerset CCG,11E,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,19131.00
2016/17,Bath and North East Somerset CCG,11E,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),587121.78
2016/17,Bath and North East Somerset CCG,11E,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,21763.00
2016/17,Bath and North East Somerset CCG,11E,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),637490.37
2016/17,Bath and North East Somerset CCG,11E,Human analogue insulins ,Prescription Items,14120.00
2016/17,Bath and North East Somerset CCG,11E,Human analogue insulins ,Net Ingredient Cost (£),815444.06
2016/17,Bath and North East Somerset CCG,11E,Other insulins ,Prescription Items,6191.00
2016/17,Bath and North East Somerset CCG,11E,Other insulins ,Net Ingredient Cost (£),210512.57
2016/17,Bedfordshire CCG,06F,Total primary care (all BNF),Prescription Items,8021891.00
2016/17,Bedfordshire CCG,06F,Total primary care (all BNF),Net Ingredient Cost (£),62607576.09
2016/17,Bedfordshire CCG,06F,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,386397.00
2016/17,Bedfordshire CCG,06F,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),7029144.77
2016/17,Bedfordshire CCG,06F,Insulins (BNF 6.1.1) ,Prescription Items,52269.00
2016/17,Bedfordshire CCG,06F,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2316325.39
2016/17,Bedfordshire CCG,06F,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,16561.00
2016/17,Bedfordshire CCG,06F,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),754870.59
2016/17,Bedfordshire CCG,06F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,35708.00
2016/17,Bedfordshire CCG,06F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1561454.80
2016/17,Bedfordshire CCG,06F,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,274797.00
2016/17,Bedfordshire CCG,06F,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3166743.21
2016/17,Bedfordshire CCG,06F,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,74507.00
2016/17,Bedfordshire CCG,06F,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),282369.60
2016/17,Bedfordshire CCG,06F,Biguanides (BNF 6.1.2.2) ,Prescription Items,147204.00
2016/17,Bedfordshire CCG,06F,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),659328.70
2016/17,Bedfordshire CCG,06F,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,53086.00
2016/17,Bedfordshire CCG,06F,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2225044.91
2016/17,Bedfordshire CCG,06F,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,57758.00
2016/17,Bedfordshire CCG,06F,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1527169.98
2016/17,Bedfordshire CCG,06F,Human analogue insulins ,Prescription Items,37113.00
2016/17,Bedfordshire CCG,06F,Human analogue insulins ,Net Ingredient Cost (£),1855986.82
2016/17,Bedfordshire CCG,06F,Other insulins ,Prescription Items,15156.00
2016/17,Bedfordshire CCG,06F,Other insulins ,Net Ingredient Cost (£),460338.57
2016/17,Bexley CCG,07N,Total primary care (all BNF),Prescription Items,3800797.00
2016/17,Bexley CCG,07N,Total primary care (all BNF),Net Ingredient Cost (£),33489083.29
2016/17,Bexley CCG,07N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,195824.00
2016/17,Bexley CCG,07N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3992014.88
2016/17,Bexley CCG,07N,Insulins (BNF 6.1.1) ,Prescription Items,27807.00
2016/17,Bexley CCG,07N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1348590.34
2016/17,Bexley CCG,07N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9735.00
2016/17,Bexley CCG,07N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),452319.24
2016/17,Bexley CCG,07N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,18072.00
2016/17,Bexley CCG,07N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),896271.10
2016/17,Bexley CCG,07N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,140560.00
2016/17,Bexley CCG,07N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1920457.78
2016/17,Bexley CCG,07N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,32805.00
2016/17,Bexley CCG,07N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),97008.68
2016/17,Bexley CCG,07N,Biguanides (BNF 6.1.2.2) ,Prescription Items,79272.00
2016/17,Bexley CCG,07N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),504851.64
2016/17,Bexley CCG,07N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,28483.00
2016/17,Bexley CCG,07N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1318597.46
2016/17,Bexley CCG,07N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,26564.00
2016/17,Bexley CCG,07N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),712948.90
2016/17,Bexley CCG,07N,Human analogue insulins ,Prescription Items,22751.00
2016/17,Bexley CCG,07N,Human analogue insulins ,Net Ingredient Cost (£),1195432.12
2016/17,Bexley CCG,07N,Other insulins ,Prescription Items,5056.00
2016/17,Bexley CCG,07N,Other insulins ,Net Ingredient Cost (£),153158.22
2016/17,Birmingham Crosscity CCG,13P,Total primary care (all BNF),Prescription Items,12185248.00
2016/17,Birmingham Crosscity CCG,13P,Total primary care (all BNF),Net Ingredient Cost (£),114225971.37
2016/17,Birmingham Crosscity CCG,13P,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,654757.00
2016/17,Birmingham Crosscity CCG,13P,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),15533590.99
2016/17,Birmingham Crosscity CCG,13P,Insulins (BNF 6.1.1) ,Prescription Items,99047.00
2016/17,Birmingham Crosscity CCG,13P,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),5461037.38
2016/17,Birmingham Crosscity CCG,13P,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,27775.00
2016/17,Birmingham Crosscity CCG,13P,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1363827.98
2016/17,Birmingham Crosscity CCG,13P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,71272.00
2016/17,Birmingham Crosscity CCG,13P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),4097209.40
2016/17,Birmingham Crosscity CCG,13P,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,455976.00
2016/17,Birmingham Crosscity CCG,13P,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),7559052.34
2016/17,Birmingham Crosscity CCG,13P,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,80398.00
2016/17,Birmingham Crosscity CCG,13P,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),361307.46
2016/17,Birmingham Crosscity CCG,13P,Biguanides (BNF 6.1.2.2) ,Prescription Items,250178.00
2016/17,Birmingham Crosscity CCG,13P,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),1372933.62
2016/17,Birmingham Crosscity CCG,13P,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,125400.00
2016/17,Birmingham Crosscity CCG,13P,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),5824811.26
2016/17,Birmingham Crosscity CCG,13P,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,95958.00
2016/17,Birmingham Crosscity CCG,13P,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),2467909.13
2016/17,Birmingham Crosscity CCG,13P,Human analogue insulins ,Prescription Items,89023.00
2016/17,Birmingham Crosscity CCG,13P,Human analogue insulins ,Net Ingredient Cost (£),5099832.94
2016/17,Birmingham Crosscity CCG,13P,Other insulins ,Prescription Items,10024.00
2016/17,Birmingham Crosscity CCG,13P,Other insulins ,Net Ingredient Cost (£),361204.44
2016/17,Birmingham South and Central CCG,04X,Total primary care (all BNF),Prescription Items,4786284.00
2016/17,Birmingham South and Central CCG,04X,Total primary care (all BNF),Net Ingredient Cost (£),42423488.41
2016/17,Birmingham South and Central CCG,04X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,272867.00
2016/17,Birmingham South and Central CCG,04X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6284221.28
2016/17,Birmingham South and Central CCG,04X,Insulins (BNF 6.1.1) ,Prescription Items,40917.00
2016/17,Birmingham South and Central CCG,04X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2337882.81
2016/17,Birmingham South and Central CCG,04X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10810.00
2016/17,Birmingham South and Central CCG,04X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),579125.46
2016/17,Birmingham South and Central CCG,04X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,30107.00
2016/17,Birmingham South and Central CCG,04X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1758757.35
2016/17,Birmingham South and Central CCG,04X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,191323.00
2016/17,Birmingham South and Central CCG,04X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2965240.31
2016/17,Birmingham South and Central CCG,04X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,37950.00
2016/17,Birmingham South and Central CCG,04X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),174672.58
2016/17,Birmingham South and Central CCG,04X,Biguanides (BNF 6.1.2.2) ,Prescription Items,107389.00
2016/17,Birmingham South and Central CCG,04X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),570670.36
2016/17,Birmingham South and Central CCG,04X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,45984.00
2016/17,Birmingham South and Central CCG,04X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2219897.37
2016/17,Birmingham South and Central CCG,04X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,39497.00
2016/17,Birmingham South and Central CCG,04X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),967531.16
2016/17,Birmingham South and Central CCG,04X,Human analogue insulins ,Prescription Items,35925.00
2016/17,Birmingham South and Central CCG,04X,Human analogue insulins ,Net Ingredient Cost (£),2152750.66
2016/17,Birmingham South and Central CCG,04X,Other insulins ,Prescription Items,4992.00
2016/17,Birmingham South and Central CCG,04X,Other insulins ,Net Ingredient Cost (£),185132.15
2016/17,Blackburn With Darwen CCG,00Q,Total primary care (all BNF),Prescription Items,3631160.00
2016/17,Blackburn With Darwen CCG,00Q,Total primary care (all BNF),Net Ingredient Cost (£),28608496.73
2016/17,Blackburn With Darwen CCG,00Q,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,195349.00
2016/17,Blackburn With Darwen CCG,00Q,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3418380.94
2016/17,Blackburn With Darwen CCG,00Q,Insulins (BNF 6.1.1) ,Prescription Items,22884.00
2016/17,Blackburn With Darwen CCG,00Q,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1035136.93
2016/17,Blackburn With Darwen CCG,00Q,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6388.00
2016/17,Blackburn With Darwen CCG,00Q,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),262176.59
2016/17,Blackburn With Darwen CCG,00Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,16496.00
2016/17,Blackburn With Darwen CCG,00Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),772960.34
2016/17,Blackburn With Darwen CCG,00Q,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,149338.00
2016/17,Blackburn With Darwen CCG,00Q,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1774851.12
2016/17,Blackburn With Darwen CCG,00Q,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,30368.00
2016/17,Blackburn With Darwen CCG,00Q,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),86571.30
2016/17,Blackburn With Darwen CCG,00Q,Biguanides (BNF 6.1.2.2) ,Prescription Items,82931.00
2016/17,Blackburn With Darwen CCG,00Q,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),322710.77
2016/17,Blackburn With Darwen CCG,00Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,36039.00
2016/17,Blackburn With Darwen CCG,00Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1365569.05
2016/17,Blackburn With Darwen CCG,00Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,22302.00
2016/17,Blackburn With Darwen CCG,00Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),589794.77
2016/17,Blackburn With Darwen CCG,00Q,Human analogue insulins ,Prescription Items,17663.00
2016/17,Blackburn With Darwen CCG,00Q,Human analogue insulins ,Net Ingredient Cost (£),857423.09
2016/17,Blackburn With Darwen CCG,00Q,Other insulins ,Prescription Items,5221.00
2016/17,Blackburn With Darwen CCG,00Q,Other insulins ,Net Ingredient Cost (£),177713.84
2016/17,Blackpool CCG,00R,Total primary care (all BNF),Prescription Items,4832929.00
2016/17,Blackpool CCG,00R,Total primary care (all BNF),Net Ingredient Cost (£),34863157.31
2016/17,Blackpool CCG,00R,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,207990.00
2016/17,Blackpool CCG,00R,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3834399.12
2016/17,Blackpool CCG,00R,Insulins (BNF 6.1.1) ,Prescription Items,28220.00
2016/17,Blackpool CCG,00R,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1295105.58
2016/17,Blackpool CCG,00R,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7593.00
2016/17,Blackpool CCG,00R,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),307832.11
2016/17,Blackpool CCG,00R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,20627.00
2016/17,Blackpool CCG,00R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),987273.47
2016/17,Blackpool CCG,00R,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,154888.00
2016/17,Blackpool CCG,00R,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1903943.12
2016/17,Blackpool CCG,00R,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,30159.00
2016/17,Blackpool CCG,00R,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),83360.04
2016/17,Blackpool CCG,00R,Biguanides (BNF 6.1.2.2) ,Prescription Items,86055.00
2016/17,Blackpool CCG,00R,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),330050.54
2016/17,Blackpool CCG,00R,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,38674.00
2016/17,Blackpool CCG,00R,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1490532.54
2016/17,Blackpool CCG,00R,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,23949.00
2016/17,Blackpool CCG,00R,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),620720.06
2016/17,Blackpool CCG,00R,Human analogue insulins ,Prescription Items,24184.00
2016/17,Blackpool CCG,00R,Human analogue insulins ,Net Ingredient Cost (£),1168672.72
2016/17,Blackpool CCG,00R,Other insulins ,Prescription Items,4036.00
2016/17,Blackpool CCG,00R,Other insulins ,Net Ingredient Cost (£),126432.86
2016/17,Bolton CCG,00T,Total primary care (all BNF),Prescription Items,6122816.00
2016/17,Bolton CCG,00T,Total primary care (all BNF),Net Ingredient Cost (£),53943260.97
2016/17,Bolton CCG,00T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,303151.00
2016/17,Bolton CCG,00T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5750788.91
2016/17,Bolton CCG,00T,Insulins (BNF 6.1.1) ,Prescription Items,36035.00
2016/17,Bolton CCG,00T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1818192.25
2016/17,Bolton CCG,00T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10800.00
2016/17,Bolton CCG,00T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),495365.70
2016/17,Bolton CCG,00T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,25235.00
2016/17,Bolton CCG,00T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1322826.55
2016/17,Bolton CCG,00T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,231423.00
2016/17,Bolton CCG,00T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3135081.61
2016/17,Bolton CCG,00T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,50793.00
2016/17,Bolton CCG,00T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),110016.62
2016/17,Bolton CCG,00T,Biguanides (BNF 6.1.2.2) ,Prescription Items,118987.00
2016/17,Bolton CCG,00T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),576447.75
2016/17,Bolton CCG,00T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,61643.00
2016/17,Bolton CCG,00T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2448617.24
2016/17,Bolton CCG,00T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,34390.00
2016/17,Bolton CCG,00T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),780327.05
2016/17,Bolton CCG,00T,Human analogue insulins ,Prescription Items,32458.00
2016/17,Bolton CCG,00T,Human analogue insulins ,Net Ingredient Cost (£),1707868.78
2016/17,Bolton CCG,00T,Other insulins ,Prescription Items,3577.00
2016/17,Bolton CCG,00T,Other insulins ,Net Ingredient Cost (£),110323.47
2016/17,Bracknell and Ascot CCG,10G,Total primary care (all BNF),Prescription Items,1691418.00
2016/17,Bracknell and Ascot CCG,10G,Total primary care (all BNF),Net Ingredient Cost (£),16024991.30
2016/17,Bracknell and Ascot CCG,10G,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,85403.00
2016/17,Bracknell and Ascot CCG,10G,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2096342.10
2016/17,Bracknell and Ascot CCG,10G,Insulins (BNF 6.1.1) ,Prescription Items,14455.00
2016/17,Bracknell and Ascot CCG,10G,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),742599.49
2016/17,Bracknell and Ascot CCG,10G,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5132.00
2016/17,Bracknell and Ascot CCG,10G,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),251048.95
2016/17,Bracknell and Ascot CCG,10G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,9323.00
2016/17,Bracknell and Ascot CCG,10G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),491550.54
2016/17,Bracknell and Ascot CCG,10G,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,56480.00
2016/17,Bracknell and Ascot CCG,10G,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),969579.82
2016/17,Bracknell and Ascot CCG,10G,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,12792.00
2016/17,Bracknell and Ascot CCG,10G,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),68627.65
2016/17,Bracknell and Ascot CCG,10G,Biguanides (BNF 6.1.2.2) ,Prescription Items,29941.00
2016/17,Bracknell and Ascot CCG,10G,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),178907.93
2016/17,Bracknell and Ascot CCG,10G,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,13747.00
2016/17,Bracknell and Ascot CCG,10G,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),722044.24
2016/17,Bracknell and Ascot CCG,10G,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,13966.00
2016/17,Bracknell and Ascot CCG,10G,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),372293.57
2016/17,Bracknell and Ascot CCG,10G,Human analogue insulins ,Prescription Items,11907.00
2016/17,Bracknell and Ascot CCG,10G,Human analogue insulins ,Net Ingredient Cost (£),656292.42
2016/17,Bracknell and Ascot CCG,10G,Other insulins ,Prescription Items,2548.00
2016/17,Bracknell and Ascot CCG,10G,Other insulins ,Net Ingredient Cost (£),86307.07
2016/17,Bradford City CCG,02W,Total primary care (all BNF),Prescription Items,2332040.00
2016/17,Bradford City CCG,02W,Total primary care (all BNF),Net Ingredient Cost (£),18285619.64
2016/17,Bradford City CCG,02W,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,210831.00
2016/17,Bradford City CCG,02W,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2887531.22
2016/17,Bradford City CCG,02W,Insulins (BNF 6.1.1) ,Prescription Items,18003.00
2016/17,Bradford City CCG,02W,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),992441.40
2016/17,Bradford City CCG,02W,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,2199.00
2016/17,Bradford City CCG,02W,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),120573.40
2016/17,Bradford City CCG,02W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15804.00
2016/17,Bradford City CCG,02W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),871868.00
2016/17,Bradford City CCG,02W,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,167636.00
2016/17,Bradford City CCG,02W,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1409753.72
2016/17,Bradford City CCG,02W,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,46065.00
2016/17,Bradford City CCG,02W,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),59111.88
2016/17,Bradford City CCG,02W,Biguanides (BNF 6.1.2.2) ,Prescription Items,83519.00
2016/17,Bradford City CCG,02W,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),367764.67
2016/17,Bradford City CCG,02W,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,38052.00
2016/17,Bradford City CCG,02W,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),982877.17
2016/17,Bradford City CCG,02W,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,24740.00
2016/17,Bradford City CCG,02W,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),480853.49
2016/17,Bradford City CCG,02W,Human analogue insulins ,Prescription Items,12335.00
2016/17,Bradford City CCG,02W,Human analogue insulins ,Net Ingredient Cost (£),811627.83
2016/17,Bradford City CCG,02W,Other insulins ,Prescription Items,5668.00
2016/17,Bradford City CCG,02W,Other insulins ,Net Ingredient Cost (£),180813.57
2016/17,Bradford Districts CCG,02R,Total primary care (all BNF),Prescription Items,7163311.00
2016/17,Bradford Districts CCG,02R,Total primary care (all BNF),Net Ingredient Cost (£),58584567.89
2016/17,Bradford Districts CCG,02R,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,361483.00
2016/17,Bradford Districts CCG,02R,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5625118.64
2016/17,Bradford Districts CCG,02R,Insulins (BNF 6.1.1) ,Prescription Items,40763.00
2016/17,Bradford Districts CCG,02R,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2061077.95
2016/17,Bradford Districts CCG,02R,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9842.00
2016/17,Bradford Districts CCG,02R,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),498545.94
2016/17,Bradford Districts CCG,02R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,30921.00
2016/17,Bradford Districts CCG,02R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1562532.01
2016/17,Bradford Districts CCG,02R,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,270291.00
2016/17,Bradford Districts CCG,02R,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2316657.10
2016/17,Bradford Districts CCG,02R,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,78235.00
2016/17,Bradford Districts CCG,02R,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),99816.22
2016/17,Bradford Districts CCG,02R,Biguanides (BNF 6.1.2.2) ,Prescription Items,138335.00
2016/17,Bradford Districts CCG,02R,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),686749.31
2016/17,Bradford Districts CCG,02R,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,53721.00
2016/17,Bradford Districts CCG,02R,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1530091.57
2016/17,Bradford Districts CCG,02R,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,48888.00
2016/17,Bradford Districts CCG,02R,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1222876.19
2016/17,Bradford Districts CCG,02R,Human analogue insulins ,Prescription Items,30506.00
2016/17,Bradford Districts CCG,02R,Human analogue insulins ,Net Ingredient Cost (£),1742253.29
2016/17,Bradford Districts CCG,02R,Other insulins ,Prescription Items,10257.00
2016/17,Bradford Districts CCG,02R,Other insulins ,Net Ingredient Cost (£),318824.66
2016/17,Brent CCG,07P,Total primary care (all BNF),Prescription Items,5086726.00
2016/17,Brent CCG,07P,Total primary care (all BNF),Net Ingredient Cost (£),38843243.55
2016/17,Brent CCG,07P,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,394265.00
2016/17,Brent CCG,07P,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6153390.51
2016/17,Brent CCG,07P,Insulins (BNF 6.1.1) ,Prescription Items,35568.00
2016/17,Brent CCG,07P,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1724835.29
2016/17,Brent CCG,07P,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8240.00
2016/17,Brent CCG,07P,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),404325.71
2016/17,Brent CCG,07P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,27328.00
2016/17,Brent CCG,07P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1320509.58
2016/17,Brent CCG,07P,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,315509.00
2016/17,Brent CCG,07P,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3561753.63
2016/17,Brent CCG,07P,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,85113.00
2016/17,Brent CCG,07P,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),272786.99
2016/17,Brent CCG,07P,Biguanides (BNF 6.1.2.2) ,Prescription Items,167153.00
2016/17,Brent CCG,07P,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),780728.96
2016/17,Brent CCG,07P,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,63243.00
2016/17,Brent CCG,07P,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2508237.68
2016/17,Brent CCG,07P,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,41997.00
2016/17,Brent CCG,07P,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),838902.47
2016/17,Brent CCG,07P,Human analogue insulins ,Prescription Items,24860.00
2016/17,Brent CCG,07P,Human analogue insulins ,Net Ingredient Cost (£),1368947.96
2016/17,Brent CCG,07P,Other insulins ,Prescription Items,10708.00
2016/17,Brent CCG,07P,Other insulins ,Net Ingredient Cost (£),355887.33
2016/17,Brighton & Hove CCG,09D,Total primary care (all BNF),Prescription Items,4730090.00
2016/17,Brighton & Hove CCG,09D,Total primary care (all BNF),Net Ingredient Cost (£),38967716.54
2016/17,Brighton & Hove CCG,09D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,183763.00
2016/17,Brighton & Hove CCG,09D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3516963.75
2016/17,Brighton & Hove CCG,09D,Insulins (BNF 6.1.1) ,Prescription Items,28126.00
2016/17,Brighton & Hove CCG,09D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1602119.76
2016/17,Brighton & Hove CCG,09D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9756.00
2016/17,Brighton & Hove CCG,09D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),486413.42
2016/17,Brighton & Hove CCG,09D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,18370.00
2016/17,Brighton & Hove CCG,09D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1115706.34
2016/17,Brighton & Hove CCG,09D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,128955.00
2016/17,Brighton & Hove CCG,09D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1054082.37
2016/17,Brighton & Hove CCG,09D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,40291.00
2016/17,Brighton & Hove CCG,09D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),104116.84
2016/17,Brighton & Hove CCG,09D,Biguanides (BNF 6.1.2.2) ,Prescription Items,69910.00
2016/17,Brighton & Hove CCG,09D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),299051.60
2016/17,Brighton & Hove CCG,09D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,18754.00
2016/17,Brighton & Hove CCG,09D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),650913.93
2016/17,Brighton & Hove CCG,09D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,25583.00
2016/17,Brighton & Hove CCG,09D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),826965.34
2016/17,Brighton & Hove CCG,09D,Human analogue insulins ,Prescription Items,24862.00
2016/17,Brighton & Hove CCG,09D,Human analogue insulins ,Net Ingredient Cost (£),1481000.98
2016/17,Brighton & Hove CCG,09D,Other insulins ,Prescription Items,3264.00
2016/17,Brighton & Hove CCG,09D,Other insulins ,Net Ingredient Cost (£),121118.78
2016/17,Bristol CCG,11H,Total primary care (all BNF),Prescription Items,8468502.00
2016/17,Bristol CCG,11H,Total primary care (all BNF),Net Ingredient Cost (£),62009080.88
2016/17,Bristol CCG,11H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,398002.00
2016/17,Bristol CCG,11H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),7255533.11
2016/17,Bristol CCG,11H,Insulins (BNF 6.1.1) ,Prescription Items,47025.00
2016/17,Bristol CCG,11H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2545614.48
2016/17,Bristol CCG,11H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,13843.00
2016/17,Bristol CCG,11H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),719519.54
2016/17,Bristol CCG,11H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,33182.00
2016/17,Bristol CCG,11H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1826094.94
2016/17,Bristol CCG,11H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,299499.00
2016/17,Bristol CCG,11H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3110366.99
2016/17,Bristol CCG,11H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,73568.00
2016/17,Bristol CCG,11H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),204666.71
2016/17,Bristol CCG,11H,Biguanides (BNF 6.1.2.2) ,Prescription Items,159796.00
2016/17,Bristol CCG,11H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),545135.21
2016/17,Bristol CCG,11H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,66135.00
2016/17,Bristol CCG,11H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2360565.07
2016/17,Bristol CCG,11H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,49035.00
2016/17,Bristol CCG,11H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1568052.43
2016/17,Bristol CCG,11H,Human analogue insulins ,Prescription Items,33262.00
2016/17,Bristol CCG,11H,Human analogue insulins ,Net Ingredient Cost (£),2000270.49
2016/17,Bristol CCG,11H,Other insulins ,Prescription Items,13763.00
2016/17,Bristol CCG,11H,Other insulins ,Net Ingredient Cost (£),545343.99
2016/17,Bromley CCG,07Q,Total primary care (all BNF),Prescription Items,4227811.00
2016/17,Bromley CCG,07Q,Total primary care (all BNF),Net Ingredient Cost (£),46750522.18
2016/17,Bromley CCG,07Q,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,179383.00
2016/17,Bromley CCG,07Q,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4612382.76
2016/17,Bromley CCG,07Q,Insulins (BNF 6.1.1) ,Prescription Items,31880.00
2016/17,Bromley CCG,07Q,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1805098.50
2016/17,Bromley CCG,07Q,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11879.00
2016/17,Bromley CCG,07Q,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),640395.81
2016/17,Bromley CCG,07Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,20001.00
2016/17,Bromley CCG,07Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1164702.69
2016/17,Bromley CCG,07Q,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,115425.00
2016/17,Bromley CCG,07Q,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1781661.00
2016/17,Bromley CCG,07Q,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,26752.00
2016/17,Bromley CCG,07Q,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),128702.49
2016/17,Bromley CCG,07Q,Biguanides (BNF 6.1.2.2) ,Prescription Items,67530.00
2016/17,Bromley CCG,07Q,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),457281.39
2016/17,Bromley CCG,07Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,21143.00
2016/17,Bromley CCG,07Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1195677.12
2016/17,Bromley CCG,07Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,31182.00
2016/17,Bromley CCG,07Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1013246.49
2016/17,Bromley CCG,07Q,Human analogue insulins ,Prescription Items,27961.00
2016/17,Bromley CCG,07Q,Human analogue insulins ,Net Ingredient Cost (£),1669958.30
2016/17,Bromley CCG,07Q,Other insulins ,Prescription Items,3919.00
2016/17,Bromley CCG,07Q,Other insulins ,Net Ingredient Cost (£),135140.20
2016/17,Bury CCG,00V,Total primary care (all BNF),Prescription Items,3775899.00
2016/17,Bury CCG,00V,Total primary care (all BNF),Net Ingredient Cost (£),32634582.10
2016/17,Bury CCG,00V,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,176114.00
2016/17,Bury CCG,00V,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3187835.87
2016/17,Bury CCG,00V,Insulins (BNF 6.1.1) ,Prescription Items,24305.00
2016/17,Bury CCG,00V,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),974467.21
2016/17,Bury CCG,00V,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8739.00
2016/17,Bury CCG,00V,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),332720.16
2016/17,Bury CCG,00V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15566.00
2016/17,Bury CCG,00V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),641747.05
2016/17,Bury CCG,00V,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,127381.00
2016/17,Bury CCG,00V,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1656011.59
2016/17,Bury CCG,00V,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,26825.00
2016/17,Bury CCG,00V,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),74882.59
2016/17,Bury CCG,00V,Biguanides (BNF 6.1.2.2) ,Prescription Items,71295.00
2016/17,Bury CCG,00V,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),368878.71
2016/17,Bury CCG,00V,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,29261.00
2016/17,Bury CCG,00V,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1212250.29
2016/17,Bury CCG,00V,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,23235.00
2016/17,Bury CCG,00V,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),538813.39
2016/17,Bury CCG,00V,Human analogue insulins ,Prescription Items,18630.00
2016/17,Bury CCG,00V,Human analogue insulins ,Net Ingredient Cost (£),828751.71
2016/17,Bury CCG,00V,Other insulins ,Prescription Items,5675.00
2016/17,Bury CCG,00V,Other insulins ,Net Ingredient Cost (£),145715.50
2016/17,Calderdale CCG,02T,Total primary care (all BNF),Prescription Items,4747334.00
2016/17,Calderdale CCG,02T,Total primary care (all BNF),Net Ingredient Cost (£),38822837.40
2016/17,Calderdale CCG,02T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,215616.00
2016/17,Calderdale CCG,02T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3870719.13
2016/17,Calderdale CCG,02T,Insulins (BNF 6.1.1) ,Prescription Items,25645.00
2016/17,Calderdale CCG,02T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1269741.05
2016/17,Calderdale CCG,02T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8215.00
2016/17,Calderdale CCG,02T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),376354.34
2016/17,Calderdale CCG,02T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,17430.00
2016/17,Calderdale CCG,02T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),893386.71
2016/17,Calderdale CCG,02T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,160869.00
2016/17,Calderdale CCG,02T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1836251.89
2016/17,Calderdale CCG,02T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,33504.00
2016/17,Calderdale CCG,02T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),61408.76
2016/17,Calderdale CCG,02T,Biguanides (BNF 6.1.2.2) ,Prescription Items,85942.00
2016/17,Calderdale CCG,02T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),356860.73
2016/17,Calderdale CCG,02T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,41423.00
2016/17,Calderdale CCG,02T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1417982.40
2016/17,Calderdale CCG,02T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,26998.00
2016/17,Calderdale CCG,02T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),744568.46
2016/17,Calderdale CCG,02T,Human analogue insulins ,Prescription Items,20963.00
2016/17,Calderdale CCG,02T,Human analogue insulins ,Net Ingredient Cost (£),1117668.34
2016/17,Calderdale CCG,02T,Other insulins ,Prescription Items,4682.00
2016/17,Calderdale CCG,02T,Other insulins ,Net Ingredient Cost (£),152072.71
2016/17,Cambridgeshire and Peterborough CCG,06H,Total primary care (all BNF),Prescription Items,16987142.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Total primary care (all BNF),Net Ingredient Cost (£),124758532.64
2016/17,Cambridgeshire and Peterborough CCG,06H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,822351.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),13657502.30
2016/17,Cambridgeshire and Peterborough CCG,06H,Insulins (BNF 6.1.1) ,Prescription Items,113387.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),4777058.29
2016/17,Cambridgeshire and Peterborough CCG,06H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,45878.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1907871.23
2016/17,Cambridgeshire and Peterborough CCG,06H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,67509.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2869187.06
2016/17,Cambridgeshire and Peterborough CCG,06H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,585020.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),5909357.68
2016/17,Cambridgeshire and Peterborough CCG,06H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,132109.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),441480.90
2016/17,Cambridgeshire and Peterborough CCG,06H,Biguanides (BNF 6.1.2.2) ,Prescription Items,335198.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),1334851.49
2016/17,Cambridgeshire and Peterborough CCG,06H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,117713.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),4133025.29
2016/17,Cambridgeshire and Peterborough CCG,06H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,116778.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),2896368.74
2016/17,Cambridgeshire and Peterborough CCG,06H,Human analogue insulins ,Prescription Items,95848.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Human analogue insulins ,Net Ingredient Cost (£),4305119.43
2016/17,Cambridgeshire and Peterborough CCG,06H,Other insulins ,Prescription Items,17539.00
2016/17,Cambridgeshire and Peterborough CCG,06H,Other insulins ,Net Ingredient Cost (£),471938.86
2016/17,Camden CCG,07R,Total primary care (all BNF),Prescription Items,2553502.00
2016/17,Camden CCG,07R,Total primary care (all BNF),Net Ingredient Cost (£),25163528.47
2016/17,Camden CCG,07R,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,119411.00
2016/17,Camden CCG,07R,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2672407.54
2016/17,Camden CCG,07R,Insulins (BNF 6.1.1) ,Prescription Items,15723.00
2016/17,Camden CCG,07R,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),846519.45
2016/17,Camden CCG,07R,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5052.00
2016/17,Camden CCG,07R,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),254067.14
2016/17,Camden CCG,07R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,10671.00
2016/17,Camden CCG,07R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),592452.31
2016/17,Camden CCG,07R,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,85691.00
2016/17,Camden CCG,07R,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1267586.74
2016/17,Camden CCG,07R,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,21440.00
2016/17,Camden CCG,07R,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),98056.95
2016/17,Camden CCG,07R,Biguanides (BNF 6.1.2.2) ,Prescription Items,47639.00
2016/17,Camden CCG,07R,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),264749.30
2016/17,Camden CCG,07R,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,16612.00
2016/17,Camden CCG,07R,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),904780.49
2016/17,Camden CCG,07R,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,17379.00
2016/17,Camden CCG,07R,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),549146.75
2016/17,Camden CCG,07R,Human analogue insulins ,Prescription Items,13145.00
2016/17,Camden CCG,07R,Human analogue insulins ,Net Ingredient Cost (£),758750.70
2016/17,Camden CCG,07R,Other insulins ,Prescription Items,2578.00
2016/17,Camden CCG,07R,Other insulins ,Net Ingredient Cost (£),87768.75
2016/17,Cannock Chase CCG,04Y,Total primary care (all BNF),Prescription Items,2725534.00
2016/17,Cannock Chase CCG,04Y,Total primary care (all BNF),Net Ingredient Cost (£),24326259.30
2016/17,Cannock Chase CCG,04Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,138463.00
2016/17,Cannock Chase CCG,04Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3001897.68
2016/17,Cannock Chase CCG,04Y,Insulins (BNF 6.1.1) ,Prescription Items,22558.00
2016/17,Cannock Chase CCG,04Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1132892.30
2016/17,Cannock Chase CCG,04Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6838.00
2016/17,Cannock Chase CCG,04Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),296317.24
2016/17,Cannock Chase CCG,04Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15720.00
2016/17,Cannock Chase CCG,04Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),836575.06
2016/17,Cannock Chase CCG,04Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,95587.00
2016/17,Cannock Chase CCG,04Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1462144.45
2016/17,Cannock Chase CCG,04Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,16430.00
2016/17,Cannock Chase CCG,04Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),54480.72
2016/17,Cannock Chase CCG,04Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,53894.00
2016/17,Cannock Chase CCG,04Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),315760.77
2016/17,Cannock Chase CCG,04Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,25263.00
2016/17,Cannock Chase CCG,04Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1091902.96
2016/17,Cannock Chase CCG,04Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,19592.00
2016/17,Cannock Chase CCG,04Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),399084.14
2016/17,Cannock Chase CCG,04Y,Human analogue insulins ,Prescription Items,18319.00
2016/17,Cannock Chase CCG,04Y,Human analogue insulins ,Net Ingredient Cost (£),963608.69
2016/17,Cannock Chase CCG,04Y,Other insulins ,Prescription Items,4239.00
2016/17,Cannock Chase CCG,04Y,Other insulins ,Net Ingredient Cost (£),169283.61
2016/17,Canterbury and Coastal CCG,09E,Total primary care (all BNF),Prescription Items,3712818.00
2016/17,Canterbury and Coastal CCG,09E,Total primary care (all BNF),Net Ingredient Cost (£),34334721.45
2016/17,Canterbury and Coastal CCG,09E,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,164026.00
2016/17,Canterbury and Coastal CCG,09E,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3887717.85
2016/17,Canterbury and Coastal CCG,09E,Insulins (BNF 6.1.1) ,Prescription Items,29122.00
2016/17,Canterbury and Coastal CCG,09E,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1604038.32
2016/17,Canterbury and Coastal CCG,09E,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9792.00
2016/17,Canterbury and Coastal CCG,09E,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),530541.67
2016/17,Canterbury and Coastal CCG,09E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19330.00
2016/17,Canterbury and Coastal CCG,09E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1073496.65
2016/17,Canterbury and Coastal CCG,09E,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,107406.00
2016/17,Canterbury and Coastal CCG,09E,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1542021.67
2016/17,Canterbury and Coastal CCG,09E,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,22706.00
2016/17,Canterbury and Coastal CCG,09E,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),76951.28
2016/17,Canterbury and Coastal CCG,09E,Biguanides (BNF 6.1.2.2) ,Prescription Items,60666.00
2016/17,Canterbury and Coastal CCG,09E,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),371297.04
2016/17,Canterbury and Coastal CCG,09E,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,24034.00
2016/17,Canterbury and Coastal CCG,09E,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1093773.35
2016/17,Canterbury and Coastal CCG,09E,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,25263.00
2016/17,Canterbury and Coastal CCG,09E,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),718859.87
2016/17,Canterbury and Coastal CCG,09E,Human analogue insulins ,Prescription Items,25743.00
2016/17,Canterbury and Coastal CCG,09E,Human analogue insulins ,Net Ingredient Cost (£),1493093.12
2016/17,Canterbury and Coastal CCG,09E,Other insulins ,Prescription Items,3379.00
2016/17,Canterbury and Coastal CCG,09E,Other insulins ,Net Ingredient Cost (£),110945.20
2016/17,Castle Point and Rochford CCG,99F,Total primary care (all BNF),Prescription Items,3333084.00
2016/17,Castle Point and Rochford CCG,99F,Total primary care (all BNF),Net Ingredient Cost (£),30599701.35
2016/17,Castle Point and Rochford CCG,99F,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,157996.00
2016/17,Castle Point and Rochford CCG,99F,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3543345.19
2016/17,Castle Point and Rochford CCG,99F,Insulins (BNF 6.1.1) ,Prescription Items,25487.00
2016/17,Castle Point and Rochford CCG,99F,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1318440.43
2016/17,Castle Point and Rochford CCG,99F,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8094.00
2016/17,Castle Point and Rochford CCG,99F,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),382586.63
2016/17,Castle Point and Rochford CCG,99F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,17393.00
2016/17,Castle Point and Rochford CCG,99F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),935853.80
2016/17,Castle Point and Rochford CCG,99F,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,109080.00
2016/17,Castle Point and Rochford CCG,99F,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1624714.91
2016/17,Castle Point and Rochford CCG,99F,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23949.00
2016/17,Castle Point and Rochford CCG,99F,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),97271.13
2016/17,Castle Point and Rochford CCG,99F,Biguanides (BNF 6.1.2.2) ,Prescription Items,58874.00
2016/17,Castle Point and Rochford CCG,99F,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),337737.52
2016/17,Castle Point and Rochford CCG,99F,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,26257.00
2016/17,Castle Point and Rochford CCG,99F,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1189706.26
2016/17,Castle Point and Rochford CCG,99F,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,22570.00
2016/17,Castle Point and Rochford CCG,99F,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),589480.14
2016/17,Castle Point and Rochford CCG,99F,Human analogue insulins ,Prescription Items,20606.00
2016/17,Castle Point and Rochford CCG,99F,Human analogue insulins ,Net Ingredient Cost (£),1138206.37
2016/17,Castle Point and Rochford CCG,99F,Other insulins ,Prescription Items,4881.00
2016/17,Castle Point and Rochford CCG,99F,Other insulins ,Net Ingredient Cost (£),180234.06
2016/17,Central London (Westminster) CCG,09A,Total primary care (all BNF),Prescription Items,2506394.00
2016/17,Central London (Westminster) CCG,09A,Total primary care (all BNF),Net Ingredient Cost (£),22053400.88
2016/17,Central London (Westminster) CCG,09A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,130396.00
2016/17,Central London (Westminster) CCG,09A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2354603.68
2016/17,Central London (Westminster) CCG,09A,Insulins (BNF 6.1.1) ,Prescription Items,14953.00
2016/17,Central London (Westminster) CCG,09A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),797315.45
2016/17,Central London (Westminster) CCG,09A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,4857.00
2016/17,Central London (Westminster) CCG,09A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),239915.50
2016/17,Central London (Westminster) CCG,09A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,10096.00
2016/17,Central London (Westminster) CCG,09A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),557399.95
2016/17,Central London (Westminster) CCG,09A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,99286.00
2016/17,Central London (Westminster) CCG,09A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1137027.59
2016/17,Central London (Westminster) CCG,09A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,24622.00
2016/17,Central London (Westminster) CCG,09A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),72087.96
2016/17,Central London (Westminster) CCG,09A,Biguanides (BNF 6.1.2.2) ,Prescription Items,54422.00
2016/17,Central London (Westminster) CCG,09A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),240158.26
2016/17,Central London (Westminster) CCG,09A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,20242.00
2016/17,Central London (Westminster) CCG,09A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),824781.37
2016/17,Central London (Westminster) CCG,09A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,15554.00
2016/17,Central London (Westminster) CCG,09A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),410567.53
2016/17,Central London (Westminster) CCG,09A,Human analogue insulins ,Prescription Items,12411.00
2016/17,Central London (Westminster) CCG,09A,Human analogue insulins ,Net Ingredient Cost (£),702382.27
2016/17,Central London (Westminster) CCG,09A,Other insulins ,Prescription Items,2542.00
2016/17,Central London (Westminster) CCG,09A,Other insulins ,Net Ingredient Cost (£),94933.18
2016/17,Central Manchester CCG,00W,Total primary care (all BNF),Prescription Items,3633882.00
2016/17,Central Manchester CCG,00W,Total primary care (all BNF),Net Ingredient Cost (£),29428522.75
2016/17,Central Manchester CCG,00W,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,223734.00
2016/17,Central Manchester CCG,00W,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4211959.79
2016/17,Central Manchester CCG,00W,Insulins (BNF 6.1.1) ,Prescription Items,31325.00
2016/17,Central Manchester CCG,00W,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1353581.95
2016/17,Central Manchester CCG,00W,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9823.00
2016/17,Central Manchester CCG,00W,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),390116.91
2016/17,Central Manchester CCG,00W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21502.00
2016/17,Central Manchester CCG,00W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),963465.04
2016/17,Central Manchester CCG,00W,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,163054.00
2016/17,Central Manchester CCG,00W,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2178311.77
2016/17,Central Manchester CCG,00W,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,30300.00
2016/17,Central Manchester CCG,00W,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),81450.26
2016/17,Central Manchester CCG,00W,Biguanides (BNF 6.1.2.2) ,Prescription Items,86359.00
2016/17,Central Manchester CCG,00W,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),364658.93
2016/17,Central Manchester CCG,00W,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,46395.00
2016/17,Central Manchester CCG,00W,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1732202.58
2016/17,Central Manchester CCG,00W,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,28610.00
2016/17,Central Manchester CCG,00W,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),673021.10
2016/17,Central Manchester CCG,00W,Human analogue insulins ,Prescription Items,28895.00
2016/17,Central Manchester CCG,00W,Human analogue insulins ,Net Ingredient Cost (£),1285488.54
2016/17,Central Manchester CCG,00W,Other insulins ,Prescription Items,2430.00
2016/17,Central Manchester CCG,00W,Other insulins ,Net Ingredient Cost (£),68093.41
2016/17,Chiltern CCG,10H,Total primary care (all BNF),Prescription Items,4706356.00
2016/17,Chiltern CCG,10H,Total primary care (all BNF),Net Ingredient Cost (£),39497155.76
2016/17,Chiltern CCG,10H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,232734.00
2016/17,Chiltern CCG,10H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4819608.04
2016/17,Chiltern CCG,10H,Insulins (BNF 6.1.1) ,Prescription Items,39971.00
2016/17,Chiltern CCG,10H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2131163.26
2016/17,Chiltern CCG,10H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,13709.00
2016/17,Chiltern CCG,10H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),701315.98
2016/17,Chiltern CCG,10H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,26262.00
2016/17,Chiltern CCG,10H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1429847.28
2016/17,Chiltern CCG,10H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,151927.00
2016/17,Chiltern CCG,10H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1576208.71
2016/17,Chiltern CCG,10H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,38558.00
2016/17,Chiltern CCG,10H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),152272.98
2016/17,Chiltern CCG,10H,Biguanides (BNF 6.1.2.2) ,Prescription Items,94429.00
2016/17,Chiltern CCG,10H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),539406.07
2016/17,Chiltern CCG,10H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,18940.00
2016/17,Chiltern CCG,10H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),884529.66
2016/17,Chiltern CCG,10H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,39413.00
2016/17,Chiltern CCG,10H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1054007.86
2016/17,Chiltern CCG,10H,Human analogue insulins ,Prescription Items,34244.00
2016/17,Chiltern CCG,10H,Human analogue insulins ,Net Ingredient Cost (£),1946253.96
2016/17,Chiltern CCG,10H,Other insulins ,Prescription Items,5727.00
2016/17,Chiltern CCG,10H,Other insulins ,Net Ingredient Cost (£),184909.30
2016/17,Chorley and South Ribble CCG,00X,Total primary care (all BNF),Prescription Items,3646363.00
2016/17,Chorley and South Ribble CCG,00X,Total primary care (all BNF),Net Ingredient Cost (£),30368285.38
2016/17,Chorley and South Ribble CCG,00X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,152747.00
2016/17,Chorley and South Ribble CCG,00X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3141017.09
2016/17,Chorley and South Ribble CCG,00X,Insulins (BNF 6.1.1) ,Prescription Items,20355.00
2016/17,Chorley and South Ribble CCG,00X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),999489.67
2016/17,Chorley and South Ribble CCG,00X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6791.00
2016/17,Chorley and South Ribble CCG,00X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),305287.49
2016/17,Chorley and South Ribble CCG,00X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13564.00
2016/17,Chorley and South Ribble CCG,00X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),694202.18
2016/17,Chorley and South Ribble CCG,00X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,111894.00
2016/17,Chorley and South Ribble CCG,00X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1564656.02
2016/17,Chorley and South Ribble CCG,00X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23398.00
2016/17,Chorley and South Ribble CCG,00X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),86607.41
2016/17,Chorley and South Ribble CCG,00X,Biguanides (BNF 6.1.2.2) ,Prescription Items,60054.00
2016/17,Chorley and South Ribble CCG,00X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),313332.09
2016/17,Chorley and South Ribble CCG,00X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,28442.00
2016/17,Chorley and South Ribble CCG,00X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1164716.52
2016/17,Chorley and South Ribble CCG,00X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,19903.00
2016/17,Chorley and South Ribble CCG,00X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),569664.87
2016/17,Chorley and South Ribble CCG,00X,Human analogue insulins ,Prescription Items,17021.00
2016/17,Chorley and South Ribble CCG,00X,Human analogue insulins ,Net Ingredient Cost (£),893871.04
2016/17,Chorley and South Ribble CCG,00X,Other insulins ,Prescription Items,3334.00
2016/17,Chorley and South Ribble CCG,00X,Other insulins ,Net Ingredient Cost (£),105618.63
2016/17,City and Hackney CCG,07T,Total primary care (all BNF),Prescription Items,3254480.00
2016/17,City and Hackney CCG,07T,Total primary care (all BNF),Net Ingredient Cost (£),28887632.90
2016/17,City and Hackney CCG,07T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,209320.00
2016/17,City and Hackney CCG,07T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4169550.59
2016/17,City and Hackney CCG,07T,Insulins (BNF 6.1.1) ,Prescription Items,35091.00
2016/17,City and Hackney CCG,07T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1679646.37
2016/17,City and Hackney CCG,07T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,13788.00
2016/17,City and Hackney CCG,07T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),687594.71
2016/17,City and Hackney CCG,07T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21303.00
2016/17,City and Hackney CCG,07T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),992051.66
2016/17,City and Hackney CCG,07T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,146759.00
2016/17,City and Hackney CCG,07T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1700302.12
2016/17,City and Hackney CCG,07T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,36594.00
2016/17,City and Hackney CCG,07T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),256913.40
2016/17,City and Hackney CCG,07T,Biguanides (BNF 6.1.2.2) ,Prescription Items,86827.00
2016/17,City and Hackney CCG,07T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),432245.28
2016/17,City and Hackney CCG,07T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,23338.00
2016/17,City and Hackney CCG,07T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1011143.44
2016/17,City and Hackney CCG,07T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,26741.00
2016/17,City and Hackney CCG,07T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),779312.88
2016/17,City and Hackney CCG,07T,Human analogue insulins ,Prescription Items,24613.00
2016/17,City and Hackney CCG,07T,Human analogue insulins ,Net Ingredient Cost (£),1368763.13
2016/17,City and Hackney CCG,07T,Other insulins ,Prescription Items,10478.00
2016/17,City and Hackney CCG,07T,Other insulins ,Net Ingredient Cost (£),310883.24
2016/17,Coastal West Sussex CCG,09G,Total primary care (all BNF),Prescription Items,10158836.00
2016/17,Coastal West Sussex CCG,09G,Total primary care (all BNF),Net Ingredient Cost (£),94636692.75
2016/17,Coastal West Sussex CCG,09G,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,419176.00
2016/17,Coastal West Sussex CCG,09G,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),9725539.06
2016/17,Coastal West Sussex CCG,09G,Insulins (BNF 6.1.1) ,Prescription Items,66867.00
2016/17,Coastal West Sussex CCG,09G,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3541785.52
2016/17,Coastal West Sussex CCG,09G,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,17231.00
2016/17,Coastal West Sussex CCG,09G,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),864055.36
2016/17,Coastal West Sussex CCG,09G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,49636.00
2016/17,Coastal West Sussex CCG,09G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2677730.16
2016/17,Coastal West Sussex CCG,09G,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,280139.00
2016/17,Coastal West Sussex CCG,09G,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),4183465.07
2016/17,Coastal West Sussex CCG,09G,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,45957.00
2016/17,Coastal West Sussex CCG,09G,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),194208.55
2016/17,Coastal West Sussex CCG,09G,Biguanides (BNF 6.1.2.2) ,Prescription Items,160746.00
2016/17,Coastal West Sussex CCG,09G,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),949166.13
2016/17,Coastal West Sussex CCG,09G,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,73436.00
2016/17,Coastal West Sussex CCG,09G,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),3040090.39
2016/17,Coastal West Sussex CCG,09G,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,70003.00
2016/17,Coastal West Sussex CCG,09G,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1968557.70
2016/17,Coastal West Sussex CCG,09G,Human analogue insulins ,Prescription Items,49108.00
2016/17,Coastal West Sussex CCG,09G,Human analogue insulins ,Net Ingredient Cost (£),2950361.56
2016/17,Coastal West Sussex CCG,09G,Other insulins ,Prescription Items,17759.00
2016/17,Coastal West Sussex CCG,09G,Other insulins ,Net Ingredient Cost (£),591423.96
2016/17,Corby CCG,03V,Total primary care (all BNF),Prescription Items,1534228.00
2016/17,Corby CCG,03V,Total primary care (all BNF),Net Ingredient Cost (£),10576228.10
2016/17,Corby CCG,03V,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,67578.00
2016/17,Corby CCG,03V,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1109802.27
2016/17,Corby CCG,03V,Insulins (BNF 6.1.1) ,Prescription Items,12338.00
2016/17,Corby CCG,03V,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),497662.81
2016/17,Corby CCG,03V,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,2754.00
2016/17,Corby CCG,03V,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),111967.03
2016/17,Corby CCG,03V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,9584.00
2016/17,Corby CCG,03V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),385695.78
2016/17,Corby CCG,03V,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,42913.00
2016/17,Corby CCG,03V,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),327571.26
2016/17,Corby CCG,03V,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,10161.00
2016/17,Corby CCG,03V,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),25101.52
2016/17,Corby CCG,03V,Biguanides (BNF 6.1.2.2) ,Prescription Items,27336.00
2016/17,Corby CCG,03V,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),102163.49
2016/17,Corby CCG,03V,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,5416.00
2016/17,Corby CCG,03V,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),200306.25
2016/17,Corby CCG,03V,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,11813.00
2016/17,Corby CCG,03V,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),277569.92
2016/17,Corby CCG,03V,Human analogue insulins ,Prescription Items,6034.00
2016/17,Corby CCG,03V,Human analogue insulins ,Net Ingredient Cost (£),280016.91
2016/17,Corby CCG,03V,Other insulins ,Prescription Items,6304.00
2016/17,Corby CCG,03V,Other insulins ,Net Ingredient Cost (£),217645.90
2016/17,Coventry and Rugby CCG,05A,Total primary care (all BNF),Prescription Items,8746046.00
2016/17,Coventry and Rugby CCG,05A,Total primary care (all BNF),Net Ingredient Cost (£),67520431.98
2016/17,Coventry and Rugby CCG,05A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,466365.00
2016/17,Coventry and Rugby CCG,05A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),8505524.00
2016/17,Coventry and Rugby CCG,05A,Insulins (BNF 6.1.1) ,Prescription Items,63921.00
2016/17,Coventry and Rugby CCG,05A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2891684.81
2016/17,Coventry and Rugby CCG,05A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,20369.00
2016/17,Coventry and Rugby CCG,05A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),824328.45
2016/17,Coventry and Rugby CCG,05A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,43552.00
2016/17,Coventry and Rugby CCG,05A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2067356.36
2016/17,Coventry and Rugby CCG,05A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,339002.00
2016/17,Coventry and Rugby CCG,05A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3993175.34
2016/17,Coventry and Rugby CCG,05A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,65801.00
2016/17,Coventry and Rugby CCG,05A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),212019.61
2016/17,Coventry and Rugby CCG,05A,Biguanides (BNF 6.1.2.2) ,Prescription Items,193840.00
2016/17,Coventry and Rugby CCG,05A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),652785.32
2016/17,Coventry and Rugby CCG,05A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,79361.00
2016/17,Coventry and Rugby CCG,05A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),3128370.41
2016/17,Coventry and Rugby CCG,05A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,61052.00
2016/17,Coventry and Rugby CCG,05A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1594220.94
2016/17,Coventry and Rugby CCG,05A,Human analogue insulins ,Prescription Items,60989.00
2016/17,Coventry and Rugby CCG,05A,Human analogue insulins ,Net Ingredient Cost (£),2798545.46
2016/17,Coventry and Rugby CCG,05A,Other insulins ,Prescription Items,2932.00
2016/17,Coventry and Rugby CCG,05A,Other insulins ,Net Ingredient Cost (£),93139.35
2016/17,Crawley CCG,09H,Total primary care (all BNF),Prescription Items,2180058.00
2016/17,Crawley CCG,09H,Total primary care (all BNF),Net Ingredient Cost (£),19932253.54
2016/17,Crawley CCG,09H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,114700.00
2016/17,Crawley CCG,09H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2690029.06
2016/17,Crawley CCG,09H,Insulins (BNF 6.1.1) ,Prescription Items,16704.00
2016/17,Crawley CCG,09H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),983921.45
2016/17,Crawley CCG,09H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5580.00
2016/17,Crawley CCG,09H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),269032.84
2016/17,Crawley CCG,09H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,11124.00
2016/17,Crawley CCG,09H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),714888.61
2016/17,Crawley CCG,09H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,79351.00
2016/17,Crawley CCG,09H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1221454.40
2016/17,Crawley CCG,09H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,13122.00
2016/17,Crawley CCG,09H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),44339.10
2016/17,Crawley CCG,09H,Biguanides (BNF 6.1.2.2) ,Prescription Items,44013.00
2016/17,Crawley CCG,09H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),231506.83
2016/17,Crawley CCG,09H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,22216.00
2016/17,Crawley CCG,09H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),945608.47
2016/17,Crawley CCG,09H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,17756.00
2016/17,Crawley CCG,09H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),463906.86
2016/17,Crawley CCG,09H,Human analogue insulins ,Prescription Items,15931.00
2016/17,Crawley CCG,09H,Human analogue insulins ,Net Ingredient Cost (£),954352.87
2016/17,Crawley CCG,09H,Other insulins ,Prescription Items,773.00
2016/17,Crawley CCG,09H,Other insulins ,Net Ingredient Cost (£),29568.58
2016/17,Croydon CCG,07V,Total primary care (all BNF),Prescription Items,5656496.00
2016/17,Croydon CCG,07V,Total primary care (all BNF),Net Ingredient Cost (£),43914637.14
2016/17,Croydon CCG,07V,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,326796.00
2016/17,Croydon CCG,07V,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5868306.31
2016/17,Croydon CCG,07V,Insulins (BNF 6.1.1) ,Prescription Items,43923.00
2016/17,Croydon CCG,07V,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2228425.93
2016/17,Croydon CCG,07V,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,14798.00
2016/17,Croydon CCG,07V,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),695689.20
2016/17,Croydon CCG,07V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,29125.00
2016/17,Croydon CCG,07V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1532736.73
2016/17,Croydon CCG,07V,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,239176.00
2016/17,Croydon CCG,07V,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2649638.30
2016/17,Croydon CCG,07V,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,57342.00
2016/17,Croydon CCG,07V,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),178321.84
2016/17,Croydon CCG,07V,Biguanides (BNF 6.1.2.2) ,Prescription Items,141011.00
2016/17,Croydon CCG,07V,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),684118.03
2016/17,Croydon CCG,07V,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,40823.00
2016/17,Croydon CCG,07V,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1787198.43
2016/17,Croydon CCG,07V,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,42739.00
2016/17,Croydon CCG,07V,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),976782.90
2016/17,Croydon CCG,07V,Human analogue insulins ,Prescription Items,38050.00
2016/17,Croydon CCG,07V,Human analogue insulins ,Net Ingredient Cost (£),2040480.82
2016/17,Croydon CCG,07V,Other insulins ,Prescription Items,5873.00
2016/17,Croydon CCG,07V,Other insulins ,Net Ingredient Cost (£),187945.11
2016/17,Cumbria CCG,01H,Total primary care (all BNF),Prescription Items,12005765.00
2016/17,Cumbria CCG,01H,Total primary care (all BNF),Net Ingredient Cost (£),92100182.34
2016/17,Cumbria CCG,01H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,464283.00
2016/17,Cumbria CCG,01H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),7932739.14
2016/17,Cumbria CCG,01H,Insulins (BNF 6.1.1) ,Prescription Items,78597.00
2016/17,Cumbria CCG,01H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3441107.65
2016/17,Cumbria CCG,01H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,28444.00
2016/17,Cumbria CCG,01H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1262984.01
2016/17,Cumbria CCG,01H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,50153.00
2016/17,Cumbria CCG,01H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2178123.64
2016/17,Cumbria CCG,01H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,307630.00
2016/17,Cumbria CCG,01H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2548088.55
2016/17,Cumbria CCG,01H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,87116.00
2016/17,Cumbria CCG,01H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),272309.11
2016/17,Cumbria CCG,01H,Biguanides (BNF 6.1.2.2) ,Prescription Items,182783.00
2016/17,Cumbria CCG,01H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),764645.73
2016/17,Cumbria CCG,01H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,37731.00
2016/17,Cumbria CCG,01H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1511133.71
2016/17,Cumbria CCG,01H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,74640.00
2016/17,Cumbria CCG,01H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1905075.63
2016/17,Cumbria CCG,01H,Human analogue insulins ,Prescription Items,58421.00
2016/17,Cumbria CCG,01H,Human analogue insulins ,Net Ingredient Cost (£),2828108.82
2016/17,Cumbria CCG,01H,Other insulins ,Prescription Items,20176.00
2016/17,Cumbria CCG,01H,Other insulins ,Net Ingredient Cost (£),612998.83
2016/17,Darlington CCG,00C,Total primary care (all BNF),Prescription Items,2593330.00
2016/17,Darlington CCG,00C,Total primary care (all BNF),Net Ingredient Cost (£),19146927.34
2016/17,Darlington CCG,00C,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,107791.00
2016/17,Darlington CCG,00C,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1782197.89
2016/17,Darlington CCG,00C,Insulins (BNF 6.1.1) ,Prescription Items,14045.00
2016/17,Darlington CCG,00C,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),632742.93
2016/17,Darlington CCG,00C,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,4836.00
2016/17,Darlington CCG,00C,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),210253.63
2016/17,Darlington CCG,00C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,9209.00
2016/17,Darlington CCG,00C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),422489.30
2016/17,Darlington CCG,00C,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,78190.00
2016/17,Darlington CCG,00C,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),799480.99
2016/17,Darlington CCG,00C,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,17638.00
2016/17,Darlington CCG,00C,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),39703.24
2016/17,Darlington CCG,00C,Biguanides (BNF 6.1.2.2) ,Prescription Items,42151.00
2016/17,Darlington CCG,00C,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),166848.81
2016/17,Darlington CCG,00C,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,18401.00
2016/17,Darlington CCG,00C,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),592928.94
2016/17,Darlington CCG,00C,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,14764.00
2016/17,Darlington CCG,00C,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),341440.92
2016/17,Darlington CCG,00C,Human analogue insulins ,Prescription Items,11388.00
2016/17,Darlington CCG,00C,Human analogue insulins ,Net Ingredient Cost (£),559404.13
2016/17,Darlington CCG,00C,Other insulins ,Prescription Items,2657.00
2016/17,Darlington CCG,00C,Other insulins ,Net Ingredient Cost (£),73338.80
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Total primary care (all BNF),Prescription Items,4689066.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Total primary care (all BNF),Net Ingredient Cost (£),41975926.93
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,241092.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5084518.77
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Insulins (BNF 6.1.1) ,Prescription Items,31186.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1620721.25
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11478.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),569320.42
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19708.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1051400.83
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,174257.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2459367.71
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,37149.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),109402.19
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Biguanides (BNF 6.1.2.2) ,Prescription Items,94171.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),526717.22
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,42937.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1823248.30
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,34428.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),990356.37
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Human analogue insulins ,Prescription Items,27811.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Human analogue insulins ,Net Ingredient Cost (£),1505208.85
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Other insulins ,Prescription Items,3375.00
2016/17,"Dartford, Gravesham and Swanley CCG",09J,Other insulins ,Net Ingredient Cost (£),115512.40
2016/17,Doncaster CCG,02X,Total primary care (all BNF),Prescription Items,7766562.00
2016/17,Doncaster CCG,02X,Total primary care (all BNF),Net Ingredient Cost (£),65196255.69
2016/17,Doncaster CCG,02X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,379819.00
2016/17,Doncaster CCG,02X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),7774031.78
2016/17,Doncaster CCG,02X,Insulins (BNF 6.1.1) ,Prescription Items,44008.00
2016/17,Doncaster CCG,02X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2387629.12
2016/17,Doncaster CCG,02X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,13759.00
2016/17,Doncaster CCG,02X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),631944.55
2016/17,Doncaster CCG,02X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,30249.00
2016/17,Doncaster CCG,02X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1755684.57
2016/17,Doncaster CCG,02X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,288527.00
2016/17,Doncaster CCG,02X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),4037776.31
2016/17,Doncaster CCG,02X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,55309.00
2016/17,Doncaster CCG,02X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),209346.03
2016/17,Doncaster CCG,02X,Biguanides (BNF 6.1.2.2) ,Prescription Items,150192.00
2016/17,Doncaster CCG,02X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),742079.46
2016/17,Doncaster CCG,02X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,83026.00
2016/17,Doncaster CCG,02X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),3086350.82
2016/17,Doncaster CCG,02X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,45902.00
2016/17,Doncaster CCG,02X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1332800.02
2016/17,Doncaster CCG,02X,Human analogue insulins ,Prescription Items,40694.00
2016/17,Doncaster CCG,02X,Human analogue insulins ,Net Ingredient Cost (£),2261431.63
2016/17,Doncaster CCG,02X,Other insulins ,Prescription Items,3314.00
2016/17,Doncaster CCG,02X,Other insulins ,Net Ingredient Cost (£),126197.49
2016/17,Dorset CCG,11J,Total primary care (all BNF),Prescription Items,15487163.00
2016/17,Dorset CCG,11J,Total primary care (all BNF),Net Ingredient Cost (£),127776534.52
2016/17,Dorset CCG,11J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,614942.00
2016/17,Dorset CCG,11J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),13665350.36
2016/17,Dorset CCG,11J,Insulins (BNF 6.1.1) ,Prescription Items,100110.00
2016/17,Dorset CCG,11J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),4989770.20
2016/17,Dorset CCG,11J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,35656.00
2016/17,Dorset CCG,11J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1635003.62
2016/17,Dorset CCG,11J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,64454.00
2016/17,Dorset CCG,11J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),3354766.58
2016/17,Dorset CCG,11J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,404860.00
2016/17,Dorset CCG,11J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),5962791.85
2016/17,Dorset CCG,11J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,89941.00
2016/17,Dorset CCG,11J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),318956.61
2016/17,Dorset CCG,11J,Biguanides (BNF 6.1.2.2) ,Prescription Items,214478.00
2016/17,Dorset CCG,11J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),1170017.12
2016/17,Dorset CCG,11J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,100441.00
2016/17,Dorset CCG,11J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),4473818.12
2016/17,Dorset CCG,11J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,106967.00
2016/17,Dorset CCG,11J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),2670959.88
2016/17,Dorset CCG,11J,Human analogue insulins ,Prescription Items,87493.00
2016/17,Dorset CCG,11J,Human analogue insulins ,Net Ingredient Cost (£),4588971.83
2016/17,Dorset CCG,11J,Other insulins ,Prescription Items,12617.00
2016/17,Dorset CCG,11J,Other insulins ,Net Ingredient Cost (£),400798.37
2016/17,Dudley CCG,05C,Total primary care (all BNF),Prescription Items,5991236.00
2016/17,Dudley CCG,05C,Total primary care (all BNF),Net Ingredient Cost (£),56488530.00
2016/17,Dudley CCG,05C,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,279262.00
2016/17,Dudley CCG,05C,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6309855.43
2016/17,Dudley CCG,05C,Insulins (BNF 6.1.1) ,Prescription Items,43683.00
2016/17,Dudley CCG,05C,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2270403.06
2016/17,Dudley CCG,05C,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12275.00
2016/17,Dudley CCG,05C,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),560137.92
2016/17,Dudley CCG,05C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,31408.00
2016/17,Dudley CCG,05C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1710265.14
2016/17,Dudley CCG,05C,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,185023.00
2016/17,Dudley CCG,05C,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2894419.61
2016/17,Dudley CCG,05C,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,39669.00
2016/17,Dudley CCG,05C,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),182601.32
2016/17,Dudley CCG,05C,Biguanides (BNF 6.1.2.2) ,Prescription Items,100382.00
2016/17,Dudley CCG,05C,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),582719.25
2016/17,Dudley CCG,05C,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,44972.00
2016/17,Dudley CCG,05C,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2129099.04
2016/17,Dudley CCG,05C,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,49245.00
2016/17,Dudley CCG,05C,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1129097.59
2016/17,Dudley CCG,05C,Human analogue insulins ,Prescription Items,40395.00
2016/17,Dudley CCG,05C,Human analogue insulins ,Net Ingredient Cost (£),2146701.49
2016/17,Dudley CCG,05C,Other insulins ,Prescription Items,3288.00
2016/17,Dudley CCG,05C,Other insulins ,Net Ingredient Cost (£),123701.57
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Total primary care (all BNF),Prescription Items,8983254.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Total primary care (all BNF),Net Ingredient Cost (£),60025578.36
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,388312.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5836223.80
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Insulins (BNF 6.1.1) ,Prescription Items,51301.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2324650.73
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,15626.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),678562.30
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,35675.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1646088.43
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,283831.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2460740.39
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,69070.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),129396.26
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Biguanides (BNF 6.1.2.2) ,Prescription Items,159027.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),548057.80
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,55734.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1783286.33
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,50932.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1028296.22
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Human analogue insulins ,Prescription Items,40092.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Human analogue insulins ,Net Ingredient Cost (£),1978976.98
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Other insulins ,Prescription Items,11209.00
2016/17,"Durham Dales,Easington & Sedgefield CCG",00D,Other insulins ,Net Ingredient Cost (£),345673.75
2016/17,Ealing CCG,07W,Total primary care (all BNF),Prescription Items,6040620.00
2016/17,Ealing CCG,07W,Total primary care (all BNF),Net Ingredient Cost (£),43649413.98
2016/17,Ealing CCG,07W,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,454703.00
2016/17,Ealing CCG,07W,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),7069786.06
2016/17,Ealing CCG,07W,Insulins (BNF 6.1.1) ,Prescription Items,40337.00
2016/17,Ealing CCG,07W,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2003926.00
2016/17,Ealing CCG,07W,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11078.00
2016/17,Ealing CCG,07W,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),537185.74
2016/17,Ealing CCG,07W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,29259.00
2016/17,Ealing CCG,07W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1466740.26
2016/17,Ealing CCG,07W,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,360294.00
2016/17,Ealing CCG,07W,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3908590.63
2016/17,Ealing CCG,07W,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,94858.00
2016/17,Ealing CCG,07W,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),284903.03
2016/17,Ealing CCG,07W,Biguanides (BNF 6.1.2.2) ,Prescription Items,189547.00
2016/17,Ealing CCG,07W,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),832508.19
2016/17,Ealing CCG,07W,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,75889.00
2016/17,Ealing CCG,07W,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2791179.41
2016/17,Ealing CCG,07W,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,52981.00
2016/17,Ealing CCG,07W,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1145631.45
2016/17,Ealing CCG,07W,Human analogue insulins ,Prescription Items,32015.00
2016/17,Ealing CCG,07W,Human analogue insulins ,Net Ingredient Cost (£),1713803.68
2016/17,Ealing CCG,07W,Other insulins ,Prescription Items,8322.00
2016/17,Ealing CCG,07W,Other insulins ,Net Ingredient Cost (£),290122.32
2016/17,East and North Hertfordshire CCG,06K,Total primary care (all BNF),Prescription Items,11424000.00
2016/17,East and North Hertfordshire CCG,06K,Total primary care (all BNF),Net Ingredient Cost (£),87930851.20
2016/17,East and North Hertfordshire CCG,06K,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,532767.00
2016/17,East and North Hertfordshire CCG,06K,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),9354948.68
2016/17,East and North Hertfordshire CCG,06K,Insulins (BNF 6.1.1) ,Prescription Items,68739.00
2016/17,East and North Hertfordshire CCG,06K,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3062174.20
2016/17,East and North Hertfordshire CCG,06K,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,23758.00
2016/17,East and North Hertfordshire CCG,06K,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1059800.12
2016/17,East and North Hertfordshire CCG,06K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,44981.00
2016/17,East and North Hertfordshire CCG,06K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2002374.08
2016/17,East and North Hertfordshire CCG,06K,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,386856.00
2016/17,East and North Hertfordshire CCG,06K,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),4224124.08
2016/17,East and North Hertfordshire CCG,06K,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,83424.00
2016/17,East and North Hertfordshire CCG,06K,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),246586.78
2016/17,East and North Hertfordshire CCG,06K,Biguanides (BNF 6.1.2.2) ,Prescription Items,215240.00
2016/17,East and North Hertfordshire CCG,06K,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),849645.93
2016/17,East and North Hertfordshire CCG,06K,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,88192.00
2016/17,East and North Hertfordshire CCG,06K,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),3127891.37
2016/17,East and North Hertfordshire CCG,06K,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,73407.00
2016/17,East and North Hertfordshire CCG,06K,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),2014000.91
2016/17,East and North Hertfordshire CCG,06K,Human analogue insulins ,Prescription Items,52957.00
2016/17,East and North Hertfordshire CCG,06K,Human analogue insulins ,Net Ingredient Cost (£),2584254.36
2016/17,East and North Hertfordshire CCG,06K,Other insulins ,Prescription Items,15782.00
2016/17,East and North Hertfordshire CCG,06K,Other insulins ,Net Ingredient Cost (£),477919.84
2016/17,East Lancashire CCG,01A,Total primary care (all BNF),Prescription Items,8501236.00
2016/17,East Lancashire CCG,01A,Total primary care (all BNF),Net Ingredient Cost (£),68127247.60
2016/17,East Lancashire CCG,01A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,382211.00
2016/17,East Lancashire CCG,01A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6791374.00
2016/17,East Lancashire CCG,01A,Insulins (BNF 6.1.1) ,Prescription Items,55158.00
2016/17,East Lancashire CCG,01A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2406997.22
2016/17,East Lancashire CCG,01A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,15979.00
2016/17,East Lancashire CCG,01A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),646338.64
2016/17,East Lancashire CCG,01A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,39179.00
2016/17,East Lancashire CCG,01A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1760658.58
2016/17,East Lancashire CCG,01A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,270282.00
2016/17,East Lancashire CCG,01A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2918521.10
2016/17,East Lancashire CCG,01A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,58953.00
2016/17,East Lancashire CCG,01A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),189196.46
2016/17,East Lancashire CCG,01A,Biguanides (BNF 6.1.2.2) ,Prescription Items,159965.00
2016/17,East Lancashire CCG,01A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),699564.35
2016/17,East Lancashire CCG,01A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,51364.00
2016/17,East Lancashire CCG,01A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2029760.29
2016/17,East Lancashire CCG,01A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,54924.00
2016/17,East Lancashire CCG,01A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1439695.97
2016/17,East Lancashire CCG,01A,Human analogue insulins ,Prescription Items,39734.00
2016/17,East Lancashire CCG,01A,Human analogue insulins ,Net Ingredient Cost (£),1902092.75
2016/17,East Lancashire CCG,01A,Other insulins ,Prescription Items,15424.00
2016/17,East Lancashire CCG,01A,Other insulins ,Net Ingredient Cost (£),504904.47
2016/17,East Leicestershire and Rutland CCG,03W,Total primary care (all BNF),Prescription Items,6223724.00
2016/17,East Leicestershire and Rutland CCG,03W,Total primary care (all BNF),Net Ingredient Cost (£),49784364.09
2016/17,East Leicestershire and Rutland CCG,03W,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,277268.00
2016/17,East Leicestershire and Rutland CCG,03W,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5625884.59
2016/17,East Leicestershire and Rutland CCG,03W,Insulins (BNF 6.1.1) ,Prescription Items,45866.00
2016/17,East Leicestershire and Rutland CCG,03W,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2295392.94
2016/17,East Leicestershire and Rutland CCG,03W,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,14064.00
2016/17,East Leicestershire and Rutland CCG,03W,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),650257.12
2016/17,East Leicestershire and Rutland CCG,03W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,31802.00
2016/17,East Leicestershire and Rutland CCG,03W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1645135.82
2016/17,East Leicestershire and Rutland CCG,03W,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,180891.00
2016/17,East Leicestershire and Rutland CCG,03W,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2084951.69
2016/17,East Leicestershire and Rutland CCG,03W,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,38625.00
2016/17,East Leicestershire and Rutland CCG,03W,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),134280.17
2016/17,East Leicestershire and Rutland CCG,03W,Biguanides (BNF 6.1.2.2) ,Prescription Items,105286.00
2016/17,East Leicestershire and Rutland CCG,03W,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),433743.68
2016/17,East Leicestershire and Rutland CCG,03W,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,36980.00
2016/17,East Leicestershire and Rutland CCG,03W,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1516927.84
2016/17,East Leicestershire and Rutland CCG,03W,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,48461.00
2016/17,East Leicestershire and Rutland CCG,03W,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1221628.24
2016/17,East Leicestershire and Rutland CCG,03W,Human analogue insulins ,Prescription Items,35932.00
2016/17,East Leicestershire and Rutland CCG,03W,Human analogue insulins ,Net Ingredient Cost (£),1948286.88
2016/17,East Leicestershire and Rutland CCG,03W,Other insulins ,Prescription Items,9934.00
2016/17,East Leicestershire and Rutland CCG,03W,Other insulins ,Net Ingredient Cost (£),347106.06
2016/17,East Riding of Yorkshire CCG,02Y,Total primary care (all BNF),Prescription Items,7420315.00
2016/17,East Riding of Yorkshire CCG,02Y,Total primary care (all BNF),Net Ingredient Cost (£),58487243.57
2016/17,East Riding of Yorkshire CCG,02Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,321653.00
2016/17,East Riding of Yorkshire CCG,02Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6042576.20
2016/17,East Riding of Yorkshire CCG,02Y,Insulins (BNF 6.1.1) ,Prescription Items,41025.00
2016/17,East Riding of Yorkshire CCG,02Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1976707.63
2016/17,East Riding of Yorkshire CCG,02Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,13078.00
2016/17,East Riding of Yorkshire CCG,02Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),600526.24
2016/17,East Riding of Yorkshire CCG,02Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,27947.00
2016/17,East Riding of Yorkshire CCG,02Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1376181.39
2016/17,East Riding of Yorkshire CCG,02Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,230880.00
2016/17,East Riding of Yorkshire CCG,02Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2797083.58
2016/17,East Riding of Yorkshire CCG,02Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,48066.00
2016/17,East Riding of Yorkshire CCG,02Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),130836.49
2016/17,East Riding of Yorkshire CCG,02Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,128619.00
2016/17,East Riding of Yorkshire CCG,02Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),582404.97
2016/17,East Riding of Yorkshire CCG,02Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,54195.00
2016/17,East Riding of Yorkshire CCG,02Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2083842.12
2016/17,East Riding of Yorkshire CCG,02Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,47470.00
2016/17,East Riding of Yorkshire CCG,02Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1242595.70
2016/17,East Riding of Yorkshire CCG,02Y,Human analogue insulins ,Prescription Items,33968.00
2016/17,East Riding of Yorkshire CCG,02Y,Human analogue insulins ,Net Ingredient Cost (£),1750614.25
2016/17,East Riding of Yorkshire CCG,02Y,Other insulins ,Prescription Items,7057.00
2016/17,East Riding of Yorkshire CCG,02Y,Other insulins ,Net Ingredient Cost (£),226093.38
2016/17,East Staffordshire CCG,05D,Total primary care (all BNF),Prescription Items,2772830.00
2016/17,East Staffordshire CCG,05D,Total primary care (all BNF),Net Ingredient Cost (£),22224618.28
2016/17,East Staffordshire CCG,05D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,142173.00
2016/17,East Staffordshire CCG,05D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2747233.23
2016/17,East Staffordshire CCG,05D,Insulins (BNF 6.1.1) ,Prescription Items,21265.00
2016/17,East Staffordshire CCG,05D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1019401.88
2016/17,East Staffordshire CCG,05D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9030.00
2016/17,East Staffordshire CCG,05D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),403637.60
2016/17,East Staffordshire CCG,05D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,12235.00
2016/17,East Staffordshire CCG,05D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),615764.28
2016/17,East Staffordshire CCG,05D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,100326.00
2016/17,East Staffordshire CCG,05D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1187094.18
2016/17,East Staffordshire CCG,05D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,20826.00
2016/17,East Staffordshire CCG,05D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),59841.91
2016/17,East Staffordshire CCG,05D,Biguanides (BNF 6.1.2.2) ,Prescription Items,57031.00
2016/17,East Staffordshire CCG,05D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),267299.87
2016/17,East Staffordshire CCG,05D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,22469.00
2016/17,East Staffordshire CCG,05D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),859952.40
2016/17,East Staffordshire CCG,05D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,19951.00
2016/17,East Staffordshire CCG,05D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),534004.37
2016/17,East Staffordshire CCG,05D,Human analogue insulins ,Prescription Items,19018.00
2016/17,East Staffordshire CCG,05D,Human analogue insulins ,Net Ingredient Cost (£),947726.96
2016/17,East Staffordshire CCG,05D,Other insulins ,Prescription Items,2247.00
2016/17,East Staffordshire CCG,05D,Other insulins ,Net Ingredient Cost (£),71674.92
2016/17,East Surrey CCG,09L,Total primary care (all BNF),Prescription Items,2528750.00
2016/17,East Surrey CCG,09L,Total primary care (all BNF),Net Ingredient Cost (£),25390455.99
2016/17,East Surrey CCG,09L,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,109405.00
2016/17,East Surrey CCG,09L,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2679578.28
2016/17,East Surrey CCG,09L,Insulins (BNF 6.1.1) ,Prescription Items,16766.00
2016/17,East Surrey CCG,09L,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),907396.46
2016/17,East Surrey CCG,09L,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6308.00
2016/17,East Surrey CCG,09L,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),316703.37
2016/17,East Surrey CCG,09L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,10458.00
2016/17,East Surrey CCG,09L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),590693.09
2016/17,East Surrey CCG,09L,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,75760.00
2016/17,East Surrey CCG,09L,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1270000.71
2016/17,East Surrey CCG,09L,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,15653.00
2016/17,East Surrey CCG,09L,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),60823.42
2016/17,East Surrey CCG,09L,Biguanides (BNF 6.1.2.2) ,Prescription Items,41213.00
2016/17,East Surrey CCG,09L,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),244392.50
2016/17,East Surrey CCG,09L,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,18894.00
2016/17,East Surrey CCG,09L,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),964784.79
2016/17,East Surrey CCG,09L,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,16358.00
2016/17,East Surrey CCG,09L,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),493586.54
2016/17,East Surrey CCG,09L,Human analogue insulins ,Prescription Items,15733.00
2016/17,East Surrey CCG,09L,Human analogue insulins ,Net Ingredient Cost (£),873440.14
2016/17,East Surrey CCG,09L,Other insulins ,Prescription Items,1033.00
2016/17,East Surrey CCG,09L,Other insulins ,Net Ingredient Cost (£),33956.32
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Total primary care (all BNF),Prescription Items,4089559.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Total primary care (all BNF),Net Ingredient Cost (£),35837455.13
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,167445.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3778964.32
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Insulins (BNF 6.1.1) ,Prescription Items,23920.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1312869.36
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8716.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),407642.41
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15204.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),905226.95
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,118268.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1662990.05
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,27550.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),99434.29
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Biguanides (BNF 6.1.2.2) ,Prescription Items,64028.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),357972.45
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,26690.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1205583.31
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,24187.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),774906.57
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Human analogue insulins ,Prescription Items,22647.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Human analogue insulins ,Net Ingredient Cost (£),1271701.76
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Other insulins ,Prescription Items,1273.00
2016/17,"Eastbourne, Hailsham and Seaford CCG",09F,Other insulins ,Net Ingredient Cost (£),41167.60
2016/17,Eastern Cheshire CCG,01C,Total primary care (all BNF),Prescription Items,4364025.00
2016/17,Eastern Cheshire CCG,01C,Total primary care (all BNF),Net Ingredient Cost (£),33087200.88
2016/17,Eastern Cheshire CCG,01C,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,165649.00
2016/17,Eastern Cheshire CCG,01C,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3260866.01
2016/17,Eastern Cheshire CCG,01C,Insulins (BNF 6.1.1) ,Prescription Items,22984.00
2016/17,Eastern Cheshire CCG,01C,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1166464.34
2016/17,Eastern Cheshire CCG,01C,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8861.00
2016/17,Eastern Cheshire CCG,01C,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),402705.14
2016/17,Eastern Cheshire CCG,01C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,14123.00
2016/17,Eastern Cheshire CCG,01C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),763759.20
2016/17,Eastern Cheshire CCG,01C,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,118151.00
2016/17,Eastern Cheshire CCG,01C,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1446980.20
2016/17,Eastern Cheshire CCG,01C,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23391.00
2016/17,Eastern Cheshire CCG,01C,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),75025.70
2016/17,Eastern Cheshire CCG,01C,Biguanides (BNF 6.1.2.2) ,Prescription Items,66873.00
2016/17,Eastern Cheshire CCG,01C,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),327632.38
2016/17,Eastern Cheshire CCG,01C,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,27887.00
2016/17,Eastern Cheshire CCG,01C,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1044322.12
2016/17,Eastern Cheshire CCG,01C,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,22968.00
2016/17,Eastern Cheshire CCG,01C,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),628201.60
2016/17,Eastern Cheshire CCG,01C,Human analogue insulins ,Prescription Items,20775.00
2016/17,Eastern Cheshire CCG,01C,Human analogue insulins ,Net Ingredient Cost (£),1089981.39
2016/17,Eastern Cheshire CCG,01C,Other insulins ,Prescription Items,2209.00
2016/17,Eastern Cheshire CCG,01C,Other insulins ,Net Ingredient Cost (£),76482.95
2016/17,Enfield CCG,07X,Total primary care (all BNF),Prescription Items,5298457.00
2016/17,Enfield CCG,07X,Total primary care (all BNF),Net Ingredient Cost (£),39067163.41
2016/17,Enfield CCG,07X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,350592.00
2016/17,Enfield CCG,07X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5388944.25
2016/17,Enfield CCG,07X,Insulins (BNF 6.1.1) ,Prescription Items,28725.00
2016/17,Enfield CCG,07X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1457775.39
2016/17,Enfield CCG,07X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8640.00
2016/17,Enfield CCG,07X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),445652.11
2016/17,Enfield CCG,07X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,20085.00
2016/17,Enfield CCG,07X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1012123.28
2016/17,Enfield CCG,07X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,286243.00
2016/17,Enfield CCG,07X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3155510.62
2016/17,Enfield CCG,07X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,71177.00
2016/17,Enfield CCG,07X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),216335.35
2016/17,Enfield CCG,07X,Biguanides (BNF 6.1.2.2) ,Prescription Items,147424.00
2016/17,Enfield CCG,07X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),589907.38
2016/17,Enfield CCG,07X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,67642.00
2016/17,Enfield CCG,07X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2349267.89
2016/17,Enfield CCG,07X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,34299.00
2016/17,Enfield CCG,07X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),757870.98
2016/17,Enfield CCG,07X,Human analogue insulins ,Prescription Items,24106.00
2016/17,Enfield CCG,07X,Human analogue insulins ,Net Ingredient Cost (£),1312959.14
2016/17,Enfield CCG,07X,Other insulins ,Prescription Items,4619.00
2016/17,Enfield CCG,07X,Other insulins ,Net Ingredient Cost (£),144816.25
2016/17,Erewash CCG,03X,Total primary care (all BNF),Prescription Items,1592666.00
2016/17,Erewash CCG,03X,Total primary care (all BNF),Net Ingredient Cost (£),14727908.66
2016/17,Erewash CCG,03X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,65808.00
2016/17,Erewash CCG,03X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1368032.89
2016/17,Erewash CCG,03X,Insulins (BNF 6.1.1) ,Prescription Items,10800.00
2016/17,Erewash CCG,03X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),505694.90
2016/17,Erewash CCG,03X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,3731.00
2016/17,Erewash CCG,03X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),165590.78
2016/17,Erewash CCG,03X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,7069.00
2016/17,Erewash CCG,03X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),340104.12
2016/17,Erewash CCG,03X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,44308.00
2016/17,Erewash CCG,03X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),550500.85
2016/17,Erewash CCG,03X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,10322.00
2016/17,Erewash CCG,03X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),44075.93
2016/17,Erewash CCG,03X,Biguanides (BNF 6.1.2.2) ,Prescription Items,27198.00
2016/17,Erewash CCG,03X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),145178.32
2016/17,Erewash CCG,03X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,6788.00
2016/17,Erewash CCG,03X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),361246.60
2016/17,Erewash CCG,03X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,10341.00
2016/17,Erewash CCG,03X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),307304.73
2016/17,Erewash CCG,03X,Human analogue insulins ,Prescription Items,8125.00
2016/17,Erewash CCG,03X,Human analogue insulins ,Net Ingredient Cost (£),414114.87
2016/17,Erewash CCG,03X,Other insulins ,Prescription Items,2675.00
2016/17,Erewash CCG,03X,Other insulins ,Net Ingredient Cost (£),91580.03
2016/17,Fareham and Gosport CCG,10K,Total primary care (all BNF),Prescription Items,3449417.00
2016/17,Fareham and Gosport CCG,10K,Total primary care (all BNF),Net Ingredient Cost (£),34449464.88
2016/17,Fareham and Gosport CCG,10K,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,149376.00
2016/17,Fareham and Gosport CCG,10K,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3750614.86
2016/17,Fareham and Gosport CCG,10K,Insulins (BNF 6.1.1) ,Prescription Items,23038.00
2016/17,Fareham and Gosport CCG,10K,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1155266.80
2016/17,Fareham and Gosport CCG,10K,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6214.00
2016/17,Fareham and Gosport CCG,10K,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),301747.69
2016/17,Fareham and Gosport CCG,10K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,16824.00
2016/17,Fareham and Gosport CCG,10K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),853519.11
2016/17,Fareham and Gosport CCG,10K,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,103055.00
2016/17,Fareham and Gosport CCG,10K,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2028910.70
2016/17,Fareham and Gosport CCG,10K,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,19648.00
2016/17,Fareham and Gosport CCG,10K,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),92805.82
2016/17,Fareham and Gosport CCG,10K,Biguanides (BNF 6.1.2.2) ,Prescription Items,54986.00
2016/17,Fareham and Gosport CCG,10K,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),381339.68
2016/17,Fareham and Gosport CCG,10K,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,28421.00
2016/17,Fareham and Gosport CCG,10K,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1554765.20
2016/17,Fareham and Gosport CCG,10K,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,22467.00
2016/17,Fareham and Gosport CCG,10K,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),553939.10
2016/17,Fareham and Gosport CCG,10K,Human analogue insulins ,Prescription Items,14742.00
2016/17,Fareham and Gosport CCG,10K,Human analogue insulins ,Net Ingredient Cost (£),872827.18
2016/17,Fareham and Gosport CCG,10K,Other insulins ,Prescription Items,8296.00
2016/17,Fareham and Gosport CCG,10K,Other insulins ,Net Ingredient Cost (£),282439.62
2016/17,Fylde & Wyre CCG,02M,Total primary care (all BNF),Prescription Items,4088997.00
2016/17,Fylde & Wyre CCG,02M,Total primary care (all BNF),Net Ingredient Cost (£),30157000.21
2016/17,Fylde & Wyre CCG,02M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,165461.00
2016/17,Fylde & Wyre CCG,02M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3105958.78
2016/17,Fylde & Wyre CCG,02M,Insulins (BNF 6.1.1) ,Prescription Items,22448.00
2016/17,Fylde & Wyre CCG,02M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1016467.25
2016/17,Fylde & Wyre CCG,02M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6806.00
2016/17,Fylde & Wyre CCG,02M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),277801.34
2016/17,Fylde & Wyre CCG,02M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15642.00
2016/17,Fylde & Wyre CCG,02M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),738665.91
2016/17,Fylde & Wyre CCG,02M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,121279.00
2016/17,Fylde & Wyre CCG,02M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1526218.34
2016/17,Fylde & Wyre CCG,02M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23814.00
2016/17,Fylde & Wyre CCG,02M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),76191.26
2016/17,Fylde & Wyre CCG,02M,Biguanides (BNF 6.1.2.2) ,Prescription Items,66192.00
2016/17,Fylde & Wyre CCG,02M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),287127.40
2016/17,Fylde & Wyre CCG,02M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,31273.00
2016/17,Fylde & Wyre CCG,02M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1162899.68
2016/17,Fylde & Wyre CCG,02M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,21139.00
2016/17,Fylde & Wyre CCG,02M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),556390.96
2016/17,Fylde & Wyre CCG,02M,Human analogue insulins ,Prescription Items,19457.00
2016/17,Fylde & Wyre CCG,02M,Human analogue insulins ,Net Ingredient Cost (£),924323.71
2016/17,Fylde & Wyre CCG,02M,Other insulins ,Prescription Items,2991.00
2016/17,Fylde & Wyre CCG,02M,Other insulins ,Net Ingredient Cost (£),92143.54
2016/17,Gloucestershire CCG,11M,Total primary care (all BNF),Prescription Items,12838736.00
2016/17,Gloucestershire CCG,11M,Total primary care (all BNF),Net Ingredient Cost (£),98716611.32
2016/17,Gloucestershire CCG,11M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,549922.00
2016/17,Gloucestershire CCG,11M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),10384737.21
2016/17,Gloucestershire CCG,11M,Insulins (BNF 6.1.1) ,Prescription Items,80486.00
2016/17,Gloucestershire CCG,11M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3942103.64
2016/17,Gloucestershire CCG,11M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,26579.00
2016/17,Gloucestershire CCG,11M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1207625.40
2016/17,Gloucestershire CCG,11M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,53907.00
2016/17,Gloucestershire CCG,11M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2734478.24
2016/17,Gloucestershire CCG,11M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,393921.00
2016/17,Gloucestershire CCG,11M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),4535278.81
2016/17,Gloucestershire CCG,11M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,90417.00
2016/17,Gloucestershire CCG,11M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),272815.87
2016/17,Gloucestershire CCG,11M,Biguanides (BNF 6.1.2.2) ,Prescription Items,212807.00
2016/17,Gloucestershire CCG,11M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),956584.73
2016/17,Gloucestershire CCG,11M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,90697.00
2016/17,Gloucestershire CCG,11M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),3305878.21
2016/17,Gloucestershire CCG,11M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,72434.00
2016/17,Gloucestershire CCG,11M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1845134.53
2016/17,Gloucestershire CCG,11M,Human analogue insulins ,Prescription Items,66746.00
2016/17,Gloucestershire CCG,11M,Human analogue insulins ,Net Ingredient Cost (£),3475460.02
2016/17,Gloucestershire CCG,11M,Other insulins ,Prescription Items,13740.00
2016/17,Gloucestershire CCG,11M,Other insulins ,Net Ingredient Cost (£),466643.62
2016/17,Great Yarmouth & Waveney CCG,06M,Total primary care (all BNF),Prescription Items,5160516.00
2016/17,Great Yarmouth & Waveney CCG,06M,Total primary care (all BNF),Net Ingredient Cost (£),41414595.09
2016/17,Great Yarmouth & Waveney CCG,06M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,225116.00
2016/17,Great Yarmouth & Waveney CCG,06M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3868197.04
2016/17,Great Yarmouth & Waveney CCG,06M,Insulins (BNF 6.1.1) ,Prescription Items,34334.00
2016/17,Great Yarmouth & Waveney CCG,06M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1728757.58
2016/17,Great Yarmouth & Waveney CCG,06M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9333.00
2016/17,Great Yarmouth & Waveney CCG,06M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),438751.87
2016/17,Great Yarmouth & Waveney CCG,06M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,25001.00
2016/17,Great Yarmouth & Waveney CCG,06M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1290005.71
2016/17,Great Yarmouth & Waveney CCG,06M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,153522.00
2016/17,Great Yarmouth & Waveney CCG,06M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1291190.21
2016/17,Great Yarmouth & Waveney CCG,06M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,37417.00
2016/17,Great Yarmouth & Waveney CCG,06M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),124551.29
2016/17,Great Yarmouth & Waveney CCG,06M,Biguanides (BNF 6.1.2.2) ,Prescription Items,96611.00
2016/17,Great Yarmouth & Waveney CCG,06M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),433527.64
2016/17,Great Yarmouth & Waveney CCG,06M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,19494.00
2016/17,Great Yarmouth & Waveney CCG,06M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),733111.28
2016/17,Great Yarmouth & Waveney CCG,06M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,35506.00
2016/17,Great Yarmouth & Waveney CCG,06M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),829674.36
2016/17,Great Yarmouth & Waveney CCG,06M,Human analogue insulins ,Prescription Items,20617.00
2016/17,Great Yarmouth & Waveney CCG,06M,Human analogue insulins ,Net Ingredient Cost (£),1121357.38
2016/17,Great Yarmouth & Waveney CCG,06M,Other insulins ,Prescription Items,13717.00
2016/17,Great Yarmouth & Waveney CCG,06M,Other insulins ,Net Ingredient Cost (£),607400.20
2016/17,Greater Huddersfield CCG,03A,Total primary care (all BNF),Prescription Items,4770136.00
2016/17,Greater Huddersfield CCG,03A,Total primary care (all BNF),Net Ingredient Cost (£),38899099.39
2016/17,Greater Huddersfield CCG,03A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,225168.00
2016/17,Greater Huddersfield CCG,03A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3747120.68
2016/17,Greater Huddersfield CCG,03A,Insulins (BNF 6.1.1) ,Prescription Items,26533.00
2016/17,Greater Huddersfield CCG,03A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1252319.97
2016/17,Greater Huddersfield CCG,03A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8203.00
2016/17,Greater Huddersfield CCG,03A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),352542.84
2016/17,Greater Huddersfield CCG,03A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,18330.00
2016/17,Greater Huddersfield CCG,03A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),899777.13
2016/17,Greater Huddersfield CCG,03A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,166921.00
2016/17,Greater Huddersfield CCG,03A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1699466.03
2016/17,Greater Huddersfield CCG,03A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,41308.00
2016/17,Greater Huddersfield CCG,03A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),115323.66
2016/17,Greater Huddersfield CCG,03A,Biguanides (BNF 6.1.2.2) ,Prescription Items,90487.00
2016/17,Greater Huddersfield CCG,03A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),423868.07
2016/17,Greater Huddersfield CCG,03A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,35126.00
2016/17,Greater Huddersfield CCG,03A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1160274.30
2016/17,Greater Huddersfield CCG,03A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,30247.00
2016/17,Greater Huddersfield CCG,03A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),777979.04
2016/17,Greater Huddersfield CCG,03A,Human analogue insulins ,Prescription Items,19992.00
2016/17,Greater Huddersfield CCG,03A,Human analogue insulins ,Net Ingredient Cost (£),1033310.51
2016/17,Greater Huddersfield CCG,03A,Other insulins ,Prescription Items,6541.00
2016/17,Greater Huddersfield CCG,03A,Other insulins ,Net Ingredient Cost (£),219009.46
2016/17,Greater Preston CCG,01E,Total primary care (all BNF),Prescription Items,4368582.00
2016/17,Greater Preston CCG,01E,Total primary care (all BNF),Net Ingredient Cost (£),35396308.42
2016/17,Greater Preston CCG,01E,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,212566.00
2016/17,Greater Preston CCG,01E,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3670071.66
2016/17,Greater Preston CCG,01E,Insulins (BNF 6.1.1) ,Prescription Items,21479.00
2016/17,Greater Preston CCG,01E,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1079405.28
2016/17,Greater Preston CCG,01E,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7222.00
2016/17,Greater Preston CCG,01E,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),346568.53
2016/17,Greater Preston CCG,01E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,14257.00
2016/17,Greater Preston CCG,01E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),732836.75
2016/17,Greater Preston CCG,01E,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,165991.00
2016/17,Greater Preston CCG,01E,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1885669.41
2016/17,Greater Preston CCG,01E,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,38929.00
2016/17,Greater Preston CCG,01E,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),141986.79
2016/17,Greater Preston CCG,01E,Biguanides (BNF 6.1.2.2) ,Prescription Items,85225.00
2016/17,Greater Preston CCG,01E,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),349548.58
2016/17,Greater Preston CCG,01E,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,41837.00
2016/17,Greater Preston CCG,01E,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1394134.04
2016/17,Greater Preston CCG,01E,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,24266.00
2016/17,Greater Preston CCG,01E,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),694968.64
2016/17,Greater Preston CCG,01E,Human analogue insulins ,Prescription Items,17069.00
2016/17,Greater Preston CCG,01E,Human analogue insulins ,Net Ingredient Cost (£),936376.05
2016/17,Greater Preston CCG,01E,Other insulins ,Prescription Items,4410.00
2016/17,Greater Preston CCG,01E,Other insulins ,Net Ingredient Cost (£),143029.23
2016/17,Greenwich CCG,08A,Total primary care (all BNF),Prescription Items,4034443.00
2016/17,Greenwich CCG,08A,Total primary care (all BNF),Net Ingredient Cost (£),33959121.02
2016/17,Greenwich CCG,08A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,253325.00
2016/17,Greenwich CCG,08A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4469034.69
2016/17,Greenwich CCG,08A,Insulins (BNF 6.1.1) ,Prescription Items,29556.00
2016/17,Greenwich CCG,08A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1428260.12
2016/17,Greenwich CCG,08A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8852.00
2016/17,Greenwich CCG,08A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),414180.38
2016/17,Greenwich CCG,08A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,20704.00
2016/17,Greenwich CCG,08A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1014079.74
2016/17,Greenwich CCG,08A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,191170.00
2016/17,Greenwich CCG,08A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2217870.23
2016/17,Greenwich CCG,08A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,46696.00
2016/17,Greenwich CCG,08A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),162239.16
2016/17,Greenwich CCG,08A,Biguanides (BNF 6.1.2.2) ,Prescription Items,107048.00
2016/17,Greenwich CCG,08A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),554153.81
2016/17,Greenwich CCG,08A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,37426.00
2016/17,Greenwich CCG,08A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1501477.26
2016/17,Greenwich CCG,08A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,31365.00
2016/17,Greenwich CCG,08A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),805593.31
2016/17,Greenwich CCG,08A,Human analogue insulins ,Prescription Items,24834.00
2016/17,Greenwich CCG,08A,Human analogue insulins ,Net Ingredient Cost (£),1271203.08
2016/17,Greenwich CCG,08A,Other insulins ,Prescription Items,4722.00
2016/17,Greenwich CCG,08A,Other insulins ,Net Ingredient Cost (£),157057.04
2016/17,Guildford and Waverley CCG,09N,Total primary care (all BNF),Prescription Items,3115275.00
2016/17,Guildford and Waverley CCG,09N,Total primary care (all BNF),Net Ingredient Cost (£),30917447.19
2016/17,Guildford and Waverley CCG,09N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,122491.00
2016/17,Guildford and Waverley CCG,09N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3297148.30
2016/17,Guildford and Waverley CCG,09N,Insulins (BNF 6.1.1) ,Prescription Items,19580.00
2016/17,Guildford and Waverley CCG,09N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1134031.54
2016/17,Guildford and Waverley CCG,09N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6775.00
2016/17,Guildford and Waverley CCG,09N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),357366.71
2016/17,Guildford and Waverley CCG,09N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,12805.00
2016/17,Guildford and Waverley CCG,09N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),776664.83
2016/17,Guildford and Waverley CCG,09N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,80567.00
2016/17,Guildford and Waverley CCG,09N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1467678.00
2016/17,Guildford and Waverley CCG,09N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,16118.00
2016/17,Guildford and Waverley CCG,09N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),63935.16
2016/17,Guildford and Waverley CCG,09N,Biguanides (BNF 6.1.2.2) ,Prescription Items,44063.00
2016/17,Guildford and Waverley CCG,09N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),257001.45
2016/17,Guildford and Waverley CCG,09N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,20386.00
2016/17,Guildford and Waverley CCG,09N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1146741.39
2016/17,Guildford and Waverley CCG,09N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,20948.00
2016/17,Guildford and Waverley CCG,09N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),678432.13
2016/17,Guildford and Waverley CCG,09N,Human analogue insulins ,Prescription Items,18029.00
2016/17,Guildford and Waverley CCG,09N,Human analogue insulins ,Net Ingredient Cost (£),1079326.72
2016/17,Guildford and Waverley CCG,09N,Other insulins ,Prescription Items,1551.00
2016/17,Guildford and Waverley CCG,09N,Other insulins ,Net Ingredient Cost (£),54704.82
2016/17,Halton CCG,01F,Total primary care (all BNF),Prescription Items,2896695.00
2016/17,Halton CCG,01F,Total primary care (all BNF),Net Ingredient Cost (£),26588845.95
2016/17,Halton CCG,01F,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,135940.00
2016/17,Halton CCG,01F,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3005277.39
2016/17,Halton CCG,01F,Insulins (BNF 6.1.1) ,Prescription Items,19619.00
2016/17,Halton CCG,01F,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1021712.84
2016/17,Halton CCG,01F,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6214.00
2016/17,Halton CCG,01F,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),303282.36
2016/17,Halton CCG,01F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13405.00
2016/17,Halton CCG,01F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),718430.48
2016/17,Halton CCG,01F,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,95352.00
2016/17,Halton CCG,01F,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1416561.62
2016/17,Halton CCG,01F,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,19437.00
2016/17,Halton CCG,01F,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),60724.26
2016/17,Halton CCG,01F,Biguanides (BNF 6.1.2.2) ,Prescription Items,51620.00
2016/17,Halton CCG,01F,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),255659.62
2016/17,Halton CCG,01F,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,24295.00
2016/17,Halton CCG,01F,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1100177.74
2016/17,Halton CCG,01F,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,19818.00
2016/17,Halton CCG,01F,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),554671.60
2016/17,Halton CCG,01F,Human analogue insulins ,Prescription Items,17520.00
2016/17,Halton CCG,01F,Human analogue insulins ,Net Ingredient Cost (£),951925.76
2016/17,Halton CCG,01F,Other insulins ,Prescription Items,2099.00
2016/17,Halton CCG,01F,Other insulins ,Net Ingredient Cost (£),69787.08
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Total primary care (all BNF),Prescription Items,3374864.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Total primary care (all BNF),Net Ingredient Cost (£),26856735.15
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,141224.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2709845.87
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Insulins (BNF 6.1.1) ,Prescription Items,20056.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),941045.13
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6910.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),302303.77
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13146.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),638741.36
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,99131.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1208698.93
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,20688.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),64873.06
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Biguanides (BNF 6.1.2.2) ,Prescription Items,54501.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),210588.44
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,23942.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),933237.43
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,20944.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),547313.40
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Human analogue insulins ,Prescription Items,17206.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Human analogue insulins ,Net Ingredient Cost (£),856539.41
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Other insulins ,Prescription Items,2850.00
2016/17,"Hambleton, Richmondshire and Whitby CCG",03D,Other insulins ,Net Ingredient Cost (£),84505.72
2016/17,Hammersmith and Fulham CCG,08C,Total primary care (all BNF),Prescription Items,2587618.00
2016/17,Hammersmith and Fulham CCG,08C,Total primary care (all BNF),Net Ingredient Cost (£),21566123.01
2016/17,Hammersmith and Fulham CCG,08C,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,150018.00
2016/17,Hammersmith and Fulham CCG,08C,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2784957.88
2016/17,Hammersmith and Fulham CCG,08C,Insulins (BNF 6.1.1) ,Prescription Items,16112.00
2016/17,Hammersmith and Fulham CCG,08C,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),863701.34
2016/17,Hammersmith and Fulham CCG,08C,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5212.00
2016/17,Hammersmith and Fulham CCG,08C,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),264349.59
2016/17,Hammersmith and Fulham CCG,08C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,10900.00
2016/17,Hammersmith and Fulham CCG,08C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),599351.75
2016/17,Hammersmith and Fulham CCG,08C,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,116187.00
2016/17,Hammersmith and Fulham CCG,08C,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1445100.05
2016/17,Hammersmith and Fulham CCG,08C,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23082.00
2016/17,Hammersmith and Fulham CCG,08C,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),68602.07
2016/17,Hammersmith and Fulham CCG,08C,Biguanides (BNF 6.1.2.2) ,Prescription Items,59985.00
2016/17,Hammersmith and Fulham CCG,08C,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),240194.47
2016/17,Hammersmith and Fulham CCG,08C,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,33120.00
2016/17,Hammersmith and Fulham CCG,08C,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1136303.51
2016/17,Hammersmith and Fulham CCG,08C,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,17011.00
2016/17,Hammersmith and Fulham CCG,08C,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),468798.83
2016/17,Hammersmith and Fulham CCG,08C,Human analogue insulins ,Prescription Items,14138.00
2016/17,Hammersmith and Fulham CCG,08C,Human analogue insulins ,Net Ingredient Cost (£),796225.83
2016/17,Hammersmith and Fulham CCG,08C,Other insulins ,Prescription Items,1974.00
2016/17,Hammersmith and Fulham CCG,08C,Other insulins ,Net Ingredient Cost (£),67475.51
2016/17,Hardwick CCG,03Y,Total primary care (all BNF),Prescription Items,2872050.00
2016/17,Hardwick CCG,03Y,Total primary care (all BNF),Net Ingredient Cost (£),18956160.33
2016/17,Hardwick CCG,03Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,128510.00
2016/17,Hardwick CCG,03Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2019130.05
2016/17,Hardwick CCG,03Y,Insulins (BNF 6.1.1) ,Prescription Items,18887.00
2016/17,Hardwick CCG,03Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),925252.22
2016/17,Hardwick CCG,03Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5167.00
2016/17,Hardwick CCG,03Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),257027.46
2016/17,Hardwick CCG,03Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13720.00
2016/17,Hardwick CCG,03Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),668224.76
2016/17,Hardwick CCG,03Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,91175.00
2016/17,Hardwick CCG,03Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),653271.13
2016/17,Hardwick CCG,03Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23739.00
2016/17,Hardwick CCG,03Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),61803.50
2016/17,Hardwick CCG,03Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,57008.00
2016/17,Hardwick CCG,03Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),209865.86
2016/17,Hardwick CCG,03Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,10428.00
2016/17,Hardwick CCG,03Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),381601.77
2016/17,Hardwick CCG,03Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,17408.00
2016/17,Hardwick CCG,03Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),428519.85
2016/17,Hardwick CCG,03Y,Human analogue insulins ,Prescription Items,12445.00
2016/17,Hardwick CCG,03Y,Human analogue insulins ,Net Ingredient Cost (£),693468.38
2016/17,Hardwick CCG,03Y,Other insulins ,Prescription Items,6442.00
2016/17,Hardwick CCG,03Y,Other insulins ,Net Ingredient Cost (£),231783.84
2016/17,Haringey CCG,08D,Total primary care (all BNF),Prescription Items,4080659.00
2016/17,Haringey CCG,08D,Total primary care (all BNF),Net Ingredient Cost (£),30232564.99
2016/17,Haringey CCG,08D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,294157.00
2016/17,Haringey CCG,08D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4241473.33
2016/17,Haringey CCG,08D,Insulins (BNF 6.1.1) ,Prescription Items,21889.00
2016/17,Haringey CCG,08D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1088653.31
2016/17,Haringey CCG,08D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6038.00
2016/17,Haringey CCG,08D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),289525.90
2016/17,Haringey CCG,08D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15851.00
2016/17,Haringey CCG,08D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),799127.41
2016/17,Haringey CCG,08D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,244490.00
2016/17,Haringey CCG,08D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2527176.90
2016/17,Haringey CCG,08D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,67592.00
2016/17,Haringey CCG,08D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),184701.52
2016/17,Haringey CCG,08D,Biguanides (BNF 6.1.2.2) ,Prescription Items,121958.00
2016/17,Haringey CCG,08D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),513560.53
2016/17,Haringey CCG,08D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,54940.00
2016/17,Haringey CCG,08D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1828914.85
2016/17,Haringey CCG,08D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,26800.00
2016/17,Haringey CCG,08D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),614255.05
2016/17,Haringey CCG,08D,Human analogue insulins ,Prescription Items,18242.00
2016/17,Haringey CCG,08D,Human analogue insulins ,Net Ingredient Cost (£),980815.35
2016/17,Haringey CCG,08D,Other insulins ,Prescription Items,3647.00
2016/17,Haringey CCG,08D,Other insulins ,Net Ingredient Cost (£),107837.96
2016/17,Harrogate and Rural District CCG,03E,Total primary care (all BNF),Prescription Items,3139289.00
2016/17,Harrogate and Rural District CCG,03E,Total primary care (all BNF),Net Ingredient Cost (£),27548137.09
2016/17,Harrogate and Rural District CCG,03E,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,120862.00
2016/17,Harrogate and Rural District CCG,03E,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2711739.60
2016/17,Harrogate and Rural District CCG,03E,Insulins (BNF 6.1.1) ,Prescription Items,18066.00
2016/17,Harrogate and Rural District CCG,03E,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),854475.93
2016/17,Harrogate and Rural District CCG,03E,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6360.00
2016/17,Harrogate and Rural District CCG,03E,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),292374.50
2016/17,Harrogate and Rural District CCG,03E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,11706.00
2016/17,Harrogate and Rural District CCG,03E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),562101.43
2016/17,Harrogate and Rural District CCG,03E,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,83405.00
2016/17,Harrogate and Rural District CCG,03E,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1236338.30
2016/17,Harrogate and Rural District CCG,03E,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,11027.00
2016/17,Harrogate and Rural District CCG,03E,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),32277.65
2016/17,Harrogate and Rural District CCG,03E,Biguanides (BNF 6.1.2.2) ,Prescription Items,48987.00
2016/17,Harrogate and Rural District CCG,03E,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),221293.78
2016/17,Harrogate and Rural District CCG,03E,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,23391.00
2016/17,Harrogate and Rural District CCG,03E,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),982766.87
2016/17,Harrogate and Rural District CCG,03E,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,18052.00
2016/17,Harrogate and Rural District CCG,03E,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),603040.48
2016/17,Harrogate and Rural District CCG,03E,Human analogue insulins ,Prescription Items,15595.00
2016/17,Harrogate and Rural District CCG,03E,Human analogue insulins ,Net Ingredient Cost (£),786839.86
2016/17,Harrogate and Rural District CCG,03E,Other insulins ,Prescription Items,2471.00
2016/17,Harrogate and Rural District CCG,03E,Other insulins ,Net Ingredient Cost (£),67636.07
2016/17,Harrow CCG,08E,Total primary care (all BNF),Prescription Items,4428792.00
2016/17,Harrow CCG,08E,Total primary care (all BNF),Net Ingredient Cost (£),33373791.86
2016/17,Harrow CCG,08E,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,319066.00
2016/17,Harrow CCG,08E,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4584930.59
2016/17,Harrow CCG,08E,Insulins (BNF 6.1.1) ,Prescription Items,28488.00
2016/17,Harrow CCG,08E,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1274883.80
2016/17,Harrow CCG,08E,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8476.00
2016/17,Harrow CCG,08E,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),366296.69
2016/17,Harrow CCG,08E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,20012.00
2016/17,Harrow CCG,08E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),908587.11
2016/17,Harrow CCG,08E,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,258862.00
2016/17,Harrow CCG,08E,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2522805.74
2016/17,Harrow CCG,08E,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,66373.00
2016/17,Harrow CCG,08E,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),201387.34
2016/17,Harrow CCG,08E,Biguanides (BNF 6.1.2.2) ,Prescription Items,142267.00
2016/17,Harrow CCG,08E,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),530935.31
2016/17,Harrow CCG,08E,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,50222.00
2016/17,Harrow CCG,08E,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1790483.09
2016/17,Harrow CCG,08E,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,30836.00
2016/17,Harrow CCG,08E,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),775572.39
2016/17,Harrow CCG,08E,Human analogue insulins ,Prescription Items,24395.00
2016/17,Harrow CCG,08E,Human analogue insulins ,Net Ingredient Cost (£),1157233.45
2016/17,Harrow CCG,08E,Other insulins ,Prescription Items,4093.00
2016/17,Harrow CCG,08E,Other insulins ,Net Ingredient Cost (£),117650.35
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Total primary care (all BNF),Prescription Items,6436426.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Total primary care (all BNF),Net Ingredient Cost (£),51299204.43
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,256563.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4704696.21
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Insulins (BNF 6.1.1) ,Prescription Items,39277.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1880878.55
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11521.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),564869.21
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,27756.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1316009.34
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,174911.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1923679.50
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,42563.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),136906.59
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Biguanides (BNF 6.1.2.2) ,Prescription Items,100924.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),453635.85
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,31424.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1333137.06
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,41040.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),886445.51
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Human analogue insulins ,Prescription Items,26257.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Human analogue insulins ,Net Ingredient Cost (£),1434048.89
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Other insulins ,Prescription Items,13020.00
2016/17,Hartlepool and Stockton-On-Tees CCG,00K,Other insulins ,Net Ingredient Cost (£),446829.66
2016/17,Hastings & Rother CCG,09P,Total primary care (all BNF),Prescription Items,4378918.00
2016/17,Hastings & Rother CCG,09P,Total primary care (all BNF),Net Ingredient Cost (£),37051937.76
2016/17,Hastings & Rother CCG,09P,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,191951.00
2016/17,Hastings & Rother CCG,09P,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4300367.91
2016/17,Hastings & Rother CCG,09P,Insulins (BNF 6.1.1) ,Prescription Items,29456.00
2016/17,Hastings & Rother CCG,09P,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1701969.30
2016/17,Hastings & Rother CCG,09P,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11057.00
2016/17,Hastings & Rother CCG,09P,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),520796.68
2016/17,Hastings & Rother CCG,09P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,18399.00
2016/17,Hastings & Rother CCG,09P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1181172.62
2016/17,Hastings & Rother CCG,09P,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,135108.00
2016/17,Hastings & Rother CCG,09P,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1810595.78
2016/17,Hastings & Rother CCG,09P,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,28492.00
2016/17,Hastings & Rother CCG,09P,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),69843.33
2016/17,Hastings & Rother CCG,09P,Biguanides (BNF 6.1.2.2) ,Prescription Items,72000.00
2016/17,Hastings & Rother CCG,09P,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),331296.87
2016/17,Hastings & Rother CCG,09P,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,34616.00
2016/17,Hastings & Rother CCG,09P,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1409455.58
2016/17,Hastings & Rother CCG,09P,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,26292.00
2016/17,Hastings & Rother CCG,09P,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),770712.53
2016/17,Hastings & Rother CCG,09P,Human analogue insulins ,Prescription Items,28301.00
2016/17,Hastings & Rother CCG,09P,Human analogue insulins ,Net Ingredient Cost (£),1659446.46
2016/17,Hastings & Rother CCG,09P,Other insulins ,Prescription Items,1155.00
2016/17,Hastings & Rother CCG,09P,Other insulins ,Net Ingredient Cost (£),42522.84
2016/17,Havering CCG,08F,Total primary care (all BNF),Prescription Items,4664114.00
2016/17,Havering CCG,08F,Total primary care (all BNF),Net Ingredient Cost (£),40158282.98
2016/17,Havering CCG,08F,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,233031.00
2016/17,Havering CCG,08F,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4917559.99
2016/17,Havering CCG,08F,Insulins (BNF 6.1.1) ,Prescription Items,32726.00
2016/17,Havering CCG,08F,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1678616.34
2016/17,Havering CCG,08F,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11469.00
2016/17,Havering CCG,08F,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),526317.67
2016/17,Havering CCG,08F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21257.00
2016/17,Havering CCG,08F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1152298.67
2016/17,Havering CCG,08F,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,168354.00
2016/17,Havering CCG,08F,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2435423.25
2016/17,Havering CCG,08F,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,30978.00
2016/17,Havering CCG,08F,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),115223.11
2016/17,Havering CCG,08F,Biguanides (BNF 6.1.2.2) ,Prescription Items,91606.00
2016/17,Havering CCG,08F,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),484125.84
2016/17,Havering CCG,08F,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,45770.00
2016/17,Havering CCG,08F,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1836074.30
2016/17,Havering CCG,08F,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,30469.00
2016/17,Havering CCG,08F,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),764206.81
2016/17,Havering CCG,08F,Human analogue insulins ,Prescription Items,30015.00
2016/17,Havering CCG,08F,Human analogue insulins ,Net Ingredient Cost (£),1575098.26
2016/17,Havering CCG,08F,Other insulins ,Prescription Items,2711.00
2016/17,Havering CCG,08F,Other insulins ,Net Ingredient Cost (£),103518.08
2016/17,Herefordshire CCG,05F,Total primary care (all BNF),Prescription Items,3716851.00
2016/17,Herefordshire CCG,05F,Total primary care (all BNF),Net Ingredient Cost (£),30047759.94
2016/17,Herefordshire CCG,05F,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,172168.00
2016/17,Herefordshire CCG,05F,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3263430.00
2016/17,Herefordshire CCG,05F,Insulins (BNF 6.1.1) ,Prescription Items,25925.00
2016/17,Herefordshire CCG,05F,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1238399.24
2016/17,Herefordshire CCG,05F,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8884.00
2016/17,Herefordshire CCG,05F,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),385430.47
2016/17,Herefordshire CCG,05F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,17041.00
2016/17,Herefordshire CCG,05F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),852968.77
2016/17,Herefordshire CCG,05F,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,120369.00
2016/17,Herefordshire CCG,05F,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1274150.59
2016/17,Herefordshire CCG,05F,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23970.00
2016/17,Herefordshire CCG,05F,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),84365.40
2016/17,Herefordshire CCG,05F,Biguanides (BNF 6.1.2.2) ,Prescription Items,73139.00
2016/17,Herefordshire CCG,05F,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),319039.25
2016/17,Herefordshire CCG,05F,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,23260.00
2016/17,Herefordshire CCG,05F,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),870745.94
2016/17,Herefordshire CCG,05F,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,25116.00
2016/17,Herefordshire CCG,05F,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),740393.24
2016/17,Herefordshire CCG,05F,Human analogue insulins ,Prescription Items,22298.00
2016/17,Herefordshire CCG,05F,Human analogue insulins ,Net Ingredient Cost (£),1119035.31
2016/17,Herefordshire CCG,05F,Other insulins ,Prescription Items,3627.00
2016/17,Herefordshire CCG,05F,Other insulins ,Net Ingredient Cost (£),119363.93
2016/17,Herts Valleys CCG,06N,Total primary care (all BNF),Prescription Items,9193338.00
2016/17,Herts Valleys CCG,06N,Total primary care (all BNF),Net Ingredient Cost (£),79092297.40
2016/17,Herts Valleys CCG,06N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,411915.00
2016/17,Herts Valleys CCG,06N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),7779827.06
2016/17,Herts Valleys CCG,06N,Insulins (BNF 6.1.1) ,Prescription Items,56579.00
2016/17,Herts Valleys CCG,06N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2802074.55
2016/17,Herts Valleys CCG,06N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,18870.00
2016/17,Herts Valleys CCG,06N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),956542.74
2016/17,Herts Valleys CCG,06N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,37709.00
2016/17,Herts Valleys CCG,06N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1845531.81
2016/17,Herts Valleys CCG,06N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,290644.00
2016/17,Herts Valleys CCG,06N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3157564.33
2016/17,Herts Valleys CCG,06N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,73360.00
2016/17,Herts Valleys CCG,06N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),260816.48
2016/17,Herts Valleys CCG,06N,Biguanides (BNF 6.1.2.2) ,Prescription Items,167316.00
2016/17,Herts Valleys CCG,06N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),793896.47
2016/17,Herts Valleys CCG,06N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,49968.00
2016/17,Herts Valleys CCG,06N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2102851.38
2016/17,Herts Valleys CCG,06N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,62245.00
2016/17,Herts Valleys CCG,06N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1782486.16
2016/17,Herts Valleys CCG,06N,Human analogue insulins ,Prescription Items,41165.00
2016/17,Herts Valleys CCG,06N,Human analogue insulins ,Net Ingredient Cost (£),2283797.97
2016/17,Herts Valleys CCG,06N,Other insulins ,Prescription Items,15414.00
2016/17,Herts Valleys CCG,06N,Other insulins ,Net Ingredient Cost (£),518276.58
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Total primary care (all BNF),Prescription Items,4773970.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Total primary care (all BNF),Net Ingredient Cost (£),43403381.09
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,238846.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4654734.02
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Insulins (BNF 6.1.1) ,Prescription Items,29344.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1293203.85
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9425.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),384717.76
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19919.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),908486.09
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,177307.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2629489.92
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,37573.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),120114.01
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Biguanides (BNF 6.1.2.2) ,Prescription Items,88194.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),423195.97
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,51540.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2086179.94
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,30831.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),714716.35
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Human analogue insulins ,Prescription Items,24199.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Human analogue insulins ,Net Ingredient Cost (£),1151948.13
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Other insulins ,Prescription Items,5145.00
2016/17,"Heywood, Middleton & Rochdale CCG",01D,Other insulins ,Net Ingredient Cost (£),141255.72
2016/17,High Weald Lewes Havens CCG,99K,Total primary care (all BNF),Prescription Items,3254747.00
2016/17,High Weald Lewes Havens CCG,99K,Total primary care (all BNF),Net Ingredient Cost (£),29363108.52
2016/17,High Weald Lewes Havens CCG,99K,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,124600.00
2016/17,High Weald Lewes Havens CCG,99K,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2632834.46
2016/17,High Weald Lewes Havens CCG,99K,Insulins (BNF 6.1.1) ,Prescription Items,18547.00
2016/17,High Weald Lewes Havens CCG,99K,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),935642.90
2016/17,High Weald Lewes Havens CCG,99K,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6714.00
2016/17,High Weald Lewes Havens CCG,99K,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),302258.10
2016/17,High Weald Lewes Havens CCG,99K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,11833.00
2016/17,High Weald Lewes Havens CCG,99K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),633384.80
2016/17,High Weald Lewes Havens CCG,99K,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,85918.00
2016/17,High Weald Lewes Havens CCG,99K,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1081038.76
2016/17,High Weald Lewes Havens CCG,99K,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,20760.00
2016/17,High Weald Lewes Havens CCG,99K,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),67207.70
2016/17,High Weald Lewes Havens CCG,99K,Biguanides (BNF 6.1.2.2) ,Prescription Items,46550.00
2016/17,High Weald Lewes Havens CCG,99K,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),221625.96
2016/17,High Weald Lewes Havens CCG,99K,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,18608.00
2016/17,High Weald Lewes Havens CCG,99K,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),792205.10
2016/17,High Weald Lewes Havens CCG,99K,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,19325.00
2016/17,High Weald Lewes Havens CCG,99K,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),605716.47
2016/17,High Weald Lewes Havens CCG,99K,Human analogue insulins ,Prescription Items,16831.00
2016/17,High Weald Lewes Havens CCG,99K,Human analogue insulins ,Net Ingredient Cost (£),880170.04
2016/17,High Weald Lewes Havens CCG,99K,Other insulins ,Prescription Items,1716.00
2016/17,High Weald Lewes Havens CCG,99K,Other insulins ,Net Ingredient Cost (£),55472.86
2016/17,Hillingdon CCG,08G,Total primary care (all BNF),Prescription Items,4563422.00
2016/17,Hillingdon CCG,08G,Total primary care (all BNF),Net Ingredient Cost (£),35283588.22
2016/17,Hillingdon CCG,08G,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,296646.00
2016/17,Hillingdon CCG,08G,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5290884.33
2016/17,Hillingdon CCG,08G,Insulins (BNF 6.1.1) ,Prescription Items,36343.00
2016/17,Hillingdon CCG,08G,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1694788.64
2016/17,Hillingdon CCG,08G,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11866.00
2016/17,Hillingdon CCG,08G,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),545128.46
2016/17,Hillingdon CCG,08G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,24477.00
2016/17,Hillingdon CCG,08G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1149660.18
2016/17,Hillingdon CCG,08G,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,220581.00
2016/17,Hillingdon CCG,08G,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2681182.80
2016/17,Hillingdon CCG,08G,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,52176.00
2016/17,Hillingdon CCG,08G,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),169069.56
2016/17,Hillingdon CCG,08G,Biguanides (BNF 6.1.2.2) ,Prescription Items,120561.00
2016/17,Hillingdon CCG,08G,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),568845.04
2016/17,Hillingdon CCG,08G,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,47844.00
2016/17,Hillingdon CCG,08G,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1943268.20
2016/17,Hillingdon CCG,08G,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,38737.00
2016/17,Hillingdon CCG,08G,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),903234.36
2016/17,Hillingdon CCG,08G,Human analogue insulins ,Prescription Items,29784.00
2016/17,Hillingdon CCG,08G,Human analogue insulins ,Net Ingredient Cost (£),1500359.82
2016/17,Hillingdon CCG,08G,Other insulins ,Prescription Items,6559.00
2016/17,Hillingdon CCG,08G,Other insulins ,Net Ingredient Cost (£),194428.82
2016/17,Horsham and Mid Sussex CCG,09X,Total primary care (all BNF),Prescription Items,3302809.00
2016/17,Horsham and Mid Sussex CCG,09X,Total primary care (all BNF),Net Ingredient Cost (£),35477948.17
2016/17,Horsham and Mid Sussex CCG,09X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,132047.00
2016/17,Horsham and Mid Sussex CCG,09X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3352270.32
2016/17,Horsham and Mid Sussex CCG,09X,Insulins (BNF 6.1.1) ,Prescription Items,23820.00
2016/17,Horsham and Mid Sussex CCG,09X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1282132.98
2016/17,Horsham and Mid Sussex CCG,09X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8953.00
2016/17,Horsham and Mid Sussex CCG,09X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),439468.60
2016/17,Horsham and Mid Sussex CCG,09X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,14867.00
2016/17,Horsham and Mid Sussex CCG,09X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),842664.38
2016/17,Horsham and Mid Sussex CCG,09X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,81539.00
2016/17,Horsham and Mid Sussex CCG,09X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1241122.48
2016/17,Horsham and Mid Sussex CCG,09X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,18514.00
2016/17,Horsham and Mid Sussex CCG,09X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),99398.84
2016/17,Horsham and Mid Sussex CCG,09X,Biguanides (BNF 6.1.2.2) ,Prescription Items,47459.00
2016/17,Horsham and Mid Sussex CCG,09X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),322625.79
2016/17,Horsham and Mid Sussex CCG,09X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,15566.00
2016/17,Horsham and Mid Sussex CCG,09X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),819097.85
2016/17,Horsham and Mid Sussex CCG,09X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,25706.00
2016/17,Horsham and Mid Sussex CCG,09X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),816466.81
2016/17,Horsham and Mid Sussex CCG,09X,Human analogue insulins ,Prescription Items,21648.00
2016/17,Horsham and Mid Sussex CCG,09X,Human analogue insulins ,Net Ingredient Cost (£),1208457.12
2016/17,Horsham and Mid Sussex CCG,09X,Other insulins ,Prescription Items,2172.00
2016/17,Horsham and Mid Sussex CCG,09X,Other insulins ,Net Ingredient Cost (£),73675.86
2016/17,Hounslow CCG,07Y,Total primary care (all BNF),Prescription Items,4347085.00
2016/17,Hounslow CCG,07Y,Total primary care (all BNF),Net Ingredient Cost (£),33220935.74
2016/17,Hounslow CCG,07Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,313162.00
2016/17,Hounslow CCG,07Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5572923.23
2016/17,Hounslow CCG,07Y,Insulins (BNF 6.1.1) ,Prescription Items,31952.00
2016/17,Hounslow CCG,07Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1670706.95
2016/17,Hounslow CCG,07Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9759.00
2016/17,Hounslow CCG,07Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),488871.93
2016/17,Hounslow CCG,07Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,22193.00
2016/17,Hounslow CCG,07Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1181835.02
2016/17,Hounslow CCG,07Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,247282.00
2016/17,Hounslow CCG,07Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3152035.93
2016/17,Hounslow CCG,07Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,52070.00
2016/17,Hounslow CCG,07Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),151438.98
2016/17,Hounslow CCG,07Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,127087.00
2016/17,Hounslow CCG,07Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),524915.30
2016/17,Hounslow CCG,07Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,68125.00
2016/17,Hounslow CCG,07Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2475681.65
2016/17,Hounslow CCG,07Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,33093.00
2016/17,Hounslow CCG,07Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),740010.55
2016/17,Hounslow CCG,07Y,Human analogue insulins ,Prescription Items,26948.00
2016/17,Hounslow CCG,07Y,Human analogue insulins ,Net Ingredient Cost (£),1508079.23
2016/17,Hounslow CCG,07Y,Other insulins ,Prescription Items,5004.00
2016/17,Hounslow CCG,07Y,Other insulins ,Net Ingredient Cost (£),162627.72
2016/17,Hull CCG,03F,Total primary care (all BNF),Prescription Items,6871926.00
2016/17,Hull CCG,03F,Total primary care (all BNF),Net Ingredient Cost (£),51488265.00
2016/17,Hull CCG,03F,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,335147.00
2016/17,Hull CCG,03F,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5426231.21
2016/17,Hull CCG,03F,Insulins (BNF 6.1.1) ,Prescription Items,35845.00
2016/17,Hull CCG,03F,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1649398.96
2016/17,Hull CCG,03F,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10928.00
2016/17,Hull CCG,03F,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),488893.58
2016/17,Hull CCG,03F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,24917.00
2016/17,Hull CCG,03F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1160505.38
2016/17,Hull CCG,03F,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,254675.00
2016/17,Hull CCG,03F,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2669290.31
2016/17,Hull CCG,03F,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,45797.00
2016/17,Hull CCG,03F,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),113589.92
2016/17,Hull CCG,03F,Biguanides (BNF 6.1.2.2) ,Prescription Items,147786.00
2016/17,Hull CCG,03F,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),543438.96
2016/17,Hull CCG,03F,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,61092.00
2016/17,Hull CCG,03F,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2012261.43
2016/17,Hull CCG,03F,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,42918.00
2016/17,Hull CCG,03F,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1088216.53
2016/17,Hull CCG,03F,Human analogue insulins ,Prescription Items,25861.00
2016/17,Hull CCG,03F,Human analogue insulins ,Net Ingredient Cost (£),1335004.92
2016/17,Hull CCG,03F,Other insulins ,Prescription Items,9984.00
2016/17,Hull CCG,03F,Other insulins ,Net Ingredient Cost (£),314394.04
2016/17,Ipswich and East Suffolk CCG,06L,Total primary care (all BNF),Prescription Items,7925175.00
2016/17,Ipswich and East Suffolk CCG,06L,Total primary care (all BNF),Net Ingredient Cost (£),63289507.52
2016/17,Ipswich and East Suffolk CCG,06L,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,328291.00
2016/17,Ipswich and East Suffolk CCG,06L,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6272896.71
2016/17,Ipswich and East Suffolk CCG,06L,Insulins (BNF 6.1.1) ,Prescription Items,45111.00
2016/17,Ipswich and East Suffolk CCG,06L,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2181369.52
2016/17,Ipswich and East Suffolk CCG,06L,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,14545.00
2016/17,Ipswich and East Suffolk CCG,06L,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),665621.53
2016/17,Ipswich and East Suffolk CCG,06L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,30566.00
2016/17,Ipswich and East Suffolk CCG,06L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1515747.99
2016/17,Ipswich and East Suffolk CCG,06L,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,233720.00
2016/17,Ipswich and East Suffolk CCG,06L,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2752648.92
2016/17,Ipswich and East Suffolk CCG,06L,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,49120.00
2016/17,Ipswich and East Suffolk CCG,06L,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),165576.73
2016/17,Ipswich and East Suffolk CCG,06L,Biguanides (BNF 6.1.2.2) ,Prescription Items,130859.00
2016/17,Ipswich and East Suffolk CCG,06L,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),547427.46
2016/17,Ipswich and East Suffolk CCG,06L,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,53741.00
2016/17,Ipswich and East Suffolk CCG,06L,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2039644.73
2016/17,Ipswich and East Suffolk CCG,06L,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,47386.00
2016/17,Ipswich and East Suffolk CCG,06L,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1315314.17
2016/17,Ipswich and East Suffolk CCG,06L,Human analogue insulins ,Prescription Items,35227.00
2016/17,Ipswich and East Suffolk CCG,06L,Human analogue insulins ,Net Ingredient Cost (£),1856411.54
2016/17,Ipswich and East Suffolk CCG,06L,Other insulins ,Prescription Items,9884.00
2016/17,Ipswich and East Suffolk CCG,06L,Other insulins ,Net Ingredient Cost (£),324957.98
2016/17,Isle of Wight CCG,10L,Total primary care (all BNF),Prescription Items,3273301.00
2016/17,Isle of Wight CCG,10L,Total primary care (all BNF),Net Ingredient Cost (£),26185013.46
2016/17,Isle of Wight CCG,10L,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,143744.00
2016/17,Isle of Wight CCG,10L,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2724361.16
2016/17,Isle of Wight CCG,10L,Insulins (BNF 6.1.1) ,Prescription Items,23156.00
2016/17,Isle of Wight CCG,10L,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1130128.48
2016/17,Isle of Wight CCG,10L,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8611.00
2016/17,Isle of Wight CCG,10L,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),404187.22
2016/17,Isle of Wight CCG,10L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,14545.00
2016/17,Isle of Wight CCG,10L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),725941.26
2016/17,Isle of Wight CCG,10L,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,97918.00
2016/17,Isle of Wight CCG,10L,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),944233.90
2016/17,Isle of Wight CCG,10L,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23689.00
2016/17,Isle of Wight CCG,10L,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),78562.01
2016/17,Isle of Wight CCG,10L,Biguanides (BNF 6.1.2.2) ,Prescription Items,57189.00
2016/17,Isle of Wight CCG,10L,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),228900.66
2016/17,Isle of Wight CCG,10L,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,17040.00
2016/17,Isle of Wight CCG,10L,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),636771.23
2016/17,Isle of Wight CCG,10L,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,21590.00
2016/17,Isle of Wight CCG,10L,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),638224.00
2016/17,Isle of Wight CCG,10L,Human analogue insulins ,Prescription Items,19309.00
2016/17,Isle of Wight CCG,10L,Human analogue insulins ,Net Ingredient Cost (£),1006408.16
2016/17,Isle of Wight CCG,10L,Other insulins ,Prescription Items,3847.00
2016/17,Isle of Wight CCG,10L,Other insulins ,Net Ingredient Cost (£),123720.32
2016/17,Islington CCG,08H,Total primary care (all BNF),Prescription Items,2617408.00
2016/17,Islington CCG,08H,Total primary care (all BNF),Net Ingredient Cost (£),26103759.73
2016/17,Islington CCG,08H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,130248.00
2016/17,Islington CCG,08H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2947718.90
2016/17,Islington CCG,08H,Insulins (BNF 6.1.1) ,Prescription Items,17310.00
2016/17,Islington CCG,08H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),965412.49
2016/17,Islington CCG,08H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5489.00
2016/17,Islington CCG,08H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),294237.94
2016/17,Islington CCG,08H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,11821.00
2016/17,Islington CCG,08H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),671174.55
2016/17,Islington CCG,08H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,93443.00
2016/17,Islington CCG,08H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1432280.84
2016/17,Islington CCG,08H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,25536.00
2016/17,Islington CCG,08H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),110151.07
2016/17,Islington CCG,08H,Biguanides (BNF 6.1.2.2) ,Prescription Items,51350.00
2016/17,Islington CCG,08H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),315976.59
2016/17,Islington CCG,08H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,16557.00
2016/17,Islington CCG,08H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1006153.18
2016/17,Islington CCG,08H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,18556.00
2016/17,Islington CCG,08H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),538081.08
2016/17,Islington CCG,08H,Human analogue insulins ,Prescription Items,14521.00
2016/17,Islington CCG,08H,Human analogue insulins ,Net Ingredient Cost (£),875970.41
2016/17,Islington CCG,08H,Other insulins ,Prescription Items,2789.00
2016/17,Islington CCG,08H,Other insulins ,Net Ingredient Cost (£),89442.08
2016/17,Kernow CCG,11N,Total primary care (all BNF),Prescription Items,13021507.00
2016/17,Kernow CCG,11N,Total primary care (all BNF),Net Ingredient Cost (£),100700850.16
2016/17,Kernow CCG,11N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,546234.00
2016/17,Kernow CCG,11N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),9619314.02
2016/17,Kernow CCG,11N,Insulins (BNF 6.1.1) ,Prescription Items,71917.00
2016/17,Kernow CCG,11N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3223973.63
2016/17,Kernow CCG,11N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,25104.00
2016/17,Kernow CCG,11N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1076635.08
2016/17,Kernow CCG,11N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,46813.00
2016/17,Kernow CCG,11N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2147338.55
2016/17,Kernow CCG,11N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,396557.00
2016/17,Kernow CCG,11N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),4410558.98
2016/17,Kernow CCG,11N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,76089.00
2016/17,Kernow CCG,11N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),184434.98
2016/17,Kernow CCG,11N,Biguanides (BNF 6.1.2.2) ,Prescription Items,220012.00
2016/17,Kernow CCG,11N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),838668.92
2016/17,Kernow CCG,11N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,100456.00
2016/17,Kernow CCG,11N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),3387455.08
2016/17,Kernow CCG,11N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,74225.00
2016/17,Kernow CCG,11N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1941480.21
2016/17,Kernow CCG,11N,Human analogue insulins ,Prescription Items,58011.00
2016/17,Kernow CCG,11N,Human analogue insulins ,Net Ingredient Cost (£),2794510.05
2016/17,Kernow CCG,11N,Other insulins ,Prescription Items,13906.00
2016/17,Kernow CCG,11N,Other insulins ,Net Ingredient Cost (£),429463.58
2016/17,Kingston CCG,08J,Total primary care (all BNF),Prescription Items,2560011.00
2016/17,Kingston CCG,08J,Total primary care (all BNF),Net Ingredient Cost (£),20340500.23
2016/17,Kingston CCG,08J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,126863.00
2016/17,Kingston CCG,08J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2325206.56
2016/17,Kingston CCG,08J,Insulins (BNF 6.1.1) ,Prescription Items,18236.00
2016/17,Kingston CCG,08J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),931060.43
2016/17,Kingston CCG,08J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6568.00
2016/17,Kingston CCG,08J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),314265.28
2016/17,Kingston CCG,08J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,11668.00
2016/17,Kingston CCG,08J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),616795.15
2016/17,Kingston CCG,08J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,91577.00
2016/17,Kingston CCG,08J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),954738.66
2016/17,Kingston CCG,08J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,24529.00
2016/17,Kingston CCG,08J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),86331.10
2016/17,Kingston CCG,08J,Biguanides (BNF 6.1.2.2) ,Prescription Items,52519.00
2016/17,Kingston CCG,08J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),225521.79
2016/17,Kingston CCG,08J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,14529.00
2016/17,Kingston CCG,08J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),642885.77
2016/17,Kingston CCG,08J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,16480.00
2016/17,Kingston CCG,08J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),433594.84
2016/17,Kingston CCG,08J,Human analogue insulins ,Prescription Items,16079.00
2016/17,Kingston CCG,08J,Human analogue insulins ,Net Ingredient Cost (£),863770.35
2016/17,Kingston CCG,08J,Other insulins ,Prescription Items,2157.00
2016/17,Kingston CCG,08J,Other insulins ,Net Ingredient Cost (£),67290.08
2016/17,Knowsley CCG,01J,Total primary care (all BNF),Prescription Items,4277634.00
2016/17,Knowsley CCG,01J,Total primary care (all BNF),Net Ingredient Cost (£),34142442.42
2016/17,Knowsley CCG,01J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,178690.00
2016/17,Knowsley CCG,01J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3473286.32
2016/17,Knowsley CCG,01J,Insulins (BNF 6.1.1) ,Prescription Items,26451.00
2016/17,Knowsley CCG,01J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1266430.74
2016/17,Knowsley CCG,01J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8530.00
2016/17,Knowsley CCG,01J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),364706.00
2016/17,Knowsley CCG,01J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,17921.00
2016/17,Knowsley CCG,01J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),901724.74
2016/17,Knowsley CCG,01J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,129764.00
2016/17,Knowsley CCG,01J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1635264.95
2016/17,Knowsley CCG,01J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,22555.00
2016/17,Knowsley CCG,01J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),67469.43
2016/17,Knowsley CCG,01J,Biguanides (BNF 6.1.2.2) ,Prescription Items,75012.00
2016/17,Knowsley CCG,01J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),375129.44
2016/17,Knowsley CCG,01J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,32197.00
2016/17,Knowsley CCG,01J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1192666.08
2016/17,Knowsley CCG,01J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,21162.00
2016/17,Knowsley CCG,01J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),558138.20
2016/17,Knowsley CCG,01J,Human analogue insulins ,Prescription Items,24440.00
2016/17,Knowsley CCG,01J,Human analogue insulins ,Net Ingredient Cost (£),1199608.50
2016/17,Knowsley CCG,01J,Other insulins ,Prescription Items,2011.00
2016/17,Knowsley CCG,01J,Other insulins ,Net Ingredient Cost (£),66822.24
2016/17,Lambeth CCG,08K,Total primary care (all BNF),Prescription Items,4693662.00
2016/17,Lambeth CCG,08K,Total primary care (all BNF),Net Ingredient Cost (£),36234662.51
2016/17,Lambeth CCG,08K,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,304992.00
2016/17,Lambeth CCG,08K,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4541460.24
2016/17,Lambeth CCG,08K,Insulins (BNF 6.1.1) ,Prescription Items,32683.00
2016/17,Lambeth CCG,08K,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1629521.95
2016/17,Lambeth CCG,08K,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9179.00
2016/17,Lambeth CCG,08K,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),441271.63
2016/17,Lambeth CCG,08K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,23504.00
2016/17,Lambeth CCG,08K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1188250.32
2016/17,Lambeth CCG,08K,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,238753.00
2016/17,Lambeth CCG,08K,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2026608.52
2016/17,Lambeth CCG,08K,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,68399.00
2016/17,Lambeth CCG,08K,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),194107.77
2016/17,Lambeth CCG,08K,Biguanides (BNF 6.1.2.2) ,Prescription Items,134336.00
2016/17,Lambeth CCG,08K,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),536136.11
2016/17,Lambeth CCG,08K,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,36018.00
2016/17,Lambeth CCG,08K,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1296364.64
2016/17,Lambeth CCG,08K,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,32689.00
2016/17,Lambeth CCG,08K,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),872225.35
2016/17,Lambeth CCG,08K,Human analogue insulins ,Prescription Items,25079.00
2016/17,Lambeth CCG,08K,Human analogue insulins ,Net Ingredient Cost (£),1379455.34
2016/17,Lambeth CCG,08K,Other insulins ,Prescription Items,7604.00
2016/17,Lambeth CCG,08K,Other insulins ,Net Ingredient Cost (£),250066.61
2016/17,Lancashire North CCG,01K,Total primary care (all BNF),Prescription Items,3344555.00
2016/17,Lancashire North CCG,01K,Total primary care (all BNF),Net Ingredient Cost (£),26908298.45
2016/17,Lancashire North CCG,01K,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,147830.00
2016/17,Lancashire North CCG,01K,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2598739.47
2016/17,Lancashire North CCG,01K,Insulins (BNF 6.1.1) ,Prescription Items,22301.00
2016/17,Lancashire North CCG,01K,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),955621.59
2016/17,Lancashire North CCG,01K,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8870.00
2016/17,Lancashire North CCG,01K,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),361956.38
2016/17,Lancashire North CCG,01K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13431.00
2016/17,Lancashire North CCG,01K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),593665.21
2016/17,Lancashire North CCG,01K,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,103284.00
2016/17,Lancashire North CCG,01K,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1098554.58
2016/17,Lancashire North CCG,01K,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,21584.00
2016/17,Lancashire North CCG,01K,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),59858.39
2016/17,Lancashire North CCG,01K,Biguanides (BNF 6.1.2.2) ,Prescription Items,61236.00
2016/17,Lancashire North CCG,01K,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),271906.92
2016/17,Lancashire North CCG,01K,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,20464.00
2016/17,Lancashire North CCG,01K,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),766789.27
2016/17,Lancashire North CCG,01K,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,21240.00
2016/17,Lancashire North CCG,01K,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),530582.58
2016/17,Lancashire North CCG,01K,Human analogue insulins ,Prescription Items,15836.00
2016/17,Lancashire North CCG,01K,Human analogue insulins ,Net Ingredient Cost (£),755822.21
2016/17,Lancashire North CCG,01K,Other insulins ,Prescription Items,6465.00
2016/17,Lancashire North CCG,01K,Other insulins ,Net Ingredient Cost (£),199799.38
2016/17,Leeds North CCG,02V,Total primary care (all BNF),Prescription Items,3928289.00
2016/17,Leeds North CCG,02V,Total primary care (all BNF),Net Ingredient Cost (£),31669369.49
2016/17,Leeds North CCG,02V,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,180413.00
2016/17,Leeds North CCG,02V,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3081942.01
2016/17,Leeds North CCG,02V,Insulins (BNF 6.1.1) ,Prescription Items,19142.00
2016/17,Leeds North CCG,02V,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1044109.88
2016/17,Leeds North CCG,02V,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6057.00
2016/17,Leeds North CCG,02V,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),312156.53
2016/17,Leeds North CCG,02V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13085.00
2016/17,Leeds North CCG,02V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),731953.35
2016/17,Leeds North CCG,02V,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,138189.00
2016/17,Leeds North CCG,02V,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1349713.49
2016/17,Leeds North CCG,02V,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,34115.00
2016/17,Leeds North CCG,02V,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),77548.91
2016/17,Leeds North CCG,02V,Biguanides (BNF 6.1.2.2) ,Prescription Items,75692.00
2016/17,Leeds North CCG,02V,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),317340.53
2016/17,Leeds North CCG,02V,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,28382.00
2016/17,Leeds North CCG,02V,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),954824.05
2016/17,Leeds North CCG,02V,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,22082.00
2016/17,Leeds North CCG,02V,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),670260.57
2016/17,Leeds North CCG,02V,Human analogue insulins ,Prescription Items,16192.00
2016/17,Leeds North CCG,02V,Human analogue insulins ,Net Ingredient Cost (£),934811.60
2016/17,Leeds North CCG,02V,Other insulins ,Prescription Items,2950.00
2016/17,Leeds North CCG,02V,Other insulins ,Net Ingredient Cost (£),109298.28
2016/17,Leeds South and East CCG,03G,Total primary care (all BNF),Prescription Items,5704034.00
2016/17,Leeds South and East CCG,03G,Total primary care (all BNF),Net Ingredient Cost (£),46903809.78
2016/17,Leeds South and East CCG,03G,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,254815.00
2016/17,Leeds South and East CCG,03G,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4679006.46
2016/17,Leeds South and East CCG,03G,Insulins (BNF 6.1.1) ,Prescription Items,30860.00
2016/17,Leeds South and East CCG,03G,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1671956.53
2016/17,Leeds South and East CCG,03G,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9033.00
2016/17,Leeds South and East CCG,03G,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),441497.52
2016/17,Leeds South and East CCG,03G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21827.00
2016/17,Leeds South and East CCG,03G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1230459.01
2016/17,Leeds South and East CCG,03G,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,188814.00
2016/17,Leeds South and East CCG,03G,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2030819.85
2016/17,Leeds South and East CCG,03G,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,47408.00
2016/17,Leeds South and East CCG,03G,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),124097.54
2016/17,Leeds South and East CCG,03G,Biguanides (BNF 6.1.2.2) ,Prescription Items,104149.00
2016/17,Leeds South and East CCG,03G,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),458711.41
2016/17,Leeds South and East CCG,03G,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,37257.00
2016/17,Leeds South and East CCG,03G,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1448010.90
2016/17,Leeds South and East CCG,03G,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,33665.00
2016/17,Leeds South and East CCG,03G,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),937155.22
2016/17,Leeds South and East CCG,03G,Human analogue insulins ,Prescription Items,25827.00
2016/17,Leeds South and East CCG,03G,Human analogue insulins ,Net Ingredient Cost (£),1486532.96
2016/17,Leeds South and East CCG,03G,Other insulins ,Prescription Items,5033.00
2016/17,Leeds South and East CCG,03G,Other insulins ,Net Ingredient Cost (£),185423.57
2016/17,Leeds West CCG,03C,Total primary care (all BNF),Prescription Items,6246795.00
2016/17,Leeds West CCG,03C,Total primary care (all BNF),Net Ingredient Cost (£),53615926.04
2016/17,Leeds West CCG,03C,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,257097.00
2016/17,Leeds West CCG,03C,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5037338.18
2016/17,Leeds West CCG,03C,Insulins (BNF 6.1.1) ,Prescription Items,31701.00
2016/17,Leeds West CCG,03C,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1767945.20
2016/17,Leeds West CCG,03C,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10697.00
2016/17,Leeds West CCG,03C,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),567823.20
2016/17,Leeds West CCG,03C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21004.00
2016/17,Leeds West CCG,03C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1200122.00
2016/17,Leeds West CCG,03C,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,187096.00
2016/17,Leeds West CCG,03C,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2114381.45
2016/17,Leeds West CCG,03C,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,48066.00
2016/17,Leeds West CCG,03C,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),121291.44
2016/17,Leeds West CCG,03C,Biguanides (BNF 6.1.2.2) ,Prescription Items,101249.00
2016/17,Leeds West CCG,03C,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),465105.12
2016/17,Leeds West CCG,03C,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,37781.00
2016/17,Leeds West CCG,03C,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1527984.89
2016/17,Leeds West CCG,03C,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,36534.00
2016/17,Leeds West CCG,03C,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1133623.37
2016/17,Leeds West CCG,03C,Human analogue insulins ,Prescription Items,27338.00
2016/17,Leeds West CCG,03C,Human analogue insulins ,Net Ingredient Cost (£),1601030.11
2016/17,Leeds West CCG,03C,Other insulins ,Prescription Items,4363.00
2016/17,Leeds West CCG,03C,Other insulins ,Net Ingredient Cost (£),166915.09
2016/17,Leicester City CCG,04C,Total primary care (all BNF),Prescription Items,6958743.00
2016/17,Leicester City CCG,04C,Total primary care (all BNF),Net Ingredient Cost (£),51366355.53
2016/17,Leicester City CCG,04C,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,514544.00
2016/17,Leicester City CCG,04C,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),8174373.68
2016/17,Leicester City CCG,04C,Insulins (BNF 6.1.1) ,Prescription Items,71101.00
2016/17,Leicester City CCG,04C,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3130587.34
2016/17,Leicester City CCG,04C,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,18388.00
2016/17,Leicester City CCG,04C,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),749571.20
2016/17,Leicester City CCG,04C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,52713.00
2016/17,Leicester City CCG,04C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2381016.14
2016/17,Leicester City CCG,04C,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,368456.00
2016/17,Leicester City CCG,04C,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3698934.90
2016/17,Leicester City CCG,04C,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,85076.00
2016/17,Leicester City CCG,04C,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),247267.86
2016/17,Leicester City CCG,04C,Biguanides (BNF 6.1.2.2) ,Prescription Items,213516.00
2016/17,Leicester City CCG,04C,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),778263.23
2016/17,Leicester City CCG,04C,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,69864.00
2016/17,Leicester City CCG,04C,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2673403.81
2016/17,Leicester City CCG,04C,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,73077.00
2016/17,Leicester City CCG,04C,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1326288.80
2016/17,Leicester City CCG,04C,Human analogue insulins ,Prescription Items,50677.00
2016/17,Leicester City CCG,04C,Human analogue insulins ,Net Ingredient Cost (£),2483953.81
2016/17,Leicester City CCG,04C,Other insulins ,Prescription Items,20424.00
2016/17,Leicester City CCG,04C,Other insulins ,Net Ingredient Cost (£),646633.53
2016/17,Lewisham CCG,08L,Total primary care (all BNF),Prescription Items,3593880.00
2016/17,Lewisham CCG,08L,Total primary care (all BNF),Net Ingredient Cost (£),38201303.52
2016/17,Lewisham CCG,08L,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,201392.00
2016/17,Lewisham CCG,08L,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4594228.16
2016/17,Lewisham CCG,08L,Insulins (BNF 6.1.1) ,Prescription Items,29269.00
2016/17,Lewisham CCG,08L,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1390821.01
2016/17,Lewisham CCG,08L,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8253.00
2016/17,Lewisham CCG,08L,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),394317.71
2016/17,Lewisham CCG,08L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21016.00
2016/17,Lewisham CCG,08L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),996503.30
2016/17,Lewisham CCG,08L,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,138530.00
2016/17,Lewisham CCG,08L,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2285663.59
2016/17,Lewisham CCG,08L,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,32584.00
2016/17,Lewisham CCG,08L,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),164533.43
2016/17,Lewisham CCG,08L,Biguanides (BNF 6.1.2.2) ,Prescription Items,77581.00
2016/17,Lewisham CCG,08L,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),560755.75
2016/17,Lewisham CCG,08L,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,28365.00
2016/17,Lewisham CCG,08L,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1560374.41
2016/17,Lewisham CCG,08L,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,32759.00
2016/17,Lewisham CCG,08L,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),906264.41
2016/17,Lewisham CCG,08L,Human analogue insulins ,Prescription Items,22597.00
2016/17,Lewisham CCG,08L,Human analogue insulins ,Net Ingredient Cost (£),1184871.88
2016/17,Lewisham CCG,08L,Other insulins ,Prescription Items,6672.00
2016/17,Lewisham CCG,08L,Other insulins ,Net Ingredient Cost (£),205949.13
2016/17,Lincolnshire East CCG,03T,Total primary care (all BNF),Prescription Items,7351073.00
2016/17,Lincolnshire East CCG,03T,Total primary care (all BNF),Net Ingredient Cost (£),56325320.26
2016/17,Lincolnshire East CCG,03T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,353961.00
2016/17,Lincolnshire East CCG,03T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6403919.38
2016/17,Lincolnshire East CCG,03T,Insulins (BNF 6.1.1) ,Prescription Items,42444.00
2016/17,Lincolnshire East CCG,03T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2143467.40
2016/17,Lincolnshire East CCG,03T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12381.00
2016/17,Lincolnshire East CCG,03T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),571796.82
2016/17,Lincolnshire East CCG,03T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,30063.00
2016/17,Lincolnshire East CCG,03T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1571670.58
2016/17,Lincolnshire East CCG,03T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,258289.00
2016/17,Lincolnshire East CCG,03T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3094146.36
2016/17,Lincolnshire East CCG,03T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,54229.00
2016/17,Lincolnshire East CCG,03T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),145929.04
2016/17,Lincolnshire East CCG,03T,Biguanides (BNF 6.1.2.2) ,Prescription Items,133869.00
2016/17,Lincolnshire East CCG,03T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),553452.24
2016/17,Lincolnshire East CCG,03T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,70191.00
2016/17,Lincolnshire East CCG,03T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2394765.08
2016/17,Lincolnshire East CCG,03T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,51044.00
2016/17,Lincolnshire East CCG,03T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1143994.28
2016/17,Lincolnshire East CCG,03T,Human analogue insulins ,Prescription Items,35572.00
2016/17,Lincolnshire East CCG,03T,Human analogue insulins ,Net Ingredient Cost (£),1903381.81
2016/17,Lincolnshire East CCG,03T,Other insulins ,Prescription Items,6872.00
2016/17,Lincolnshire East CCG,03T,Other insulins ,Net Ingredient Cost (£),240085.59
2016/17,Lincolnshire West CCG,04D,Total primary care (all BNF),Prescription Items,5585743.00
2016/17,Lincolnshire West CCG,04D,Total primary care (all BNF),Net Ingredient Cost (£),44307043.08
2016/17,Lincolnshire West CCG,04D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,247441.00
2016/17,Lincolnshire West CCG,04D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4321951.48
2016/17,Lincolnshire West CCG,04D,Insulins (BNF 6.1.1) ,Prescription Items,31558.00
2016/17,Lincolnshire West CCG,04D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1548149.03
2016/17,Lincolnshire West CCG,04D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10043.00
2016/17,Lincolnshire West CCG,04D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),453137.39
2016/17,Lincolnshire West CCG,04D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21515.00
2016/17,Lincolnshire West CCG,04D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1095011.64
2016/17,Lincolnshire West CCG,04D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,183298.00
2016/17,Lincolnshire West CCG,04D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1911516.31
2016/17,Lincolnshire West CCG,04D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,41907.00
2016/17,Lincolnshire West CCG,04D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),106537.07
2016/17,Lincolnshire West CCG,04D,Biguanides (BNF 6.1.2.2) ,Prescription Items,97971.00
2016/17,Lincolnshire West CCG,04D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),365535.26
2016/17,Lincolnshire West CCG,04D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,43420.00
2016/17,Lincolnshire West CCG,04D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1439443.98
2016/17,Lincolnshire West CCG,04D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,31127.00
2016/17,Lincolnshire West CCG,04D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),842522.79
2016/17,Lincolnshire West CCG,04D,Human analogue insulins ,Prescription Items,26204.00
2016/17,Lincolnshire West CCG,04D,Human analogue insulins ,Net Ingredient Cost (£),1362730.62
2016/17,Lincolnshire West CCG,04D,Other insulins ,Prescription Items,5354.00
2016/17,Lincolnshire West CCG,04D,Other insulins ,Net Ingredient Cost (£),185418.41
2016/17,Liverpool CCG,99A,Total primary care (all BNF),Prescription Items,11346209.00
2016/17,Liverpool CCG,99A,Total primary care (all BNF),Net Ingredient Cost (£),92238434.34
2016/17,Liverpool CCG,99A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,457305.00
2016/17,Liverpool CCG,99A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),9145935.20
2016/17,Liverpool CCG,99A,Insulins (BNF 6.1.1) ,Prescription Items,63334.00
2016/17,Liverpool CCG,99A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3036740.00
2016/17,Liverpool CCG,99A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,21015.00
2016/17,Liverpool CCG,99A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),939407.34
2016/17,Liverpool CCG,99A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,42319.00
2016/17,Liverpool CCG,99A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2097332.66
2016/17,Liverpool CCG,99A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,334554.00
2016/17,Liverpool CCG,99A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),4514817.75
2016/17,Liverpool CCG,99A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,55161.00
2016/17,Liverpool CCG,99A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),159360.94
2016/17,Liverpool CCG,99A,Biguanides (BNF 6.1.2.2) ,Prescription Items,193609.00
2016/17,Liverpool CCG,99A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),1027060.85
2016/17,Liverpool CCG,99A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,85784.00
2016/17,Liverpool CCG,99A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),3328395.96
2016/17,Liverpool CCG,99A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,56743.00
2016/17,Liverpool CCG,99A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1556866.38
2016/17,Liverpool CCG,99A,Human analogue insulins ,Prescription Items,58239.00
2016/17,Liverpool CCG,99A,Human analogue insulins ,Net Ingredient Cost (£),2861495.52
2016/17,Liverpool CCG,99A,Other insulins ,Prescription Items,5095.00
2016/17,Liverpool CCG,99A,Other insulins ,Net Ingredient Cost (£),175244.48
2016/17,Luton CCG,06P,Total primary care (all BNF),Prescription Items,3193726.00
2016/17,Luton CCG,06P,Total primary care (all BNF),Net Ingredient Cost (£),29922365.54
2016/17,Luton CCG,06P,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,199426.00
2016/17,Luton CCG,06P,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3764938.32
2016/17,Luton CCG,06P,Insulins (BNF 6.1.1) ,Prescription Items,22810.00
2016/17,Luton CCG,06P,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1141054.47
2016/17,Luton CCG,06P,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5545.00
2016/17,Luton CCG,06P,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),244598.72
2016/17,Luton CCG,06P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,17265.00
2016/17,Luton CCG,06P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),896455.75
2016/17,Luton CCG,06P,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,149584.00
2016/17,Luton CCG,06P,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1944971.52
2016/17,Luton CCG,06P,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,39376.00
2016/17,Luton CCG,06P,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),168870.43
2016/17,Luton CCG,06P,Biguanides (BNF 6.1.2.2) ,Prescription Items,74827.00
2016/17,Luton CCG,06P,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),385471.43
2016/17,Luton CCG,06P,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,35381.00
2016/17,Luton CCG,06P,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1390629.66
2016/17,Luton CCG,06P,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,25908.00
2016/17,Luton CCG,06P,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),667259.84
2016/17,Luton CCG,06P,Human analogue insulins ,Prescription Items,17025.00
2016/17,Luton CCG,06P,Human analogue insulins ,Net Ingredient Cost (£),947045.39
2016/17,Luton CCG,06P,Other insulins ,Prescription Items,5785.00
2016/17,Luton CCG,06P,Other insulins ,Net Ingredient Cost (£),194009.08
2016/17,Mansfield & Ashfield CCG,04E,Total primary care (all BNF),Prescription Items,4737609.00
2016/17,Mansfield & Ashfield CCG,04E,Total primary care (all BNF),Net Ingredient Cost (£),32006612.84
2016/17,Mansfield & Ashfield CCG,04E,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,216462.00
2016/17,Mansfield & Ashfield CCG,04E,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3408855.80
2016/17,Mansfield & Ashfield CCG,04E,Insulins (BNF 6.1.1) ,Prescription Items,30971.00
2016/17,Mansfield & Ashfield CCG,04E,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1479159.53
2016/17,Mansfield & Ashfield CCG,04E,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8850.00
2016/17,Mansfield & Ashfield CCG,04E,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),400375.46
2016/17,Mansfield & Ashfield CCG,04E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,22121.00
2016/17,Mansfield & Ashfield CCG,04E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1078784.07
2016/17,Mansfield & Ashfield CCG,04E,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,152459.00
2016/17,Mansfield & Ashfield CCG,04E,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1272699.30
2016/17,Mansfield & Ashfield CCG,04E,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,42071.00
2016/17,Mansfield & Ashfield CCG,04E,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),104956.78
2016/17,Mansfield & Ashfield CCG,04E,Biguanides (BNF 6.1.2.2) ,Prescription Items,88663.00
2016/17,Mansfield & Ashfield CCG,04E,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),289463.51
2016/17,Mansfield & Ashfield CCG,04E,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,21725.00
2016/17,Mansfield & Ashfield CCG,04E,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),878279.01
2016/17,Mansfield & Ashfield CCG,04E,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,32082.00
2016/17,Mansfield & Ashfield CCG,04E,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),647448.37
2016/17,Mansfield & Ashfield CCG,04E,Human analogue insulins ,Prescription Items,23595.00
2016/17,Mansfield & Ashfield CCG,04E,Human analogue insulins ,Net Ingredient Cost (£),1235504.58
2016/17,Mansfield & Ashfield CCG,04E,Other insulins ,Prescription Items,7376.00
2016/17,Mansfield & Ashfield CCG,04E,Other insulins ,Net Ingredient Cost (£),243654.95
2016/17,Medway CCG,09W,Total primary care (all BNF),Prescription Items,5157335.00
2016/17,Medway CCG,09W,Total primary care (all BNF),Net Ingredient Cost (£),48063646.58
2016/17,Medway CCG,09W,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,288744.00
2016/17,Medway CCG,09W,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6387793.90
2016/17,Medway CCG,09W,Insulins (BNF 6.1.1) ,Prescription Items,35986.00
2016/17,Medway CCG,09W,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1939806.10
2016/17,Medway CCG,09W,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12418.00
2016/17,Medway CCG,09W,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),611343.94
2016/17,Medway CCG,09W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,23568.00
2016/17,Medway CCG,09W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1328462.16
2016/17,Medway CCG,09W,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,211990.00
2016/17,Medway CCG,09W,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3455358.01
2016/17,Medway CCG,09W,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,32970.00
2016/17,Medway CCG,09W,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),101806.07
2016/17,Medway CCG,09W,Biguanides (BNF 6.1.2.2) ,Prescription Items,109846.00
2016/17,Medway CCG,09W,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),567437.26
2016/17,Medway CCG,09W,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,69174.00
2016/17,Medway CCG,09W,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2786114.68
2016/17,Medway CCG,09W,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,39281.00
2016/17,Medway CCG,09W,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),974434.34
2016/17,Medway CCG,09W,Human analogue insulins ,Prescription Items,33573.00
2016/17,Medway CCG,09W,Human analogue insulins ,Net Ingredient Cost (£),1852702.20
2016/17,Medway CCG,09W,Other insulins ,Prescription Items,2413.00
2016/17,Medway CCG,09W,Other insulins ,Net Ingredient Cost (£),87103.90
2016/17,Merton CCG,08R,Total primary care (all BNF),Prescription Items,2963652.00
2016/17,Merton CCG,08R,Total primary care (all BNF),Net Ingredient Cost (£),24613507.07
2016/17,Merton CCG,08R,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,178671.00
2016/17,Merton CCG,08R,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3435589.34
2016/17,Merton CCG,08R,Insulins (BNF 6.1.1) ,Prescription Items,20139.00
2016/17,Merton CCG,08R,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1045180.01
2016/17,Merton CCG,08R,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6870.00
2016/17,Merton CCG,08R,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),325642.98
2016/17,Merton CCG,08R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13269.00
2016/17,Merton CCG,08R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),719537.03
2016/17,Merton CCG,08R,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,134086.00
2016/17,Merton CCG,08R,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1776617.74
2016/17,Merton CCG,08R,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,27270.00
2016/17,Merton CCG,08R,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),84967.73
2016/17,Merton CCG,08R,Biguanides (BNF 6.1.2.2) ,Prescription Items,73299.00
2016/17,Merton CCG,08R,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),320327.62
2016/17,Merton CCG,08R,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,33517.00
2016/17,Merton CCG,08R,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1371322.39
2016/17,Merton CCG,08R,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,23643.00
2016/17,Merton CCG,08R,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),603091.73
2016/17,Merton CCG,08R,Human analogue insulins ,Prescription Items,18221.00
2016/17,Merton CCG,08R,Human analogue insulins ,Net Ingredient Cost (£),982453.64
2016/17,Merton CCG,08R,Other insulins ,Prescription Items,1918.00
2016/17,Merton CCG,08R,Other insulins ,Net Ingredient Cost (£),62726.37
2016/17,Mid Essex CCG,06Q,Total primary care (all BNF),Prescription Items,7738598.00
2016/17,Mid Essex CCG,06Q,Total primary care (all BNF),Net Ingredient Cost (£),61431684.08
2016/17,Mid Essex CCG,06Q,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,329927.00
2016/17,Mid Essex CCG,06Q,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5944797.23
2016/17,Mid Essex CCG,06Q,Insulins (BNF 6.1.1) ,Prescription Items,55103.00
2016/17,Mid Essex CCG,06Q,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2542159.66
2016/17,Mid Essex CCG,06Q,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,20156.00
2016/17,Mid Essex CCG,06Q,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),879103.19
2016/17,Mid Essex CCG,06Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,34947.00
2016/17,Mid Essex CCG,06Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1663056.47
2016/17,Mid Essex CCG,06Q,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,218861.00
2016/17,Mid Essex CCG,06Q,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2020737.38
2016/17,Mid Essex CCG,06Q,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,48485.00
2016/17,Mid Essex CCG,06Q,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),145691.74
2016/17,Mid Essex CCG,06Q,Biguanides (BNF 6.1.2.2) ,Prescription Items,130913.00
2016/17,Mid Essex CCG,06Q,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),500390.11
2016/17,Mid Essex CCG,06Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,39463.00
2016/17,Mid Essex CCG,06Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1374655.53
2016/17,Mid Essex CCG,06Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,53720.00
2016/17,Mid Essex CCG,06Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1357379.32
2016/17,Mid Essex CCG,06Q,Human analogue insulins ,Prescription Items,49074.00
2016/17,Mid Essex CCG,06Q,Human analogue insulins ,Net Ingredient Cost (£),2340411.49
2016/17,Mid Essex CCG,06Q,Other insulins ,Prescription Items,6029.00
2016/17,Mid Essex CCG,06Q,Other insulins ,Net Ingredient Cost (£),201748.17
2016/17,Milton Keynes CCG,04F,Total primary care (all BNF),Prescription Items,3775575.00
2016/17,Milton Keynes CCG,04F,Total primary care (all BNF),Net Ingredient Cost (£),36024275.30
2016/17,Milton Keynes CCG,04F,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,194700.00
2016/17,Milton Keynes CCG,04F,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4611316.06
2016/17,Milton Keynes CCG,04F,Insulins (BNF 6.1.1) ,Prescription Items,34604.00
2016/17,Milton Keynes CCG,04F,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1853351.27
2016/17,Milton Keynes CCG,04F,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12397.00
2016/17,Milton Keynes CCG,04F,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),632617.45
2016/17,Milton Keynes CCG,04F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,22207.00
2016/17,Milton Keynes CCG,04F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1220733.82
2016/17,Milton Keynes CCG,04F,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,123038.00
2016/17,Milton Keynes CCG,04F,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1705892.53
2016/17,Milton Keynes CCG,04F,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,31252.00
2016/17,Milton Keynes CCG,04F,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),136926.91
2016/17,Milton Keynes CCG,04F,Biguanides (BNF 6.1.2.2) ,Prescription Items,69897.00
2016/17,Milton Keynes CCG,04F,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),427749.34
2016/17,Milton Keynes CCG,04F,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,21889.00
2016/17,Milton Keynes CCG,04F,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1141216.28
2016/17,Milton Keynes CCG,04F,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,35611.00
2016/17,Milton Keynes CCG,04F,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1037423.61
2016/17,Milton Keynes CCG,04F,Human analogue insulins ,Prescription Items,29888.00
2016/17,Milton Keynes CCG,04F,Human analogue insulins ,Net Ingredient Cost (£),1700672.65
2016/17,Milton Keynes CCG,04F,Other insulins ,Prescription Items,4716.00
2016/17,Milton Keynes CCG,04F,Other insulins ,Net Ingredient Cost (£),152678.62
2016/17,Nene CCG,04G,Total primary care (all BNF),Prescription Items,13994886.00
2016/17,Nene CCG,04G,Total primary care (all BNF),Net Ingredient Cost (£),92494442.90
2016/17,Nene CCG,04G,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,647506.00
2016/17,Nene CCG,04G,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),10644352.90
2016/17,Nene CCG,04G,Insulins (BNF 6.1.1) ,Prescription Items,98641.00
2016/17,Nene CCG,04G,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),4187636.94
2016/17,Nene CCG,04G,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,31428.00
2016/17,Nene CCG,04G,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1353333.18
2016/17,Nene CCG,04G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,67213.00
2016/17,Nene CCG,04G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2834303.76
2016/17,Nene CCG,04G,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,446991.00
2016/17,Nene CCG,04G,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3769695.64
2016/17,Nene CCG,04G,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,101459.00
2016/17,Nene CCG,04G,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),265126.93
2016/17,Nene CCG,04G,Biguanides (BNF 6.1.2.2) ,Prescription Items,267512.00
2016/17,Nene CCG,04G,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),1021007.83
2016/17,Nene CCG,04G,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,78020.00
2016/17,Nene CCG,04G,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2483560.88
2016/17,Nene CCG,04G,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,97683.00
2016/17,Nene CCG,04G,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),2646447.62
2016/17,Nene CCG,04G,Human analogue insulins ,Prescription Items,62543.00
2016/17,Nene CCG,04G,Human analogue insulins ,Net Ingredient Cost (£),3029890.94
2016/17,Nene CCG,04G,Other insulins ,Prescription Items,36098.00
2016/17,Nene CCG,04G,Other insulins ,Net Ingredient Cost (£),1157746.00
2016/17,Newark & Sherwood CCG,04H,Total primary care (all BNF),Prescription Items,2859819.00
2016/17,Newark & Sherwood CCG,04H,Total primary care (all BNF),Net Ingredient Cost (£),22458735.42
2016/17,Newark & Sherwood CCG,04H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,125312.00
2016/17,Newark & Sherwood CCG,04H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2339678.94
2016/17,Newark & Sherwood CCG,04H,Insulins (BNF 6.1.1) ,Prescription Items,19428.00
2016/17,Newark & Sherwood CCG,04H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),955431.20
2016/17,Newark & Sherwood CCG,04H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6118.00
2016/17,Newark & Sherwood CCG,04H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),274844.25
2016/17,Newark & Sherwood CCG,04H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13310.00
2016/17,Newark & Sherwood CCG,04H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),680586.95
2016/17,Newark & Sherwood CCG,04H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,85989.00
2016/17,Newark & Sherwood CCG,04H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),895425.43
2016/17,Newark & Sherwood CCG,04H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,20679.00
2016/17,Newark & Sherwood CCG,04H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),63199.83
2016/17,Newark & Sherwood CCG,04H,Biguanides (BNF 6.1.2.2) ,Prescription Items,49999.00
2016/17,Newark & Sherwood CCG,04H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),209297.48
2016/17,Newark & Sherwood CCG,04H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,15311.00
2016/17,Newark & Sherwood CCG,04H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),622928.12
2016/17,Newark & Sherwood CCG,04H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,19303.00
2016/17,Newark & Sherwood CCG,04H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),482333.31
2016/17,Newark & Sherwood CCG,04H,Human analogue insulins ,Prescription Items,16190.00
2016/17,Newark & Sherwood CCG,04H,Human analogue insulins ,Net Ingredient Cost (£),847918.14
2016/17,Newark & Sherwood CCG,04H,Other insulins ,Prescription Items,3238.00
2016/17,Newark & Sherwood CCG,04H,Other insulins ,Net Ingredient Cost (£),107513.06
2016/17,Newbury and District CCG,10M,Total primary care (all BNF),Prescription Items,1822503.00
2016/17,Newbury and District CCG,10M,Total primary care (all BNF),Net Ingredient Cost (£),14890798.65
2016/17,Newbury and District CCG,10M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,82453.00
2016/17,Newbury and District CCG,10M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1515487.04
2016/17,Newbury and District CCG,10M,Insulins (BNF 6.1.1) ,Prescription Items,13086.00
2016/17,Newbury and District CCG,10M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),563061.94
2016/17,Newbury and District CCG,10M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,4029.00
2016/17,Newbury and District CCG,10M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),169509.80
2016/17,Newbury and District CCG,10M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,9057.00
2016/17,Newbury and District CCG,10M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),393552.14
2016/17,Newbury and District CCG,10M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,56558.00
2016/17,Newbury and District CCG,10M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),618540.22
2016/17,Newbury and District CCG,10M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,11647.00
2016/17,Newbury and District CCG,10M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),36128.25
2016/17,Newbury and District CCG,10M,Biguanides (BNF 6.1.2.2) ,Prescription Items,33098.00
2016/17,Newbury and District CCG,10M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),143735.58
2016/17,Newbury and District CCG,10M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,11813.00
2016/17,Newbury and District CCG,10M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),438676.39
2016/17,Newbury and District CCG,10M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,12233.00
2016/17,Newbury and District CCG,10M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),327488.82
2016/17,Newbury and District CCG,10M,Human analogue insulins ,Prescription Items,8910.00
2016/17,Newbury and District CCG,10M,Human analogue insulins ,Net Ingredient Cost (£),429959.70
2016/17,Newbury and District CCG,10M,Other insulins ,Prescription Items,4176.00
2016/17,Newbury and District CCG,10M,Other insulins ,Net Ingredient Cost (£),133102.24
2016/17,Newcastle and Gateshead CCG,13T,Total primary care (all BNF),Prescription Items,12662086.00
2016/17,Newcastle and Gateshead CCG,13T,Total primary care (all BNF),Net Ingredient Cost (£),88233838.32
2016/17,Newcastle and Gateshead CCG,13T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,482964.00
2016/17,Newcastle and Gateshead CCG,13T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6856026.01
2016/17,Newcastle and Gateshead CCG,13T,Insulins (BNF 6.1.1) ,Prescription Items,57386.00
2016/17,Newcastle and Gateshead CCG,13T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2753833.98
2016/17,Newcastle and Gateshead CCG,13T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,14947.00
2016/17,Newcastle and Gateshead CCG,13T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),710574.75
2016/17,Newcastle and Gateshead CCG,13T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,42439.00
2016/17,Newcastle and Gateshead CCG,13T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2043259.23
2016/17,Newcastle and Gateshead CCG,13T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,363099.00
2016/17,Newcastle and Gateshead CCG,13T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2538852.89
2016/17,Newcastle and Gateshead CCG,13T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,101489.00
2016/17,Newcastle and Gateshead CCG,13T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),249609.33
2016/17,Newcastle and Gateshead CCG,13T,Biguanides (BNF 6.1.2.2) ,Prescription Items,211891.00
2016/17,Newcastle and Gateshead CCG,13T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),743128.26
2016/17,Newcastle and Gateshead CCG,13T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,49719.00
2016/17,Newcastle and Gateshead CCG,13T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1546115.30
2016/17,Newcastle and Gateshead CCG,13T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,59951.00
2016/17,Newcastle and Gateshead CCG,13T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1530611.55
2016/17,Newcastle and Gateshead CCG,13T,Human analogue insulins ,Prescription Items,34824.00
2016/17,Newcastle and Gateshead CCG,13T,Human analogue insulins ,Net Ingredient Cost (£),1926230.14
2016/17,Newcastle and Gateshead CCG,13T,Other insulins ,Prescription Items,22562.00
2016/17,Newcastle and Gateshead CCG,13T,Other insulins ,Net Ingredient Cost (£),827603.84
2016/17,Newham CCG,08M,Total primary care (all BNF),Prescription Items,6375180.00
2016/17,Newham CCG,08M,Total primary care (all BNF),Net Ingredient Cost (£),43431639.53
2016/17,Newham CCG,08M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,589334.00
2016/17,Newham CCG,08M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),8049906.52
2016/17,Newham CCG,08M,Insulins (BNF 6.1.1) ,Prescription Items,65917.00
2016/17,Newham CCG,08M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2622354.71
2016/17,Newham CCG,08M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,19159.00
2016/17,Newham CCG,08M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),755772.55
2016/17,Newham CCG,08M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,46758.00
2016/17,Newham CCG,08M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1866582.16
2016/17,Newham CCG,08M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,473286.00
2016/17,Newham CCG,08M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),4461652.01
2016/17,Newham CCG,08M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,93491.00
2016/17,Newham CCG,08M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),224440.44
2016/17,Newham CCG,08M,Biguanides (BNF 6.1.2.2) ,Prescription Items,256074.00
2016/17,Newham CCG,08M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),815112.19
2016/17,Newham CCG,08M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,123721.00
2016/17,Newham CCG,08M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),3422099.38
2016/17,Newham CCG,08M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,49261.00
2016/17,Newham CCG,08M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),954073.30
2016/17,Newham CCG,08M,Human analogue insulins ,Prescription Items,56228.00
2016/17,Newham CCG,08M,Human analogue insulins ,Net Ingredient Cost (£),2396694.71
2016/17,Newham CCG,08M,Other insulins ,Prescription Items,9689.00
2016/17,Newham CCG,08M,Other insulins ,Net Ingredient Cost (£),225660.00
2016/17,North & West Reading CCG,10N,Total primary care (all BNF),Prescription Items,1812069.00
2016/17,North & West Reading CCG,10N,Total primary care (all BNF),Net Ingredient Cost (£),14508213.59
2016/17,North & West Reading CCG,10N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,81668.00
2016/17,North & West Reading CCG,10N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1607635.02
2016/17,North & West Reading CCG,10N,Insulins (BNF 6.1.1) ,Prescription Items,11754.00
2016/17,North & West Reading CCG,10N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),519451.94
2016/17,North & West Reading CCG,10N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,3494.00
2016/17,North & West Reading CCG,10N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),153714.18
2016/17,North & West Reading CCG,10N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,8260.00
2016/17,North & West Reading CCG,10N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),365737.76
2016/17,North & West Reading CCG,10N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,57725.00
2016/17,North & West Reading CCG,10N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),785898.22
2016/17,North & West Reading CCG,10N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,8541.00
2016/17,North & West Reading CCG,10N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),25211.59
2016/17,North & West Reading CCG,10N,Biguanides (BNF 6.1.2.2) ,Prescription Items,33308.00
2016/17,North & West Reading CCG,10N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),157940.01
2016/17,North & West Reading CCG,10N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,15876.00
2016/17,North & West Reading CCG,10N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),602746.62
2016/17,North & West Reading CCG,10N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,11611.00
2016/17,North & West Reading CCG,10N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),295101.94
2016/17,North & West Reading CCG,10N,Human analogue insulins ,Prescription Items,7857.00
2016/17,North & West Reading CCG,10N,Human analogue insulins ,Net Ingredient Cost (£),393515.22
2016/17,North & West Reading CCG,10N,Other insulins ,Prescription Items,3897.00
2016/17,North & West Reading CCG,10N,Other insulins ,Net Ingredient Cost (£),125936.72
2016/17,North Derbyshire CCG,04J,Total primary care (all BNF),Prescription Items,6593337.00
2016/17,North Derbyshire CCG,04J,Total primary care (all BNF),Net Ingredient Cost (£),50161217.61
2016/17,North Derbyshire CCG,04J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,262333.00
2016/17,North Derbyshire CCG,04J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4757392.03
2016/17,North Derbyshire CCG,04J,Insulins (BNF 6.1.1) ,Prescription Items,39722.00
2016/17,North Derbyshire CCG,04J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2043822.46
2016/17,North Derbyshire CCG,04J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11810.00
2016/17,North Derbyshire CCG,04J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),624180.94
2016/17,North Derbyshire CCG,04J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,27912.00
2016/17,North Derbyshire CCG,04J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1419641.52
2016/17,North Derbyshire CCG,04J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,181555.00
2016/17,North Derbyshire CCG,04J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1557447.44
2016/17,North Derbyshire CCG,04J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,45716.00
2016/17,North Derbyshire CCG,04J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),130721.90
2016/17,North Derbyshire CCG,04J,Biguanides (BNF 6.1.2.2) ,Prescription Items,112949.00
2016/17,North Derbyshire CCG,04J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),492548.29
2016/17,North Derbyshire CCG,04J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,22890.00
2016/17,North Derbyshire CCG,04J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),934177.25
2016/17,North Derbyshire CCG,04J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,38918.00
2016/17,North Derbyshire CCG,04J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1129793.79
2016/17,North Derbyshire CCG,04J,Human analogue insulins ,Prescription Items,26731.00
2016/17,North Derbyshire CCG,04J,Human analogue insulins ,Net Ingredient Cost (£),1570981.09
2016/17,North Derbyshire CCG,04J,Other insulins ,Prescription Items,12991.00
2016/17,North Derbyshire CCG,04J,Other insulins ,Net Ingredient Cost (£),472841.37
2016/17,North Durham CCG,00J,Total primary care (all BNF),Prescription Items,6541525.00
2016/17,North Durham CCG,00J,Total primary care (all BNF),Net Ingredient Cost (£),46636006.28
2016/17,North Durham CCG,00J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,262192.00
2016/17,North Durham CCG,00J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4665612.90
2016/17,North Durham CCG,00J,Insulins (BNF 6.1.1) ,Prescription Items,39948.00
2016/17,North Durham CCG,00J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1955032.93
2016/17,North Durham CCG,00J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,15238.00
2016/17,North Durham CCG,00J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),726235.33
2016/17,North Durham CCG,00J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,24710.00
2016/17,North Durham CCG,00J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1228797.60
2016/17,North Durham CCG,00J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,184707.00
2016/17,North Durham CCG,00J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1751402.01
2016/17,North Durham CCG,00J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,41220.00
2016/17,North Durham CCG,00J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),97848.30
2016/17,North Durham CCG,00J,Biguanides (BNF 6.1.2.2) ,Prescription Items,109026.00
2016/17,North Durham CCG,00J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),403633.55
2016/17,North Durham CCG,00J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,34461.00
2016/17,North Durham CCG,00J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1249920.16
2016/17,North Durham CCG,00J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,35875.00
2016/17,North Durham CCG,00J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),929319.62
2016/17,North Durham CCG,00J,Human analogue insulins ,Prescription Items,35227.00
2016/17,North Durham CCG,00J,Human analogue insulins ,Net Ingredient Cost (£),1814470.57
2016/17,North Durham CCG,00J,Other insulins ,Prescription Items,4721.00
2016/17,North Durham CCG,00J,Other insulins ,Net Ingredient Cost (£),140562.36
2016/17,North East Essex CCG,06T,Total primary care (all BNF),Prescription Items,8095010.00
2016/17,North East Essex CCG,06T,Total primary care (all BNF),Net Ingredient Cost (£),65894283.66
2016/17,North East Essex CCG,06T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,357810.00
2016/17,North East Essex CCG,06T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6577566.72
2016/17,North East Essex CCG,06T,Insulins (BNF 6.1.1) ,Prescription Items,54946.00
2016/17,North East Essex CCG,06T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2572890.01
2016/17,North East Essex CCG,06T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,14419.00
2016/17,North East Essex CCG,06T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),624071.12
2016/17,North East Essex CCG,06T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,40527.00
2016/17,North East Essex CCG,06T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1948818.89
2016/17,North East Essex CCG,06T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,249919.00
2016/17,North East Essex CCG,06T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2734347.37
2016/17,North East Essex CCG,06T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,62208.00
2016/17,North East Essex CCG,06T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),207586.12
2016/17,North East Essex CCG,06T,Biguanides (BNF 6.1.2.2) ,Prescription Items,139477.00
2016/17,North East Essex CCG,06T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),662176.83
2016/17,North East Essex CCG,06T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,48234.00
2016/17,North East Essex CCG,06T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1864584.42
2016/17,North East Essex CCG,06T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,51315.00
2016/17,North East Essex CCG,06T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1251083.03
2016/17,North East Essex CCG,06T,Human analogue insulins ,Prescription Items,36884.00
2016/17,North East Essex CCG,06T,Human analogue insulins ,Net Ingredient Cost (£),1968393.39
2016/17,North East Essex CCG,06T,Other insulins ,Prescription Items,18062.00
2016/17,North East Essex CCG,06T,Other insulins ,Net Ingredient Cost (£),604496.62
2016/17,North East Hampshire and Farnham CCG,99M,Total primary care (all BNF),Prescription Items,3278405.00
2016/17,North East Hampshire and Farnham CCG,99M,Total primary care (all BNF),Net Ingredient Cost (£),31313166.04
2016/17,North East Hampshire and Farnham CCG,99M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,160599.00
2016/17,North East Hampshire and Farnham CCG,99M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4099187.39
2016/17,North East Hampshire and Farnham CCG,99M,Insulins (BNF 6.1.1) ,Prescription Items,24962.00
2016/17,North East Hampshire and Farnham CCG,99M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1423107.49
2016/17,North East Hampshire and Farnham CCG,99M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9802.00
2016/17,North East Hampshire and Farnham CCG,99M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),517522.37
2016/17,North East Hampshire and Farnham CCG,99M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15160.00
2016/17,North East Hampshire and Farnham CCG,99M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),905585.12
2016/17,North East Hampshire and Farnham CCG,99M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,113286.00
2016/17,North East Hampshire and Farnham CCG,99M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2012930.27
2016/17,North East Hampshire and Farnham CCG,99M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,20105.00
2016/17,North East Hampshire and Farnham CCG,99M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),80406.45
2016/17,North East Hampshire and Farnham CCG,99M,Biguanides (BNF 6.1.2.2) ,Prescription Items,61283.00
2016/17,North East Hampshire and Farnham CCG,99M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),357042.29
2016/17,North East Hampshire and Farnham CCG,99M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,31898.00
2016/17,North East Hampshire and Farnham CCG,99M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1575481.53
2016/17,North East Hampshire and Farnham CCG,99M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,21170.00
2016/17,North East Hampshire and Farnham CCG,99M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),648991.32
2016/17,North East Hampshire and Farnham CCG,99M,Human analogue insulins ,Prescription Items,22775.00
2016/17,North East Hampshire and Farnham CCG,99M,Human analogue insulins ,Net Ingredient Cost (£),1353091.89
2016/17,North East Hampshire and Farnham CCG,99M,Other insulins ,Prescription Items,2187.00
2016/17,North East Hampshire and Farnham CCG,99M,Other insulins ,Net Ingredient Cost (£),70015.60
2016/17,North East Lincolnshire CCG,03H,Total primary care (all BNF),Prescription Items,3838826.00
2016/17,North East Lincolnshire CCG,03H,Total primary care (all BNF),Net Ingredient Cost (£),28341966.26
2016/17,North East Lincolnshire CCG,03H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,182900.00
2016/17,North East Lincolnshire CCG,03H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3475171.62
2016/17,North East Lincolnshire CCG,03H,Insulins (BNF 6.1.1) ,Prescription Items,25726.00
2016/17,North East Lincolnshire CCG,03H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1382373.94
2016/17,North East Lincolnshire CCG,03H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6629.00
2016/17,North East Lincolnshire CCG,03H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),309287.59
2016/17,North East Lincolnshire CCG,03H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19097.00
2016/17,North East Lincolnshire CCG,03H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1073086.35
2016/17,North East Lincolnshire CCG,03H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,130230.00
2016/17,North East Lincolnshire CCG,03H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1449893.78
2016/17,North East Lincolnshire CCG,03H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,33750.00
2016/17,North East Lincolnshire CCG,03H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),90946.21
2016/17,North East Lincolnshire CCG,03H,Biguanides (BNF 6.1.2.2) ,Prescription Items,69754.00
2016/17,North East Lincolnshire CCG,03H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),305362.79
2016/17,North East Lincolnshire CCG,03H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,26726.00
2016/17,North East Lincolnshire CCG,03H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1053584.78
2016/17,North East Lincolnshire CCG,03H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,25830.00
2016/17,North East Lincolnshire CCG,03H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),621495.44
2016/17,North East Lincolnshire CCG,03H,Human analogue insulins ,Prescription Items,24338.00
2016/17,North East Lincolnshire CCG,03H,Human analogue insulins ,Net Ingredient Cost (£),1330986.06
2016/17,North East Lincolnshire CCG,03H,Other insulins ,Prescription Items,1388.00
2016/17,North East Lincolnshire CCG,03H,Other insulins ,Net Ingredient Cost (£),51387.88
2016/17,North Hampshire CCG,10J,Total primary care (all BNF),Prescription Items,3740571.00
2016/17,North Hampshire CCG,10J,Total primary care (all BNF),Net Ingredient Cost (£),32091323.60
2016/17,North Hampshire CCG,10J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,167889.00
2016/17,North Hampshire CCG,10J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3459056.22
2016/17,North Hampshire CCG,10J,Insulins (BNF 6.1.1) ,Prescription Items,25771.00
2016/17,North Hampshire CCG,10J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1382010.98
2016/17,North Hampshire CCG,10J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9592.00
2016/17,North Hampshire CCG,10J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),515015.62
2016/17,North Hampshire CCG,10J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,16179.00
2016/17,North Hampshire CCG,10J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),866995.36
2016/17,North Hampshire CCG,10J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,114340.00
2016/17,North Hampshire CCG,10J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1351101.22
2016/17,North Hampshire CCG,10J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,30752.00
2016/17,North Hampshire CCG,10J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),142594.53
2016/17,North Hampshire CCG,10J,Biguanides (BNF 6.1.2.2) ,Prescription Items,63486.00
2016/17,North Hampshire CCG,10J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),340708.19
2016/17,North Hampshire CCG,10J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,20102.00
2016/17,North Hampshire CCG,10J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),867798.50
2016/17,North Hampshire CCG,10J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,26900.00
2016/17,North Hampshire CCG,10J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),714564.72
2016/17,North Hampshire CCG,10J,Human analogue insulins ,Prescription Items,21682.00
2016/17,North Hampshire CCG,10J,Human analogue insulins ,Net Ingredient Cost (£),1255518.35
2016/17,North Hampshire CCG,10J,Other insulins ,Prescription Items,4089.00
2016/17,North Hampshire CCG,10J,Other insulins ,Net Ingredient Cost (£),126492.63
2016/17,North Kirklees CCG,03J,Total primary care (all BNF),Prescription Items,4047474.00
2016/17,North Kirklees CCG,03J,Total primary care (all BNF),Net Ingredient Cost (£),34027092.03
2016/17,North Kirklees CCG,03J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,206353.00
2016/17,North Kirklees CCG,03J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3844867.77
2016/17,North Kirklees CCG,03J,Insulins (BNF 6.1.1) ,Prescription Items,24197.00
2016/17,North Kirklees CCG,03J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1234239.33
2016/17,North Kirklees CCG,03J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6161.00
2016/17,North Kirklees CCG,03J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),295238.15
2016/17,North Kirklees CCG,03J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,18036.00
2016/17,North Kirklees CCG,03J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),939001.18
2016/17,North Kirklees CCG,03J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,155099.00
2016/17,North Kirklees CCG,03J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1959178.98
2016/17,North Kirklees CCG,03J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,35147.00
2016/17,North Kirklees CCG,03J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),115175.06
2016/17,North Kirklees CCG,03J,Biguanides (BNF 6.1.2.2) ,Prescription Items,83607.00
2016/17,North Kirklees CCG,03J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),386279.66
2016/17,North Kirklees CCG,03J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,36345.00
2016/17,North Kirklees CCG,03J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1457724.26
2016/17,North Kirklees CCG,03J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,25882.00
2016/17,North Kirklees CCG,03J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),639768.16
2016/17,North Kirklees CCG,03J,Human analogue insulins ,Prescription Items,18051.00
2016/17,North Kirklees CCG,03J,Human analogue insulins ,Net Ingredient Cost (£),988865.39
2016/17,North Kirklees CCG,03J,Other insulins ,Prescription Items,6146.00
2016/17,North Kirklees CCG,03J,Other insulins ,Net Ingredient Cost (£),245373.94
2016/17,North Lincolnshire CCG,03K,Total primary care (all BNF),Prescription Items,4504196.00
2016/17,North Lincolnshire CCG,03K,Total primary care (all BNF),Net Ingredient Cost (£),34748294.89
2016/17,North Lincolnshire CCG,03K,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,208991.00
2016/17,North Lincolnshire CCG,03K,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4041175.49
2016/17,North Lincolnshire CCG,03K,Insulins (BNF 6.1.1) ,Prescription Items,29094.00
2016/17,North Lincolnshire CCG,03K,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1437327.30
2016/17,North Lincolnshire CCG,03K,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8122.00
2016/17,North Lincolnshire CCG,03K,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),336872.39
2016/17,North Lincolnshire CCG,03K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,20972.00
2016/17,North Lincolnshire CCG,03K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1100454.91
2016/17,North Lincolnshire CCG,03K,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,146985.00
2016/17,North Lincolnshire CCG,03K,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1811764.61
2016/17,North Lincolnshire CCG,03K,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,32934.00
2016/17,North Lincolnshire CCG,03K,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),86182.76
2016/17,North Lincolnshire CCG,03K,Biguanides (BNF 6.1.2.2) ,Prescription Items,77952.00
2016/17,North Lincolnshire CCG,03K,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),361530.74
2016/17,North Lincolnshire CCG,03K,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,36099.00
2016/17,North Lincolnshire CCG,03K,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1364051.11
2016/17,North Lincolnshire CCG,03K,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,31537.00
2016/17,North Lincolnshire CCG,03K,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),776736.79
2016/17,North Lincolnshire CCG,03K,Human analogue insulins ,Prescription Items,26746.00
2016/17,North Lincolnshire CCG,03K,Human analogue insulins ,Net Ingredient Cost (£),1352739.78
2016/17,North Lincolnshire CCG,03K,Other insulins ,Prescription Items,2348.00
2016/17,North Lincolnshire CCG,03K,Other insulins ,Net Ingredient Cost (£),84587.52
2016/17,North Manchester CCG,01M,Total primary care (all BNF),Prescription Items,4361603.00
2016/17,North Manchester CCG,01M,Total primary care (all BNF),Net Ingredient Cost (£),36780306.37
2016/17,North Manchester CCG,01M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,235503.00
2016/17,North Manchester CCG,01M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4166869.53
2016/17,North Manchester CCG,01M,Insulins (BNF 6.1.1) ,Prescription Items,30414.00
2016/17,North Manchester CCG,01M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1227529.19
2016/17,North Manchester CCG,01M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10681.00
2016/17,North Manchester CCG,01M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),396787.28
2016/17,North Manchester CCG,01M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19733.00
2016/17,North Manchester CCG,01M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),830741.91
2016/17,North Manchester CCG,01M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,174335.00
2016/17,North Manchester CCG,01M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2195846.89
2016/17,North Manchester CCG,01M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,35508.00
2016/17,North Manchester CCG,01M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),104037.98
2016/17,North Manchester CCG,01M,Biguanides (BNF 6.1.2.2) ,Prescription Items,91407.00
2016/17,North Manchester CCG,01M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),375343.88
2016/17,North Manchester CCG,01M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,47420.00
2016/17,North Manchester CCG,01M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1716465.03
2016/17,North Manchester CCG,01M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,29979.00
2016/17,North Manchester CCG,01M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),733383.64
2016/17,North Manchester CCG,01M,Human analogue insulins ,Prescription Items,25802.00
2016/17,North Manchester CCG,01M,Human analogue insulins ,Net Ingredient Cost (£),1112023.75
2016/17,North Manchester CCG,01M,Other insulins ,Prescription Items,4612.00
2016/17,North Manchester CCG,01M,Other insulins ,Net Ingredient Cost (£),115505.44
2016/17,North Norfolk CCG,06V,Total primary care (all BNF),Prescription Items,4781177.00
2016/17,North Norfolk CCG,06V,Total primary care (all BNF),Net Ingredient Cost (£),34034763.51
2016/17,North Norfolk CCG,06V,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,200459.00
2016/17,North Norfolk CCG,06V,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2913420.12
2016/17,North Norfolk CCG,06V,Insulins (BNF 6.1.1) ,Prescription Items,25277.00
2016/17,North Norfolk CCG,06V,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1146293.92
2016/17,North Norfolk CCG,06V,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7694.00
2016/17,North Norfolk CCG,06V,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),340140.54
2016/17,North Norfolk CCG,06V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,17583.00
2016/17,North Norfolk CCG,06V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),806153.38
2016/17,North Norfolk CCG,06V,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,144126.00
2016/17,North Norfolk CCG,06V,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1076811.28
2016/17,North Norfolk CCG,06V,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,37848.00
2016/17,North Norfolk CCG,06V,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),116588.44
2016/17,North Norfolk CCG,06V,Biguanides (BNF 6.1.2.2) ,Prescription Items,85425.00
2016/17,North Norfolk CCG,06V,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),315174.28
2016/17,North Norfolk CCG,06V,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,20853.00
2016/17,North Norfolk CCG,06V,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),645048.56
2016/17,North Norfolk CCG,06V,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,28747.00
2016/17,North Norfolk CCG,06V,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),668191.91
2016/17,North Norfolk CCG,06V,Human analogue insulins ,Prescription Items,18630.00
2016/17,North Norfolk CCG,06V,Human analogue insulins ,Net Ingredient Cost (£),933177.50
2016/17,North Norfolk CCG,06V,Other insulins ,Prescription Items,6647.00
2016/17,North Norfolk CCG,06V,Other insulins ,Net Ingredient Cost (£),213116.42
2016/17,North Somerset CCG,11T,Total primary care (all BNF),Prescription Items,4662470.00
2016/17,North Somerset CCG,11T,Total primary care (all BNF),Net Ingredient Cost (£),33723067.66
2016/17,North Somerset CCG,11T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,190351.00
2016/17,North Somerset CCG,11T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3662057.37
2016/17,North Somerset CCG,11T,Insulins (BNF 6.1.1) ,Prescription Items,25546.00
2016/17,North Somerset CCG,11T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1315304.52
2016/17,North Somerset CCG,11T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8472.00
2016/17,North Somerset CCG,11T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),426398.13
2016/17,North Somerset CCG,11T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,17074.00
2016/17,North Somerset CCG,11T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),888906.39
2016/17,North Somerset CCG,11T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,135255.00
2016/17,North Somerset CCG,11T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1569828.18
2016/17,North Somerset CCG,11T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,33457.00
2016/17,North Somerset CCG,11T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),112887.19
2016/17,North Somerset CCG,11T,Biguanides (BNF 6.1.2.2) ,Prescription Items,72254.00
2016/17,North Somerset CCG,11T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),307625.91
2016/17,North Somerset CCG,11T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,29544.00
2016/17,North Somerset CCG,11T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1149315.08
2016/17,North Somerset CCG,11T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,28457.00
2016/17,North Somerset CCG,11T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),763677.56
2016/17,North Somerset CCG,11T,Human analogue insulins ,Prescription Items,20225.00
2016/17,North Somerset CCG,11T,Human analogue insulins ,Net Ingredient Cost (£),1127794.09
2016/17,North Somerset CCG,11T,Other insulins ,Prescription Items,5321.00
2016/17,North Somerset CCG,11T,Other insulins ,Net Ingredient Cost (£),187510.43
2016/17,North Staffordshire CCG,05G,Total primary care (all BNF),Prescription Items,4719711.00
2016/17,North Staffordshire CCG,05G,Total primary care (all BNF),Net Ingredient Cost (£),39679419.97
2016/17,North Staffordshire CCG,05G,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,222525.00
2016/17,North Staffordshire CCG,05G,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3876873.20
2016/17,North Staffordshire CCG,05G,Insulins (BNF 6.1.1) ,Prescription Items,29187.00
2016/17,North Staffordshire CCG,05G,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1360005.39
2016/17,North Staffordshire CCG,05G,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10057.00
2016/17,North Staffordshire CCG,05G,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),402503.48
2016/17,North Staffordshire CCG,05G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19130.00
2016/17,North Staffordshire CCG,05G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),957501.91
2016/17,North Staffordshire CCG,05G,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,162927.00
2016/17,North Staffordshire CCG,05G,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1833538.77
2016/17,North Staffordshire CCG,05G,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,39562.00
2016/17,North Staffordshire CCG,05G,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),133681.22
2016/17,North Staffordshire CCG,05G,Biguanides (BNF 6.1.2.2) ,Prescription Items,92747.00
2016/17,North Staffordshire CCG,05G,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),444753.85
2016/17,North Staffordshire CCG,05G,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,30618.00
2016/17,North Staffordshire CCG,05G,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1255103.70
2016/17,North Staffordshire CCG,05G,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,28820.00
2016/17,North Staffordshire CCG,05G,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),663974.54
2016/17,North Staffordshire CCG,05G,Human analogue insulins ,Prescription Items,26562.00
2016/17,North Staffordshire CCG,05G,Human analogue insulins ,Net Ingredient Cost (£),1277758.48
2016/17,North Staffordshire CCG,05G,Other insulins ,Prescription Items,2625.00
2016/17,North Staffordshire CCG,05G,Other insulins ,Net Ingredient Cost (£),82246.91
2016/17,North Tyneside CCG,99C,Total primary care (all BNF),Prescription Items,5523162.00
2016/17,North Tyneside CCG,99C,Total primary care (all BNF),Net Ingredient Cost (£),38675339.80
2016/17,North Tyneside CCG,99C,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,200044.00
2016/17,North Tyneside CCG,99C,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2850964.52
2016/17,North Tyneside CCG,99C,Insulins (BNF 6.1.1) ,Prescription Items,26799.00
2016/17,North Tyneside CCG,99C,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1258212.06
2016/17,North Tyneside CCG,99C,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6328.00
2016/17,North Tyneside CCG,99C,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),305789.63
2016/17,North Tyneside CCG,99C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,20471.00
2016/17,North Tyneside CCG,99C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),952422.43
2016/17,North Tyneside CCG,99C,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,143289.00
2016/17,North Tyneside CCG,99C,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),912621.09
2016/17,North Tyneside CCG,99C,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,45129.00
2016/17,North Tyneside CCG,99C,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),140764.21
2016/17,North Tyneside CCG,99C,Biguanides (BNF 6.1.2.2) ,Prescription Items,85704.00
2016/17,North Tyneside CCG,99C,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),362029.60
2016/17,North Tyneside CCG,99C,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,12456.00
2016/17,North Tyneside CCG,99C,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),409827.28
2016/17,North Tyneside CCG,99C,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,28639.00
2016/17,North Tyneside CCG,99C,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),661394.45
2016/17,North Tyneside CCG,99C,Human analogue insulins ,Prescription Items,11205.00
2016/17,North Tyneside CCG,99C,Human analogue insulins ,Net Ingredient Cost (£),629335.71
2016/17,North Tyneside CCG,99C,Other insulins ,Prescription Items,15594.00
2016/17,North Tyneside CCG,99C,Other insulins ,Net Ingredient Cost (£),628876.35
2016/17,North West Surrey CCG,09Y,Total primary care (all BNF),Prescription Items,4720843.00
2016/17,North West Surrey CCG,09Y,Total primary care (all BNF),Net Ingredient Cost (£),47343211.17
2016/17,North West Surrey CCG,09Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,219434.00
2016/17,North West Surrey CCG,09Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5846501.14
2016/17,North West Surrey CCG,09Y,Insulins (BNF 6.1.1) ,Prescription Items,35953.00
2016/17,North West Surrey CCG,09Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2049395.71
2016/17,North West Surrey CCG,09Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12970.00
2016/17,North West Surrey CCG,09Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),654404.28
2016/17,North West Surrey CCG,09Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,22983.00
2016/17,North West Surrey CCG,09Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1394991.43
2016/17,North West Surrey CCG,09Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,146498.00
2016/17,North West Surrey CCG,09Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2731838.52
2016/17,North West Surrey CCG,09Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,24887.00
2016/17,North West Surrey CCG,09Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),100954.06
2016/17,North West Surrey CCG,09Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,83465.00
2016/17,North West Surrey CCG,09Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),467877.65
2016/17,North West Surrey CCG,09Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,38146.00
2016/17,North West Surrey CCG,09Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2163006.81
2016/17,North West Surrey CCG,09Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,35875.00
2016/17,North West Surrey CCG,09Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1048350.13
2016/17,North West Surrey CCG,09Y,Human analogue insulins ,Prescription Items,32796.00
2016/17,North West Surrey CCG,09Y,Human analogue insulins ,Net Ingredient Cost (£),1934278.64
2016/17,North West Surrey CCG,09Y,Other insulins ,Prescription Items,3157.00
2016/17,North West Surrey CCG,09Y,Other insulins ,Net Ingredient Cost (£),115117.07
2016/17,"North, East, West Devon CCG",99P,Total primary care (all BNF),Prescription Items,19837465.00
2016/17,"North, East, West Devon CCG",99P,Total primary care (all BNF),Net Ingredient Cost (£),151593721.37
2016/17,"North, East, West Devon CCG",99P,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,797948.00
2016/17,"North, East, West Devon CCG",99P,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),13317207.29
2016/17,"North, East, West Devon CCG",99P,Insulins (BNF 6.1.1) ,Prescription Items,112767.00
2016/17,"North, East, West Devon CCG",99P,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),5251798.33
2016/17,"North, East, West Devon CCG",99P,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,35061.00
2016/17,"North, East, West Devon CCG",99P,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1611614.11
2016/17,"North, East, West Devon CCG",99P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,77706.00
2016/17,"North, East, West Devon CCG",99P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),3640184.22
2016/17,"North, East, West Devon CCG",99P,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,563884.00
2016/17,"North, East, West Devon CCG",99P,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),5035294.70
2016/17,"North, East, West Devon CCG",99P,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,144378.00
2016/17,"North, East, West Devon CCG",99P,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),426062.34
2016/17,"North, East, West Devon CCG",99P,Biguanides (BNF 6.1.2.2) ,Prescription Items,328645.00
2016/17,"North, East, West Devon CCG",99P,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),1138511.30
2016/17,"North, East, West Devon CCG",99P,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,90861.00
2016/17,"North, East, West Devon CCG",99P,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),3470721.06
2016/17,"North, East, West Devon CCG",99P,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,116190.00
2016/17,"North, East, West Devon CCG",99P,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),2965748.16
2016/17,"North, East, West Devon CCG",99P,Human analogue insulins ,Prescription Items,71942.00
2016/17,"North, East, West Devon CCG",99P,Human analogue insulins ,Net Ingredient Cost (£),3810616.78
2016/17,"North, East, West Devon CCG",99P,Other insulins ,Prescription Items,40825.00
2016/17,"North, East, West Devon CCG",99P,Other insulins ,Net Ingredient Cost (£),1441181.55
2016/17,Northumberland CCG,00L,Total primary care (all BNF),Prescription Items,8161208.00
2016/17,Northumberland CCG,00L,Total primary care (all BNF),Net Ingredient Cost (£),57801538.05
2016/17,Northumberland CCG,00L,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,308353.00
2016/17,Northumberland CCG,00L,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4496190.49
2016/17,Northumberland CCG,00L,Insulins (BNF 6.1.1) ,Prescription Items,43371.00
2016/17,Northumberland CCG,00L,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1983520.99
2016/17,Northumberland CCG,00L,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10987.00
2016/17,Northumberland CCG,00L,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),531913.50
2016/17,Northumberland CCG,00L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,32384.00
2016/17,Northumberland CCG,00L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1451607.49
2016/17,Northumberland CCG,00L,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,216179.00
2016/17,Northumberland CCG,00L,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1423675.86
2016/17,Northumberland CCG,00L,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,67070.00
2016/17,Northumberland CCG,00L,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),229958.90
2016/17,Northumberland CCG,00L,Biguanides (BNF 6.1.2.2) ,Prescription Items,128272.00
2016/17,Northumberland CCG,00L,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),564239.24
2016/17,Northumberland CCG,00L,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,20837.00
2016/17,Northumberland CCG,00L,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),629477.72
2016/17,Northumberland CCG,00L,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,46975.00
2016/17,Northumberland CCG,00L,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1058473.66
2016/17,Northumberland CCG,00L,Human analogue insulins ,Prescription Items,19937.00
2016/17,Northumberland CCG,00L,Human analogue insulins ,Net Ingredient Cost (£),1094778.15
2016/17,Northumberland CCG,00L,Other insulins ,Prescription Items,23434.00
2016/17,Northumberland CCG,00L,Other insulins ,Net Ingredient Cost (£),888742.84
2016/17,Norwich CCG,06W,Total primary care (all BNF),Prescription Items,3832614.00
2016/17,Norwich CCG,06W,Total primary care (all BNF),Net Ingredient Cost (£),33352357.31
2016/17,Norwich CCG,06W,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,148353.00
2016/17,Norwich CCG,06W,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2913328.84
2016/17,Norwich CCG,06W,Insulins (BNF 6.1.1) ,Prescription Items,23605.00
2016/17,Norwich CCG,06W,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1109961.04
2016/17,Norwich CCG,06W,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8113.00
2016/17,Norwich CCG,06W,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),374259.28
2016/17,Norwich CCG,06W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15492.00
2016/17,Norwich CCG,06W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),735701.76
2016/17,Norwich CCG,06W,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,98243.00
2016/17,Norwich CCG,06W,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1073133.96
2016/17,Norwich CCG,06W,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,26615.00
2016/17,Norwich CCG,06W,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),115246.75
2016/17,Norwich CCG,06W,Biguanides (BNF 6.1.2.2) ,Prescription Items,56132.00
2016/17,Norwich CCG,06W,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),279738.31
2016/17,Norwich CCG,06W,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,15496.00
2016/17,Norwich CCG,06W,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),678148.90
2016/17,Norwich CCG,06W,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,24047.00
2016/17,Norwich CCG,06W,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),703642.20
2016/17,Norwich CCG,06W,Human analogue insulins ,Prescription Items,17779.00
2016/17,Norwich CCG,06W,Human analogue insulins ,Net Ingredient Cost (£),920552.29
2016/17,Norwich CCG,06W,Other insulins ,Prescription Items,5826.00
2016/17,Norwich CCG,06W,Other insulins ,Net Ingredient Cost (£),189408.75
2016/17,Nottingham City CCG,04K,Total primary care (all BNF),Prescription Items,5567327.00
2016/17,Nottingham City CCG,04K,Total primary care (all BNF),Net Ingredient Cost (£),45927360.92
2016/17,Nottingham City CCG,04K,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,281235.00
2016/17,Nottingham City CCG,04K,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4713835.00
2016/17,Nottingham City CCG,04K,Insulins (BNF 6.1.1) ,Prescription Items,41614.00
2016/17,Nottingham City CCG,04K,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1939726.43
2016/17,Nottingham City CCG,04K,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11481.00
2016/17,Nottingham City CCG,04K,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),520814.62
2016/17,Nottingham City CCG,04K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,30133.00
2016/17,Nottingham City CCG,04K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1418911.81
2016/17,Nottingham City CCG,04K,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,189341.00
2016/17,Nottingham City CCG,04K,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1504881.37
2016/17,Nottingham City CCG,04K,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,52638.00
2016/17,Nottingham City CCG,04K,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),202761.94
2016/17,Nottingham City CCG,04K,Biguanides (BNF 6.1.2.2) ,Prescription Items,117628.00
2016/17,Nottingham City CCG,04K,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),582087.32
2016/17,Nottingham City CCG,04K,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,19075.00
2016/17,Nottingham City CCG,04K,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),720032.11
2016/17,Nottingham City CCG,04K,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,48543.00
2016/17,Nottingham City CCG,04K,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1250529.73
2016/17,Nottingham City CCG,04K,Human analogue insulins ,Prescription Items,31688.00
2016/17,Nottingham City CCG,04K,Human analogue insulins ,Net Ingredient Cost (£),1631830.35
2016/17,Nottingham City CCG,04K,Other insulins ,Prescription Items,9926.00
2016/17,Nottingham City CCG,04K,Other insulins ,Net Ingredient Cost (£),307896.08
2016/17,Nottingham North & East CCG,04L,Total primary care (all BNF),Prescription Items,2785337.00
2016/17,Nottingham North & East CCG,04L,Total primary care (all BNF),Net Ingredient Cost (£),23864462.99
2016/17,Nottingham North & East CCG,04L,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,121277.00
2016/17,Nottingham North & East CCG,04L,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2319003.26
2016/17,Nottingham North & East CCG,04L,Insulins (BNF 6.1.1) ,Prescription Items,20191.00
2016/17,Nottingham North & East CCG,04L,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),968590.41
2016/17,Nottingham North & East CCG,04L,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6714.00
2016/17,Nottingham North & East CCG,04L,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),310526.57
2016/17,Nottingham North & East CCG,04L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13477.00
2016/17,Nottingham North & East CCG,04L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),658063.84
2016/17,Nottingham North & East CCG,04L,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,80960.00
2016/17,Nottingham North & East CCG,04L,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),823787.24
2016/17,Nottingham North & East CCG,04L,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,20604.00
2016/17,Nottingham North & East CCG,04L,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),77737.31
2016/17,Nottingham North & East CCG,04L,Biguanides (BNF 6.1.2.2) ,Prescription Items,49354.00
2016/17,Nottingham North & East CCG,04L,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),261708.07
2016/17,Nottingham North & East CCG,04L,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,11002.00
2016/17,Nottingham North & East CCG,04L,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),484341.86
2016/17,Nottingham North & East CCG,04L,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,19468.00
2016/17,Nottingham North & East CCG,04L,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),520239.36
2016/17,Nottingham North & East CCG,04L,Human analogue insulins ,Prescription Items,16277.00
2016/17,Nottingham North & East CCG,04L,Human analogue insulins ,Net Ingredient Cost (£),839546.07
2016/17,Nottingham North & East CCG,04L,Other insulins ,Prescription Items,3914.00
2016/17,Nottingham North & East CCG,04L,Other insulins ,Net Ingredient Cost (£),129044.34
2016/17,Nottingham West CCG,04M,Total primary care (all BNF),Prescription Items,1598805.00
2016/17,Nottingham West CCG,04M,Total primary care (all BNF),Net Ingredient Cost (£),14427152.43
2016/17,Nottingham West CCG,04M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,67346.00
2016/17,Nottingham West CCG,04M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1410550.99
2016/17,Nottingham West CCG,04M,Insulins (BNF 6.1.1) ,Prescription Items,11232.00
2016/17,Nottingham West CCG,04M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),574201.57
2016/17,Nottingham West CCG,04M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,3128.00
2016/17,Nottingham West CCG,04M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),156455.72
2016/17,Nottingham West CCG,04M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,8104.00
2016/17,Nottingham West CCG,04M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),417745.85
2016/17,Nottingham West CCG,04M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,43794.00
2016/17,Nottingham West CCG,04M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),496171.06
2016/17,Nottingham West CCG,04M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,11136.00
2016/17,Nottingham West CCG,04M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),42583.10
2016/17,Nottingham West CCG,04M,Biguanides (BNF 6.1.2.2) ,Prescription Items,26325.00
2016/17,Nottingham West CCG,04M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),150957.99
2016/17,Nottingham West CCG,04M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,6333.00
2016/17,Nottingham West CCG,04M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),302629.97
2016/17,Nottingham West CCG,04M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,11852.00
2016/17,Nottingham West CCG,04M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),335361.44
2016/17,Nottingham West CCG,04M,Human analogue insulins ,Prescription Items,8936.00
2016/17,Nottingham West CCG,04M,Human analogue insulins ,Net Ingredient Cost (£),496294.61
2016/17,Nottingham West CCG,04M,Other insulins ,Prescription Items,2296.00
2016/17,Nottingham West CCG,04M,Other insulins ,Net Ingredient Cost (£),77906.96
2016/17,Oldham CCG,00Y,Total primary care (all BNF),Prescription Items,5420687.00
2016/17,Oldham CCG,00Y,Total primary care (all BNF),Net Ingredient Cost (£),46658126.68
2016/17,Oldham CCG,00Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,297738.00
2016/17,Oldham CCG,00Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5489841.27
2016/17,Oldham CCG,00Y,Insulins (BNF 6.1.1) ,Prescription Items,36326.00
2016/17,Oldham CCG,00Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1773906.74
2016/17,Oldham CCG,00Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10923.00
2016/17,Oldham CCG,00Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),480908.39
2016/17,Oldham CCG,00Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,25403.00
2016/17,Oldham CCG,00Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1292998.35
2016/17,Oldham CCG,00Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,224109.00
2016/17,Oldham CCG,00Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2900264.72
2016/17,Oldham CCG,00Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,45928.00
2016/17,Oldham CCG,00Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),124493.21
2016/17,Oldham CCG,00Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,115657.00
2016/17,Oldham CCG,00Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),526201.98
2016/17,Oldham CCG,00Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,62524.00
2016/17,Oldham CCG,00Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2249569.53
2016/17,Oldham CCG,00Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,36326.00
2016/17,Oldham CCG,00Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),803140.92
2016/17,Oldham CCG,00Y,Human analogue insulins ,Prescription Items,32436.00
2016/17,Oldham CCG,00Y,Human analogue insulins ,Net Ingredient Cost (£),1663890.77
2016/17,Oldham CCG,00Y,Other insulins ,Prescription Items,3890.00
2016/17,Oldham CCG,00Y,Other insulins ,Net Ingredient Cost (£),110015.97
2016/17,Oxfordshire CCG,10Q,Total primary care (all BNF),Prescription Items,11097512.00
2016/17,Oxfordshire CCG,10Q,Total primary care (all BNF),Net Ingredient Cost (£),88600187.35
2016/17,Oxfordshire CCG,10Q,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,499606.00
2016/17,Oxfordshire CCG,10Q,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),9096231.98
2016/17,Oxfordshire CCG,10Q,Insulins (BNF 6.1.1) ,Prescription Items,77192.00
2016/17,Oxfordshire CCG,10Q,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3832167.64
2016/17,Oxfordshire CCG,10Q,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,24588.00
2016/17,Oxfordshire CCG,10Q,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1103606.75
2016/17,Oxfordshire CCG,10Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,52604.00
2016/17,Oxfordshire CCG,10Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2728560.89
2016/17,Oxfordshire CCG,10Q,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,350022.00
2016/17,Oxfordshire CCG,10Q,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3225751.09
2016/17,Oxfordshire CCG,10Q,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,94317.00
2016/17,Oxfordshire CCG,10Q,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),281929.72
2016/17,Oxfordshire CCG,10Q,Biguanides (BNF 6.1.2.2) ,Prescription Items,205074.00
2016/17,Oxfordshire CCG,10Q,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),874453.78
2016/17,Oxfordshire CCG,10Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,50631.00
2016/17,Oxfordshire CCG,10Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2069367.59
2016/17,Oxfordshire CCG,10Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,69282.00
2016/17,Oxfordshire CCG,10Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1964760.18
2016/17,Oxfordshire CCG,10Q,Human analogue insulins ,Prescription Items,60340.00
2016/17,Oxfordshire CCG,10Q,Human analogue insulins ,Net Ingredient Cost (£),3279166.71
2016/17,Oxfordshire CCG,10Q,Other insulins ,Prescription Items,16852.00
2016/17,Oxfordshire CCG,10Q,Other insulins ,Net Ingredient Cost (£),553000.93
2016/17,Portsmouth CCG,10R,Total primary care (all BNF),Prescription Items,3723069.00
2016/17,Portsmouth CCG,10R,Total primary care (all BNF),Net Ingredient Cost (£),33562192.18
2016/17,Portsmouth CCG,10R,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,159628.00
2016/17,Portsmouth CCG,10R,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3559532.42
2016/17,Portsmouth CCG,10R,Insulins (BNF 6.1.1) ,Prescription Items,20783.00
2016/17,Portsmouth CCG,10R,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1027551.38
2016/17,Portsmouth CCG,10R,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5717.00
2016/17,Portsmouth CCG,10R,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),286804.81
2016/17,Portsmouth CCG,10R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15066.00
2016/17,Portsmouth CCG,10R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),740746.57
2016/17,Portsmouth CCG,10R,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,115385.00
2016/17,Portsmouth CCG,10R,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1960994.35
2016/17,Portsmouth CCG,10R,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,22083.00
2016/17,Portsmouth CCG,10R,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),77202.84
2016/17,Portsmouth CCG,10R,Biguanides (BNF 6.1.2.2) ,Prescription Items,63151.00
2016/17,Portsmouth CCG,10R,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),362344.74
2016/17,Portsmouth CCG,10R,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,30151.00
2016/17,Portsmouth CCG,10R,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1521446.77
2016/17,Portsmouth CCG,10R,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,22597.00
2016/17,Portsmouth CCG,10R,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),560464.85
2016/17,Portsmouth CCG,10R,Human analogue insulins ,Prescription Items,12279.00
2016/17,Portsmouth CCG,10R,Human analogue insulins ,Net Ingredient Cost (£),725050.67
2016/17,Portsmouth CCG,10R,Other insulins ,Prescription Items,8504.00
2016/17,Portsmouth CCG,10R,Other insulins ,Net Ingredient Cost (£),302500.71
2016/17,Redbridge CCG,08N,Total primary care (all BNF),Prescription Items,4247718.00
2016/17,Redbridge CCG,08N,Total primary care (all BNF),Net Ingredient Cost (£),39128253.36
2016/17,Redbridge CCG,08N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,287759.00
2016/17,Redbridge CCG,08N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6135656.76
2016/17,Redbridge CCG,08N,Insulins (BNF 6.1.1) ,Prescription Items,31617.00
2016/17,Redbridge CCG,08N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1706537.46
2016/17,Redbridge CCG,08N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9918.00
2016/17,Redbridge CCG,08N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),498934.44
2016/17,Redbridge CCG,08N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21699.00
2016/17,Redbridge CCG,08N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1207603.02
2016/17,Redbridge CCG,08N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,217729.00
2016/17,Redbridge CCG,08N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3628714.47
2016/17,Redbridge CCG,08N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,37968.00
2016/17,Redbridge CCG,08N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),153388.50
2016/17,Redbridge CCG,08N,Biguanides (BNF 6.1.2.2) ,Prescription Items,116134.00
2016/17,Redbridge CCG,08N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),625591.12
2016/17,Redbridge CCG,08N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,63627.00
2016/17,Redbridge CCG,08N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2849734.85
2016/17,Redbridge CCG,08N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,37684.00
2016/17,Redbridge CCG,08N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),792283.57
2016/17,Redbridge CCG,08N,Human analogue insulins ,Prescription Items,28686.00
2016/17,Redbridge CCG,08N,Human analogue insulins ,Net Ingredient Cost (£),1609341.04
2016/17,Redbridge CCG,08N,Other insulins ,Prescription Items,2931.00
2016/17,Redbridge CCG,08N,Other insulins ,Net Ingredient Cost (£),97196.42
2016/17,Redditch and Bromsgrove CCG,05J,Total primary care (all BNF),Prescription Items,2794232.00
2016/17,Redditch and Bromsgrove CCG,05J,Total primary care (all BNF),Net Ingredient Cost (£),27346682.46
2016/17,Redditch and Bromsgrove CCG,05J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,125926.00
2016/17,Redditch and Bromsgrove CCG,05J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3233463.01
2016/17,Redditch and Bromsgrove CCG,05J,Insulins (BNF 6.1.1) ,Prescription Items,24742.00
2016/17,Redditch and Bromsgrove CCG,05J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1271190.66
2016/17,Redditch and Bromsgrove CCG,05J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8204.00
2016/17,Redditch and Bromsgrove CCG,05J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),372660.08
2016/17,Redditch and Bromsgrove CCG,05J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,16538.00
2016/17,Redditch and Bromsgrove CCG,05J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),898530.58
2016/17,Redditch and Bromsgrove CCG,05J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,76955.00
2016/17,Redditch and Bromsgrove CCG,05J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1313816.67
2016/17,Redditch and Bromsgrove CCG,05J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,12815.00
2016/17,Redditch and Bromsgrove CCG,05J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),61020.43
2016/17,Redditch and Bromsgrove CCG,05J,Biguanides (BNF 6.1.2.2) ,Prescription Items,46454.00
2016/17,Redditch and Bromsgrove CCG,05J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),265133.02
2016/17,Redditch and Bromsgrove CCG,05J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,17686.00
2016/17,Redditch and Bromsgrove CCG,05J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),987663.22
2016/17,Redditch and Bromsgrove CCG,05J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,22977.00
2016/17,Redditch and Bromsgrove CCG,05J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),630456.27
2016/17,Redditch and Bromsgrove CCG,05J,Human analogue insulins ,Prescription Items,22207.00
2016/17,Redditch and Bromsgrove CCG,05J,Human analogue insulins ,Net Ingredient Cost (£),1188642.99
2016/17,Redditch and Bromsgrove CCG,05J,Other insulins ,Prescription Items,2535.00
2016/17,Redditch and Bromsgrove CCG,05J,Other insulins ,Net Ingredient Cost (£),82547.67
2016/17,Richmond CCG,08P,Total primary care (all BNF),Prescription Items,2838233.00
2016/17,Richmond CCG,08P,Total primary care (all BNF),Net Ingredient Cost (£),22189779.13
2016/17,Richmond CCG,08P,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,111893.00
2016/17,Richmond CCG,08P,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1855146.88
2016/17,Richmond CCG,08P,Insulins (BNF 6.1.1) ,Prescription Items,15333.00
2016/17,Richmond CCG,08P,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),762712.70
2016/17,Richmond CCG,08P,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5838.00
2016/17,Richmond CCG,08P,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),279780.47
2016/17,Richmond CCG,08P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,9495.00
2016/17,Richmond CCG,08P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),482932.23
2016/17,Richmond CCG,08P,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,82277.00
2016/17,Richmond CCG,08P,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),636161.06
2016/17,Richmond CCG,08P,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,21513.00
2016/17,Richmond CCG,08P,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),54262.56
2016/17,Richmond CCG,08P,Biguanides (BNF 6.1.2.2) ,Prescription Items,48859.00
2016/17,Richmond CCG,08P,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),176034.26
2016/17,Richmond CCG,08P,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,11905.00
2016/17,Richmond CCG,08P,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),405864.24
2016/17,Richmond CCG,08P,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,13740.00
2016/17,Richmond CCG,08P,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),450564.51
2016/17,Richmond CCG,08P,Human analogue insulins ,Prescription Items,13469.00
2016/17,Richmond CCG,08P,Human analogue insulins ,Net Ingredient Cost (£),705594.36
2016/17,Richmond CCG,08P,Other insulins ,Prescription Items,1864.00
2016/17,Richmond CCG,08P,Other insulins ,Net Ingredient Cost (£),57118.34
2016/17,Rotherham CCG,03L,Total primary care (all BNF),Prescription Items,6326414.00
2016/17,Rotherham CCG,03L,Total primary care (all BNF),Net Ingredient Cost (£),47772124.15
2016/17,Rotherham CCG,03L,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,285938.00
2016/17,Rotherham CCG,03L,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5546334.42
2016/17,Rotherham CCG,03L,Insulins (BNF 6.1.1) ,Prescription Items,39217.00
2016/17,Rotherham CCG,03L,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2019624.32
2016/17,Rotherham CCG,03L,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11501.00
2016/17,Rotherham CCG,03L,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),563203.26
2016/17,Rotherham CCG,03L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,27716.00
2016/17,Rotherham CCG,03L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1456421.06
2016/17,Rotherham CCG,03L,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,205519.00
2016/17,Rotherham CCG,03L,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2473093.87
2016/17,Rotherham CCG,03L,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,36656.00
2016/17,Rotherham CCG,03L,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),111198.94
2016/17,Rotherham CCG,03L,Biguanides (BNF 6.1.2.2) ,Prescription Items,120726.00
2016/17,Rotherham CCG,03L,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),469712.40
2016/17,Rotherham CCG,03L,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,48137.00
2016/17,Rotherham CCG,03L,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1892182.53
2016/17,Rotherham CCG,03L,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,38831.00
2016/17,Rotherham CCG,03L,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1013671.23
2016/17,Rotherham CCG,03L,Human analogue insulins ,Prescription Items,27135.00
2016/17,Rotherham CCG,03L,Human analogue insulins ,Net Ingredient Cost (£),1581987.23
2016/17,Rotherham CCG,03L,Other insulins ,Prescription Items,12082.00
2016/17,Rotherham CCG,03L,Other insulins ,Net Ingredient Cost (£),437637.09
2016/17,RusHCliffe CCG,04N,Total primary care (all BNF),Prescription Items,2142022.00
2016/17,RusHCliffe CCG,04N,Total primary care (all BNF),Net Ingredient Cost (£),17314801.08
2016/17,RusHCliffe CCG,04N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,89391.00
2016/17,RusHCliffe CCG,04N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1572288.04
2016/17,RusHCliffe CCG,04N,Insulins (BNF 6.1.1) ,Prescription Items,13174.00
2016/17,RusHCliffe CCG,04N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),622274.85
2016/17,RusHCliffe CCG,04N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,4208.00
2016/17,RusHCliffe CCG,04N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),189489.06
2016/17,RusHCliffe CCG,04N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,8966.00
2016/17,RusHCliffe CCG,04N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),432785.79
2016/17,RusHCliffe CCG,04N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,60945.00
2016/17,RusHCliffe CCG,04N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),576146.78
2016/17,RusHCliffe CCG,04N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,13993.00
2016/17,RusHCliffe CCG,04N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),44358.16
2016/17,RusHCliffe CCG,04N,Biguanides (BNF 6.1.2.2) ,Prescription Items,37154.00
2016/17,RusHCliffe CCG,04N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),154476.02
2016/17,RusHCliffe CCG,04N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,9798.00
2016/17,RusHCliffe CCG,04N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),377312.60
2016/17,RusHCliffe CCG,04N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,14831.00
2016/17,RusHCliffe CCG,04N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),368667.71
2016/17,RusHCliffe CCG,04N,Human analogue insulins ,Prescription Items,11032.00
2016/17,RusHCliffe CCG,04N,Human analogue insulins ,Net Ingredient Cost (£),552559.28
2016/17,RusHCliffe CCG,04N,Other insulins ,Prescription Items,2142.00
2016/17,RusHCliffe CCG,04N,Other insulins ,Net Ingredient Cost (£),69715.57
2016/17,Salford CCG,01G,Total primary care (all BNF),Prescription Items,6204976.00
2016/17,Salford CCG,01G,Total primary care (all BNF),Net Ingredient Cost (£),43609838.90
2016/17,Salford CCG,01G,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,284065.00
2016/17,Salford CCG,01G,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3832762.61
2016/17,Salford CCG,01G,Insulins (BNF 6.1.1) ,Prescription Items,26081.00
2016/17,Salford CCG,01G,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1185318.67
2016/17,Salford CCG,01G,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7496.00
2016/17,Salford CCG,01G,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),329826.28
2016/17,Salford CCG,01G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,18585.00
2016/17,Salford CCG,01G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),855492.39
2016/17,Salford CCG,01G,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,230888.00
2016/17,Salford CCG,01G,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1941532.19
2016/17,Salford CCG,01G,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,44963.00
2016/17,Salford CCG,01G,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),101866.68
2016/17,Salford CCG,01G,Biguanides (BNF 6.1.2.2) ,Prescription Items,123394.00
2016/17,Salford CCG,01G,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),442134.88
2016/17,Salford CCG,01G,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,62531.00
2016/17,Salford CCG,01G,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1397530.63
2016/17,Salford CCG,01G,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,26117.00
2016/17,Salford CCG,01G,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),693608.53
2016/17,Salford CCG,01G,Human analogue insulins ,Prescription Items,16757.00
2016/17,Salford CCG,01G,Human analogue insulins ,Net Ingredient Cost (£),861458.54
2016/17,Salford CCG,01G,Other insulins ,Prescription Items,9324.00
2016/17,Salford CCG,01G,Other insulins ,Net Ingredient Cost (£),323860.13
2016/17,Sandwell and West Birmingham CCG,05L,Total primary care (all BNF),Prescription Items,10337361.00
2016/17,Sandwell and West Birmingham CCG,05L,Total primary care (all BNF),Net Ingredient Cost (£),87043608.98
2016/17,Sandwell and West Birmingham CCG,05L,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,684658.00
2016/17,Sandwell and West Birmingham CCG,05L,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),13575538.19
2016/17,Sandwell and West Birmingham CCG,05L,Insulins (BNF 6.1.1) ,Prescription Items,85897.00
2016/17,Sandwell and West Birmingham CCG,05L,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),4458437.02
2016/17,Sandwell and West Birmingham CCG,05L,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,23218.00
2016/17,Sandwell and West Birmingham CCG,05L,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1117003.38
2016/17,Sandwell and West Birmingham CCG,05L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,62679.00
2016/17,Sandwell and West Birmingham CCG,05L,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),3341433.64
2016/17,Sandwell and West Birmingham CCG,05L,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,507771.00
2016/17,Sandwell and West Birmingham CCG,05L,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),7290135.89
2016/17,Sandwell and West Birmingham CCG,05L,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,94582.00
2016/17,Sandwell and West Birmingham CCG,05L,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),338125.44
2016/17,Sandwell and West Birmingham CCG,05L,Biguanides (BNF 6.1.2.2) ,Prescription Items,267907.00
2016/17,Sandwell and West Birmingham CCG,05L,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),1234022.07
2016/17,Sandwell and West Birmingham CCG,05L,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,145282.00
2016/17,Sandwell and West Birmingham CCG,05L,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),5717988.38
2016/17,Sandwell and West Birmingham CCG,05L,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,88575.00
2016/17,Sandwell and West Birmingham CCG,05L,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1799945.83
2016/17,Sandwell and West Birmingham CCG,05L,Human analogue insulins ,Prescription Items,72180.00
2016/17,Sandwell and West Birmingham CCG,05L,Human analogue insulins ,Net Ingredient Cost (£),3984556.21
2016/17,Sandwell and West Birmingham CCG,05L,Other insulins ,Prescription Items,13717.00
2016/17,Sandwell and West Birmingham CCG,05L,Other insulins ,Net Ingredient Cost (£),473880.81
2016/17,Scarborough and Ryedale CCG,03M,Total primary care (all BNF),Prescription Items,2970046.00
2016/17,Scarborough and Ryedale CCG,03M,Total primary care (all BNF),Net Ingredient Cost (£),22387333.95
2016/17,Scarborough and Ryedale CCG,03M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,117467.00
2016/17,Scarborough and Ryedale CCG,03M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2145955.33
2016/17,Scarborough and Ryedale CCG,03M,Insulins (BNF 6.1.1) ,Prescription Items,16672.00
2016/17,Scarborough and Ryedale CCG,03M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),834888.97
2016/17,Scarborough and Ryedale CCG,03M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5261.00
2016/17,Scarborough and Ryedale CCG,03M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),245654.68
2016/17,Scarborough and Ryedale CCG,03M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,11411.00
2016/17,Scarborough and Ryedale CCG,03M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),589234.29
2016/17,Scarborough and Ryedale CCG,03M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,84635.00
2016/17,Scarborough and Ryedale CCG,03M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),897732.25
2016/17,Scarborough and Ryedale CCG,03M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,18343.00
2016/17,Scarborough and Ryedale CCG,03M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),55241.09
2016/17,Scarborough and Ryedale CCG,03M,Biguanides (BNF 6.1.2.2) ,Prescription Items,49700.00
2016/17,Scarborough and Ryedale CCG,03M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),204000.89
2016/17,Scarborough and Ryedale CCG,03M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,16592.00
2016/17,Scarborough and Ryedale CCG,03M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),638490.27
2016/17,Scarborough and Ryedale CCG,03M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,15433.00
2016/17,Scarborough and Ryedale CCG,03M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),405123.02
2016/17,Scarborough and Ryedale CCG,03M,Human analogue insulins ,Prescription Items,15142.00
2016/17,Scarborough and Ryedale CCG,03M,Human analogue insulins ,Net Ingredient Cost (£),787123.19
2016/17,Scarborough and Ryedale CCG,03M,Other insulins ,Prescription Items,1530.00
2016/17,Scarborough and Ryedale CCG,03M,Other insulins ,Net Ingredient Cost (£),47765.78
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Total primary care (all BNF),Prescription Items,4527846.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Total primary care (all BNF),Net Ingredient Cost (£),35928844.73
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,217794.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4153569.32
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Insulins (BNF 6.1.1) ,Prescription Items,31809.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1676500.13
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10777.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),514841.46
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21032.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1161658.67
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,154666.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1712949.25
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,34450.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),98550.57
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Biguanides (BNF 6.1.2.2) ,Prescription Items,89407.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),400508.63
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,30809.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1213890.05
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,29629.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),744332.67
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Human analogue insulins ,Prescription Items,27679.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Human analogue insulins ,Net Ingredient Cost (£),1531635.91
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Other insulins ,Prescription Items,4130.00
2016/17,Se Staffs & Seisdon Peninsular CCG,05Q,Other insulins ,Net Ingredient Cost (£),144864.22
2016/17,Sheffield CCG,03N,Total primary care (all BNF),Prescription Items,13294968.00
2016/17,Sheffield CCG,03N,Total primary care (all BNF),Net Ingredient Cost (£),101272164.41
2016/17,Sheffield CCG,03N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,567468.00
2016/17,Sheffield CCG,03N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),9561108.29
2016/17,Sheffield CCG,03N,Insulins (BNF 6.1.1) ,Prescription Items,67702.00
2016/17,Sheffield CCG,03N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3266749.83
2016/17,Sheffield CCG,03N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,18509.00
2016/17,Sheffield CCG,03N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),898735.42
2016/17,Sheffield CCG,03N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,49193.00
2016/17,Sheffield CCG,03N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2368014.41
2016/17,Sheffield CCG,03N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,421754.00
2016/17,Sheffield CCG,03N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),4136418.54
2016/17,Sheffield CCG,03N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,94608.00
2016/17,Sheffield CCG,03N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),259062.95
2016/17,Sheffield CCG,03N,Biguanides (BNF 6.1.2.2) ,Prescription Items,243807.00
2016/17,Sheffield CCG,03N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),954498.70
2016/17,Sheffield CCG,03N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,83339.00
2016/17,Sheffield CCG,03N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2922856.89
2016/17,Sheffield CCG,03N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,75235.00
2016/17,Sheffield CCG,03N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),2126748.81
2016/17,Sheffield CCG,03N,Human analogue insulins ,Prescription Items,42458.00
2016/17,Sheffield CCG,03N,Human analogue insulins ,Net Ingredient Cost (£),2389003.15
2016/17,Sheffield CCG,03N,Other insulins ,Prescription Items,25244.00
2016/17,Sheffield CCG,03N,Other insulins ,Net Ingredient Cost (£),877746.68
2016/17,Shropshire CCG,05N,Total primary care (all BNF),Prescription Items,6071660.00
2016/17,Shropshire CCG,05N,Total primary care (all BNF),Net Ingredient Cost (£),54224903.01
2016/17,Shropshire CCG,05N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,271346.00
2016/17,Shropshire CCG,05N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5912439.56
2016/17,Shropshire CCG,05N,Insulins (BNF 6.1.1) ,Prescription Items,37151.00
2016/17,Shropshire CCG,05N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1853825.33
2016/17,Shropshire CCG,05N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12314.00
2016/17,Shropshire CCG,05N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),544152.82
2016/17,Shropshire CCG,05N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,24837.00
2016/17,Shropshire CCG,05N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1309672.51
2016/17,Shropshire CCG,05N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,191079.00
2016/17,Shropshire CCG,05N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2759718.77
2016/17,Shropshire CCG,05N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,41772.00
2016/17,Shropshire CCG,05N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),152693.46
2016/17,Shropshire CCG,05N,Biguanides (BNF 6.1.2.2) ,Prescription Items,101298.00
2016/17,Shropshire CCG,05N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),512726.72
2016/17,Shropshire CCG,05N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,48009.00
2016/17,Shropshire CCG,05N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2094298.59
2016/17,Shropshire CCG,05N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,40472.00
2016/17,Shropshire CCG,05N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1250993.59
2016/17,Shropshire CCG,05N,Human analogue insulins ,Prescription Items,33124.00
2016/17,Shropshire CCG,05N,Human analogue insulins ,Net Ingredient Cost (£),1725821.27
2016/17,Shropshire CCG,05N,Other insulins ,Prescription Items,4027.00
2016/17,Shropshire CCG,05N,Other insulins ,Net Ingredient Cost (£),128004.06
2016/17,Slough CCG,10T,Total primary care (all BNF),Prescription Items,2485470.00
2016/17,Slough CCG,10T,Total primary care (all BNF),Net Ingredient Cost (£),16847247.20
2016/17,Slough CCG,10T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,198107.00
2016/17,Slough CCG,10T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2909326.13
2016/17,Slough CCG,10T,Insulins (BNF 6.1.1) ,Prescription Items,17578.00
2016/17,Slough CCG,10T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),858728.61
2016/17,Slough CCG,10T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,4481.00
2016/17,Slough CCG,10T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),207881.11
2016/17,Slough CCG,10T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13097.00
2016/17,Slough CCG,10T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),650847.50
2016/17,Slough CCG,10T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,157238.00
2016/17,Slough CCG,10T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1576635.46
2016/17,Slough CCG,10T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,42923.00
2016/17,Slough CCG,10T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),153320.75
2016/17,Slough CCG,10T,Biguanides (BNF 6.1.2.2) ,Prescription Items,79634.00
2016/17,Slough CCG,10T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),325043.96
2016/17,Slough CCG,10T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,34681.00
2016/17,Slough CCG,10T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1098270.75
2016/17,Slough CCG,10T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,22862.00
2016/17,Slough CCG,10T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),469415.48
2016/17,Slough CCG,10T,Human analogue insulins ,Prescription Items,12355.00
2016/17,Slough CCG,10T,Human analogue insulins ,Net Ingredient Cost (£),675028.89
2016/17,Slough CCG,10T,Other insulins ,Prescription Items,5223.00
2016/17,Slough CCG,10T,Other insulins ,Net Ingredient Cost (£),183699.72
2016/17,Solihull CCG,05P,Total primary care (all BNF),Prescription Items,4570550.00
2016/17,Solihull CCG,05P,Total primary care (all BNF),Net Ingredient Cost (£),39211540.14
2016/17,Solihull CCG,05P,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,205968.00
2016/17,Solihull CCG,05P,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4527573.13
2016/17,Solihull CCG,05P,Insulins (BNF 6.1.1) ,Prescription Items,31929.00
2016/17,Solihull CCG,05P,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1779044.68
2016/17,Solihull CCG,05P,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9599.00
2016/17,Solihull CCG,05P,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),459829.36
2016/17,Solihull CCG,05P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,22330.00
2016/17,Solihull CCG,05P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1319215.32
2016/17,Solihull CCG,05P,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,141733.00
2016/17,Solihull CCG,05P,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1918821.34
2016/17,Solihull CCG,05P,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,28475.00
2016/17,Solihull CCG,05P,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),109667.72
2016/17,Solihull CCG,05P,Biguanides (BNF 6.1.2.2) ,Prescription Items,81423.00
2016/17,Solihull CCG,05P,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),416855.19
2016/17,Solihull CCG,05P,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,31835.00
2016/17,Solihull CCG,05P,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1392298.43
2016/17,Solihull CCG,05P,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,30793.00
2016/17,Solihull CCG,05P,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),813962.62
2016/17,Solihull CCG,05P,Human analogue insulins ,Prescription Items,29760.00
2016/17,Solihull CCG,05P,Human analogue insulins ,Net Ingredient Cost (£),1699704.75
2016/17,Solihull CCG,05P,Other insulins ,Prescription Items,2169.00
2016/17,Solihull CCG,05P,Other insulins ,Net Ingredient Cost (£),79339.93
2016/17,Somerset CCG,11X,Total primary care (all BNF),Prescription Items,10962241.00
2016/17,Somerset CCG,11X,Total primary care (all BNF),Net Ingredient Cost (£),84304708.72
2016/17,Somerset CCG,11X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,460341.00
2016/17,Somerset CCG,11X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),9135810.78
2016/17,Somerset CCG,11X,Insulins (BNF 6.1.1) ,Prescription Items,68661.00
2016/17,Somerset CCG,11X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3230967.91
2016/17,Somerset CCG,11X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,23077.00
2016/17,Somerset CCG,11X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1031354.23
2016/17,Somerset CCG,11X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,45584.00
2016/17,Somerset CCG,11X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2199613.68
2016/17,Somerset CCG,11X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,318756.00
2016/17,Somerset CCG,11X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3870363.49
2016/17,Somerset CCG,11X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,68904.00
2016/17,Somerset CCG,11X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),254942.09
2016/17,Somerset CCG,11X,Biguanides (BNF 6.1.2.2) ,Prescription Items,176938.00
2016/17,Somerset CCG,11X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),771440.31
2016/17,Somerset CCG,11X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,72914.00
2016/17,Somerset CCG,11X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2843981.09
2016/17,Somerset CCG,11X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,70339.00
2016/17,Somerset CCG,11X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),2002690.92
2016/17,Somerset CCG,11X,Human analogue insulins ,Prescription Items,50898.00
2016/17,Somerset CCG,11X,Human analogue insulins ,Net Ingredient Cost (£),2662724.34
2016/17,Somerset CCG,11X,Other insulins ,Prescription Items,17763.00
2016/17,Somerset CCG,11X,Other insulins ,Net Ingredient Cost (£),568243.57
2016/17,South Cheshire CCG,01R,Total primary care (all BNF),Prescription Items,3584631.00
2016/17,South Cheshire CCG,01R,Total primary care (all BNF),Net Ingredient Cost (£),29931547.63
2016/17,South Cheshire CCG,01R,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,157651.00
2016/17,South Cheshire CCG,01R,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3304007.40
2016/17,South Cheshire CCG,01R,Insulins (BNF 6.1.1) ,Prescription Items,23561.00
2016/17,South Cheshire CCG,01R,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1214189.60
2016/17,South Cheshire CCG,01R,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8736.00
2016/17,South Cheshire CCG,01R,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),441971.01
2016/17,South Cheshire CCG,01R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,14825.00
2016/17,South Cheshire CCG,01R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),772218.59
2016/17,South Cheshire CCG,01R,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,105856.00
2016/17,South Cheshire CCG,01R,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1448999.25
2016/17,South Cheshire CCG,01R,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,24178.00
2016/17,South Cheshire CCG,01R,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),90546.87
2016/17,South Cheshire CCG,01R,Biguanides (BNF 6.1.2.2) ,Prescription Items,57150.00
2016/17,South Cheshire CCG,01R,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),304646.74
2016/17,South Cheshire CCG,01R,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,24528.00
2016/17,South Cheshire CCG,01R,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1053805.64
2016/17,South Cheshire CCG,01R,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,27149.00
2016/17,South Cheshire CCG,01R,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),625998.20
2016/17,South Cheshire CCG,01R,Human analogue insulins ,Prescription Items,18540.00
2016/17,South Cheshire CCG,01R,Human analogue insulins ,Net Ingredient Cost (£),1041007.80
2016/17,South Cheshire CCG,01R,Other insulins ,Prescription Items,5021.00
2016/17,South Cheshire CCG,01R,Other insulins ,Net Ingredient Cost (£),173181.80
2016/17,South Devon and Torbay CCG,99Q,Total primary care (all BNF),Prescription Items,5973141.00
2016/17,South Devon and Torbay CCG,99Q,Total primary care (all BNF),Net Ingredient Cost (£),51209100.60
2016/17,South Devon and Torbay CCG,99Q,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,233143.00
2016/17,South Devon and Torbay CCG,99Q,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4674648.85
2016/17,South Devon and Torbay CCG,99Q,Insulins (BNF 6.1.1) ,Prescription Items,38000.00
2016/17,South Devon and Torbay CCG,99Q,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1726398.81
2016/17,South Devon and Torbay CCG,99Q,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11416.00
2016/17,South Devon and Torbay CCG,99Q,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),527275.37
2016/17,South Devon and Torbay CCG,99Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,26584.00
2016/17,South Devon and Torbay CCG,99Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1199123.44
2016/17,South Devon and Torbay CCG,99Q,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,158148.00
2016/17,South Devon and Torbay CCG,99Q,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1965171.60
2016/17,South Devon and Torbay CCG,99Q,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,35707.00
2016/17,South Devon and Torbay CCG,99Q,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),135369.23
2016/17,South Devon and Torbay CCG,99Q,Biguanides (BNF 6.1.2.2) ,Prescription Items,95270.00
2016/17,South Devon and Torbay CCG,99Q,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),477028.05
2016/17,South Devon and Torbay CCG,99Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,27171.00
2016/17,South Devon and Torbay CCG,99Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1352774.32
2016/17,South Devon and Torbay CCG,99Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,36014.00
2016/17,South Devon and Torbay CCG,99Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),971244.09
2016/17,South Devon and Torbay CCG,99Q,Human analogue insulins ,Prescription Items,26557.00
2016/17,South Devon and Torbay CCG,99Q,Human analogue insulins ,Net Ingredient Cost (£),1373461.19
2016/17,South Devon and Torbay CCG,99Q,Other insulins ,Prescription Items,11443.00
2016/17,South Devon and Torbay CCG,99Q,Other insulins ,Net Ingredient Cost (£),352937.62
2016/17,South Eastern Hampshire CCG,10V,Total primary care (all BNF),Prescription Items,3809783.00
2016/17,South Eastern Hampshire CCG,10V,Total primary care (all BNF),Net Ingredient Cost (£),36652220.30
2016/17,South Eastern Hampshire CCG,10V,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,170008.00
2016/17,South Eastern Hampshire CCG,10V,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4222548.99
2016/17,South Eastern Hampshire CCG,10V,Insulins (BNF 6.1.1) ,Prescription Items,26016.00
2016/17,South Eastern Hampshire CCG,10V,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1313080.44
2016/17,South Eastern Hampshire CCG,10V,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7135.00
2016/17,South Eastern Hampshire CCG,10V,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),355189.67
2016/17,South Eastern Hampshire CCG,10V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,18881.00
2016/17,South Eastern Hampshire CCG,10V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),957890.77
2016/17,South Eastern Hampshire CCG,10V,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,118383.00
2016/17,South Eastern Hampshire CCG,10V,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2263708.82
2016/17,South Eastern Hampshire CCG,10V,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,19442.00
2016/17,South Eastern Hampshire CCG,10V,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),81504.31
2016/17,South Eastern Hampshire CCG,10V,Biguanides (BNF 6.1.2.2) ,Prescription Items,65415.00
2016/17,South Eastern Hampshire CCG,10V,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),419852.49
2016/17,South Eastern Hampshire CCG,10V,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,33526.00
2016/17,South Eastern Hampshire CCG,10V,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1762352.02
2016/17,South Eastern Hampshire CCG,10V,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,24873.00
2016/17,South Eastern Hampshire CCG,10V,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),636732.45
2016/17,South Eastern Hampshire CCG,10V,Human analogue insulins ,Prescription Items,17015.00
2016/17,South Eastern Hampshire CCG,10V,Human analogue insulins ,Net Ingredient Cost (£),995150.80
2016/17,South Eastern Hampshire CCG,10V,Other insulins ,Prescription Items,9001.00
2016/17,South Eastern Hampshire CCG,10V,Other insulins ,Net Ingredient Cost (£),317929.64
2016/17,South Gloucestershire CCG,12A,Total primary care (all BNF),Prescription Items,4359417.00
2016/17,South Gloucestershire CCG,12A,Total primary care (all BNF),Net Ingredient Cost (£),39878818.03
2016/17,South Gloucestershire CCG,12A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,183670.00
2016/17,South Gloucestershire CCG,12A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4435689.96
2016/17,South Gloucestershire CCG,12A,Insulins (BNF 6.1.1) ,Prescription Items,28359.00
2016/17,South Gloucestershire CCG,12A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1592349.85
2016/17,South Gloucestershire CCG,12A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8685.00
2016/17,South Gloucestershire CCG,12A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),496131.09
2016/17,South Gloucestershire CCG,12A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19674.00
2016/17,South Gloucestershire CCG,12A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1096218.76
2016/17,South Gloucestershire CCG,12A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,122730.00
2016/17,South Gloucestershire CCG,12A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1827515.92
2016/17,South Gloucestershire CCG,12A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,30800.00
2016/17,South Gloucestershire CCG,12A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),133794.44
2016/17,South Gloucestershire CCG,12A,Biguanides (BNF 6.1.2.2) ,Prescription Items,65741.00
2016/17,South Gloucestershire CCG,12A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),336822.78
2016/17,South Gloucestershire CCG,12A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,26189.00
2016/17,South Gloucestershire CCG,12A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1356898.70
2016/17,South Gloucestershire CCG,12A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,31310.00
2016/17,South Gloucestershire CCG,12A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1000500.02
2016/17,South Gloucestershire CCG,12A,Human analogue insulins ,Prescription Items,20344.00
2016/17,South Gloucestershire CCG,12A,Human analogue insulins ,Net Ingredient Cost (£),1283458.76
2016/17,South Gloucestershire CCG,12A,Other insulins ,Prescription Items,8015.00
2016/17,South Gloucestershire CCG,12A,Other insulins ,Net Ingredient Cost (£),308891.09
2016/17,South Kent Coast CCG,10A,Total primary care (all BNF),Prescription Items,3907091.00
2016/17,South Kent Coast CCG,10A,Total primary care (all BNF),Net Ingredient Cost (£),37228458.68
2016/17,South Kent Coast CCG,10A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,185433.00
2016/17,South Kent Coast CCG,10A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4385128.61
2016/17,South Kent Coast CCG,10A,Insulins (BNF 6.1.1) ,Prescription Items,29478.00
2016/17,South Kent Coast CCG,10A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1523752.03
2016/17,South Kent Coast CCG,10A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9114.00
2016/17,South Kent Coast CCG,10A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),454273.97
2016/17,South Kent Coast CCG,10A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,20364.00
2016/17,South Kent Coast CCG,10A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1069478.06
2016/17,South Kent Coast CCG,10A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,127393.00
2016/17,South Kent Coast CCG,10A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2195506.85
2016/17,South Kent Coast CCG,10A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,22331.00
2016/17,South Kent Coast CCG,10A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),74592.05
2016/17,South Kent Coast CCG,10A,Biguanides (BNF 6.1.2.2) ,Prescription Items,68328.00
2016/17,South Kent Coast CCG,10A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),417956.64
2016/17,South Kent Coast CCG,10A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,36734.00
2016/17,South Kent Coast CCG,10A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1702958.16
2016/17,South Kent Coast CCG,10A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,26900.00
2016/17,South Kent Coast CCG,10A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),646885.09
2016/17,South Kent Coast CCG,10A,Human analogue insulins ,Prescription Items,24921.00
2016/17,South Kent Coast CCG,10A,Human analogue insulins ,Net Ingredient Cost (£),1374518.57
2016/17,South Kent Coast CCG,10A,Other insulins ,Prescription Items,4557.00
2016/17,South Kent Coast CCG,10A,Other insulins ,Net Ingredient Cost (£),149233.46
2016/17,South Lincolnshire CCG,99D,Total primary care (all BNF),Prescription Items,4554724.00
2016/17,South Lincolnshire CCG,99D,Total primary care (all BNF),Net Ingredient Cost (£),32596159.85
2016/17,South Lincolnshire CCG,99D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,223867.00
2016/17,South Lincolnshire CCG,99D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3449999.18
2016/17,South Lincolnshire CCG,99D,Insulins (BNF 6.1.1) ,Prescription Items,23055.00
2016/17,South Lincolnshire CCG,99D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1097194.52
2016/17,South Lincolnshire CCG,99D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8192.00
2016/17,South Lincolnshire CCG,99D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),344410.75
2016/17,South Lincolnshire CCG,99D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,14863.00
2016/17,South Lincolnshire CCG,99D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),752783.77
2016/17,South Lincolnshire CCG,99D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,172725.00
2016/17,South Lincolnshire CCG,99D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1731115.33
2016/17,South Lincolnshire CCG,99D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,37641.00
2016/17,South Lincolnshire CCG,99D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),109379.33
2016/17,South Lincolnshire CCG,99D,Biguanides (BNF 6.1.2.2) ,Prescription Items,90851.00
2016/17,South Lincolnshire CCG,99D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),342218.60
2016/17,South Lincolnshire CCG,99D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,44233.00
2016/17,South Lincolnshire CCG,99D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1279517.40
2016/17,South Lincolnshire CCG,99D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,26923.00
2016/17,South Lincolnshire CCG,99D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),609003.57
2016/17,South Lincolnshire CCG,99D,Human analogue insulins ,Prescription Items,20989.00
2016/17,South Lincolnshire CCG,99D,Human analogue insulins ,Net Ingredient Cost (£),1023590.48
2016/17,South Lincolnshire CCG,99D,Other insulins ,Prescription Items,2066.00
2016/17,South Lincolnshire CCG,99D,Other insulins ,Net Ingredient Cost (£),73604.04
2016/17,South Manchester CCG,01N,Total primary care (all BNF),Prescription Items,3413422.00
2016/17,South Manchester CCG,01N,Total primary care (all BNF),Net Ingredient Cost (£),27657429.75
2016/17,South Manchester CCG,01N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,156959.00
2016/17,South Manchester CCG,01N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3176320.60
2016/17,South Manchester CCG,01N,Insulins (BNF 6.1.1) ,Prescription Items,22895.00
2016/17,South Manchester CCG,01N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1134724.23
2016/17,South Manchester CCG,01N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7928.00
2016/17,South Manchester CCG,01N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),383254.39
2016/17,South Manchester CCG,01N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,14967.00
2016/17,South Manchester CCG,01N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),751469.84
2016/17,South Manchester CCG,01N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,111486.00
2016/17,South Manchester CCG,01N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1471002.76
2016/17,South Manchester CCG,01N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,22332.00
2016/17,South Manchester CCG,01N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),58063.34
2016/17,South Manchester CCG,01N,Biguanides (BNF 6.1.2.2) ,Prescription Items,60959.00
2016/17,South Manchester CCG,01N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),278952.88
2016/17,South Manchester CCG,01N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,28195.00
2016/17,South Manchester CCG,01N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1133986.54
2016/17,South Manchester CCG,01N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,21875.00
2016/17,South Manchester CCG,01N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),562610.09
2016/17,South Manchester CCG,01N,Human analogue insulins ,Prescription Items,19868.00
2016/17,South Manchester CCG,01N,Human analogue insulins ,Net Ingredient Cost (£),1038180.64
2016/17,South Manchester CCG,01N,Other insulins ,Prescription Items,3027.00
2016/17,South Manchester CCG,01N,Other insulins ,Net Ingredient Cost (£),96543.59
2016/17,South Norfolk CCG,06Y,Total primary care (all BNF),Prescription Items,5281947.00
2016/17,South Norfolk CCG,06Y,Total primary care (all BNF),Net Ingredient Cost (£),39690533.41
2016/17,South Norfolk CCG,06Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,221720.00
2016/17,South Norfolk CCG,06Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3943266.87
2016/17,South Norfolk CCG,06Y,Insulins (BNF 6.1.1) ,Prescription Items,33797.00
2016/17,South Norfolk CCG,06Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1584691.16
2016/17,South Norfolk CCG,06Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11526.00
2016/17,South Norfolk CCG,06Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),518282.61
2016/17,South Norfolk CCG,06Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,22271.00
2016/17,South Norfolk CCG,06Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1066408.55
2016/17,South Norfolk CCG,06Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,148456.00
2016/17,South Norfolk CCG,06Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1391597.51
2016/17,South Norfolk CCG,06Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,38047.00
2016/17,South Norfolk CCG,06Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),131369.33
2016/17,South Norfolk CCG,06Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,88059.00
2016/17,South Norfolk CCG,06Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),378118.75
2016/17,South Norfolk CCG,06Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,22350.00
2016/17,South Norfolk CCG,06Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),882109.43
2016/17,South Norfolk CCG,06Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,36300.00
2016/17,South Norfolk CCG,06Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),934915.46
2016/17,South Norfolk CCG,06Y,Human analogue insulins ,Prescription Items,25863.00
2016/17,South Norfolk CCG,06Y,Human analogue insulins ,Net Ingredient Cost (£),1329755.59
2016/17,South Norfolk CCG,06Y,Other insulins ,Prescription Items,7934.00
2016/17,South Norfolk CCG,06Y,Other insulins ,Net Ingredient Cost (£),254935.57
2016/17,South Reading CCG,10W,Total primary care (all BNF),Prescription Items,1731213.00
2016/17,South Reading CCG,10W,Total primary care (all BNF),Net Ingredient Cost (£),15169390.82
2016/17,South Reading CCG,10W,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,96261.00
2016/17,South Reading CCG,10W,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1848100.77
2016/17,South Reading CCG,10W,Insulins (BNF 6.1.1) ,Prescription Items,13373.00
2016/17,South Reading CCG,10W,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),607470.27
2016/17,South Reading CCG,10W,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,3819.00
2016/17,South Reading CCG,10W,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),169306.05
2016/17,South Reading CCG,10W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,9554.00
2016/17,South Reading CCG,10W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),438164.22
2016/17,South Reading CCG,10W,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,68207.00
2016/17,South Reading CCG,10W,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),888127.42
2016/17,South Reading CCG,10W,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,13639.00
2016/17,South Reading CCG,10W,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),45508.26
2016/17,South Reading CCG,10W,Biguanides (BNF 6.1.2.2) ,Prescription Items,37176.00
2016/17,South Reading CCG,10W,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),164721.75
2016/17,South Reading CCG,10W,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,17392.00
2016/17,South Reading CCG,10W,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),677897.41
2016/17,South Reading CCG,10W,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,14225.00
2016/17,South Reading CCG,10W,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),347646.93
2016/17,South Reading CCG,10W,Human analogue insulins ,Prescription Items,9243.00
2016/17,South Reading CCG,10W,Human analogue insulins ,Net Ingredient Cost (£),458228.94
2016/17,South Reading CCG,10W,Other insulins ,Prescription Items,4130.00
2016/17,South Reading CCG,10W,Other insulins ,Net Ingredient Cost (£),149241.33
2016/17,South SeFTon CCG,01T,Total primary care (all BNF),Prescription Items,3683303.00
2016/17,South SeFTon CCG,01T,Total primary care (all BNF),Net Ingredient Cost (£),30075955.91
2016/17,South SeFTon CCG,01T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,145867.00
2016/17,South SeFTon CCG,01T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2976093.47
2016/17,South SeFTon CCG,01T,Insulins (BNF 6.1.1) ,Prescription Items,19884.00
2016/17,South SeFTon CCG,01T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1004932.32
2016/17,South SeFTon CCG,01T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6094.00
2016/17,South SeFTon CCG,01T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),272523.97
2016/17,South SeFTon CCG,01T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13790.00
2016/17,South SeFTon CCG,01T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),732408.35
2016/17,South SeFTon CCG,01T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,106580.00
2016/17,South SeFTon CCG,01T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1424005.11
2016/17,South SeFTon CCG,01T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,19215.00
2016/17,South SeFTon CCG,01T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),61809.06
2016/17,South SeFTon CCG,01T,Biguanides (BNF 6.1.2.2) ,Prescription Items,58491.00
2016/17,South SeFTon CCG,01T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),262141.86
2016/17,South SeFTon CCG,01T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,28874.00
2016/17,South SeFTon CCG,01T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1100054.19
2016/17,South SeFTon CCG,01T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,18848.00
2016/17,South SeFTon CCG,01T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),540434.41
2016/17,South SeFTon CCG,01T,Human analogue insulins ,Prescription Items,17438.00
2016/17,South SeFTon CCG,01T,Human analogue insulins ,Net Ingredient Cost (£),922950.02
2016/17,South SeFTon CCG,01T,Other insulins ,Prescription Items,2446.00
2016/17,South SeFTon CCG,01T,Other insulins ,Net Ingredient Cost (£),81982.30
2016/17,South Tees CCG,00M,Total primary care (all BNF),Prescription Items,7528007.00
2016/17,South Tees CCG,00M,Total primary care (all BNF),Net Ingredient Cost (£),56580572.36
2016/17,South Tees CCG,00M,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,302081.00
2016/17,South Tees CCG,00M,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5169834.58
2016/17,South Tees CCG,00M,Insulins (BNF 6.1.1) ,Prescription Items,43558.00
2016/17,South Tees CCG,00M,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2033334.05
2016/17,South Tees CCG,00M,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12112.00
2016/17,South Tees CCG,00M,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),545490.45
2016/17,South Tees CCG,00M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,31446.00
2016/17,South Tees CCG,00M,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1487843.60
2016/17,South Tees CCG,00M,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,212217.00
2016/17,South Tees CCG,00M,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2163764.11
2016/17,South Tees CCG,00M,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,47258.00
2016/17,South Tees CCG,00M,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),128531.13
2016/17,South Tees CCG,00M,Biguanides (BNF 6.1.2.2) ,Prescription Items,125935.00
2016/17,South Tees CCG,00M,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),523915.91
2016/17,South Tees CCG,00M,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,39024.00
2016/17,South Tees CCG,00M,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1511317.07
2016/17,South Tees CCG,00M,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,44549.00
2016/17,South Tees CCG,00M,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),953415.63
2016/17,South Tees CCG,00M,Human analogue insulins ,Prescription Items,32379.00
2016/17,South Tees CCG,00M,Human analogue insulins ,Net Ingredient Cost (£),1679120.38
2016/17,South Tees CCG,00M,Other insulins ,Prescription Items,11179.00
2016/17,South Tees CCG,00M,Other insulins ,Net Ingredient Cost (£),354213.67
2016/17,South Tyneside CCG,00N,Total primary care (all BNF),Prescription Items,4095043.00
2016/17,South Tyneside CCG,00N,Total primary care (all BNF),Net Ingredient Cost (£),30435906.24
2016/17,South Tyneside CCG,00N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,161909.00
2016/17,South Tyneside CCG,00N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2914875.17
2016/17,South Tyneside CCG,00N,Insulins (BNF 6.1.1) ,Prescription Items,22729.00
2016/17,South Tyneside CCG,00N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1299674.10
2016/17,South Tyneside CCG,00N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6708.00
2016/17,South Tyneside CCG,00N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),331074.08
2016/17,South Tyneside CCG,00N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,16021.00
2016/17,South Tyneside CCG,00N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),968600.02
2016/17,South Tyneside CCG,00N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,117691.00
2016/17,South Tyneside CCG,00N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1144717.36
2016/17,South Tyneside CCG,00N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,30177.00
2016/17,South Tyneside CCG,00N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),82196.93
2016/17,South Tyneside CCG,00N,Biguanides (BNF 6.1.2.2) ,Prescription Items,65975.00
2016/17,South Tyneside CCG,00N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),295580.91
2016/17,South Tyneside CCG,00N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,21539.00
2016/17,South Tyneside CCG,00N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),766939.52
2016/17,South Tyneside CCG,00N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,20780.00
2016/17,South Tyneside CCG,00N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),460465.30
2016/17,South Tyneside CCG,00N,Human analogue insulins ,Prescription Items,21453.00
2016/17,South Tyneside CCG,00N,Human analogue insulins ,Net Ingredient Cost (£),1247918.13
2016/17,South Tyneside CCG,00N,Other insulins ,Prescription Items,1276.00
2016/17,South Tyneside CCG,00N,Other insulins ,Net Ingredient Cost (£),51755.97
2016/17,South Warwickshire CCG,05R,Total primary care (all BNF),Prescription Items,5208262.00
2016/17,South Warwickshire CCG,05R,Total primary care (all BNF),Net Ingredient Cost (£),40251721.90
2016/17,South Warwickshire CCG,05R,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,219869.00
2016/17,South Warwickshire CCG,05R,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4352289.32
2016/17,South Warwickshire CCG,05R,Insulins (BNF 6.1.1) ,Prescription Items,30817.00
2016/17,South Warwickshire CCG,05R,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1498188.71
2016/17,South Warwickshire CCG,05R,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10282.00
2016/17,South Warwickshire CCG,05R,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),461728.13
2016/17,South Warwickshire CCG,05R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,20535.00
2016/17,South Warwickshire CCG,05R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1036460.58
2016/17,South Warwickshire CCG,05R,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,157490.00
2016/17,South Warwickshire CCG,05R,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1971422.36
2016/17,South Warwickshire CCG,05R,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,31146.00
2016/17,South Warwickshire CCG,05R,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),102643.59
2016/17,South Warwickshire CCG,05R,Biguanides (BNF 6.1.2.2) ,Prescription Items,85636.00
2016/17,South Warwickshire CCG,05R,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),357056.60
2016/17,South Warwickshire CCG,05R,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,40708.00
2016/17,South Warwickshire CCG,05R,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1511722.17
2016/17,South Warwickshire CCG,05R,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,30087.00
2016/17,South Warwickshire CCG,05R,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),865545.45
2016/17,South Warwickshire CCG,05R,Human analogue insulins ,Prescription Items,28663.00
2016/17,South Warwickshire CCG,05R,Human analogue insulins ,Net Ingredient Cost (£),1426284.51
2016/17,South Warwickshire CCG,05R,Other insulins ,Prescription Items,2154.00
2016/17,South Warwickshire CCG,05R,Other insulins ,Net Ingredient Cost (£),71904.20
2016/17,South West Lincolnshire CCG,04Q,Total primary care (all BNF),Prescription Items,3470690.00
2016/17,South West Lincolnshire CCG,04Q,Total primary care (all BNF),Net Ingredient Cost (£),25088126.90
2016/17,South West Lincolnshire CCG,04Q,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,162405.00
2016/17,South West Lincolnshire CCG,04Q,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2740206.89
2016/17,South West Lincolnshire CCG,04Q,Insulins (BNF 6.1.1) ,Prescription Items,18392.00
2016/17,South West Lincolnshire CCG,04Q,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),907669.27
2016/17,South West Lincolnshire CCG,04Q,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5758.00
2016/17,South West Lincolnshire CCG,04Q,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),263242.52
2016/17,South West Lincolnshire CCG,04Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,12634.00
2016/17,South West Lincolnshire CCG,04Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),644426.75
2016/17,South West Lincolnshire CCG,04Q,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,122508.00
2016/17,South West Lincolnshire CCG,04Q,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1312261.45
2016/17,South West Lincolnshire CCG,04Q,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,28233.00
2016/17,South West Lincolnshire CCG,04Q,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),80620.81
2016/17,South West Lincolnshire CCG,04Q,Biguanides (BNF 6.1.2.2) ,Prescription Items,65512.00
2016/17,South West Lincolnshire CCG,04Q,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),260942.14
2016/17,South West Lincolnshire CCG,04Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,28763.00
2016/17,South West Lincolnshire CCG,04Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),970698.50
2016/17,South West Lincolnshire CCG,04Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,20546.00
2016/17,South West Lincolnshire CCG,04Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),510380.96
2016/17,South West Lincolnshire CCG,04Q,Human analogue insulins ,Prescription Items,15379.00
2016/17,South West Lincolnshire CCG,04Q,Human analogue insulins ,Net Ingredient Cost (£),811410.21
2016/17,South West Lincolnshire CCG,04Q,Other insulins ,Prescription Items,3013.00
2016/17,South West Lincolnshire CCG,04Q,Other insulins ,Net Ingredient Cost (£),96259.06
2016/17,South Worcestershire CCG,05T,Total primary care (all BNF),Prescription Items,6386574.00
2016/17,South Worcestershire CCG,05T,Total primary care (all BNF),Net Ingredient Cost (£),51055205.65
2016/17,South Worcestershire CCG,05T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,267778.00
2016/17,South Worcestershire CCG,05T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5389052.14
2016/17,South Worcestershire CCG,05T,Insulins (BNF 6.1.1) ,Prescription Items,42543.00
2016/17,South Worcestershire CCG,05T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2190141.13
2016/17,South Worcestershire CCG,05T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12755.00
2016/17,South Worcestershire CCG,05T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),628115.70
2016/17,South Worcestershire CCG,05T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,29788.00
2016/17,South Worcestershire CCG,05T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1562025.43
2016/17,South Worcestershire CCG,05T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,184735.00
2016/17,South Worcestershire CCG,05T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2151395.32
2016/17,South Worcestershire CCG,05T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,27812.00
2016/17,South Worcestershire CCG,05T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),93880.40
2016/17,South Worcestershire CCG,05T,Biguanides (BNF 6.1.2.2) ,Prescription Items,112621.00
2016/17,South Worcestershire CCG,05T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),464009.58
2016/17,South Worcestershire CCG,05T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,44302.00
2016/17,South Worcestershire CCG,05T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1593505.34
2016/17,South Worcestershire CCG,05T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,38591.00
2016/17,South Worcestershire CCG,05T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1027114.20
2016/17,South Worcestershire CCG,05T,Human analogue insulins ,Prescription Items,33997.00
2016/17,South Worcestershire CCG,05T,Human analogue insulins ,Net Ingredient Cost (£),1915611.81
2016/17,South Worcestershire CCG,05T,Other insulins ,Prescription Items,8546.00
2016/17,South Worcestershire CCG,05T,Other insulins ,Net Ingredient Cost (£),274529.32
2016/17,Southampton CCG,10X,Total primary care (all BNF),Prescription Items,3849304.00
2016/17,Southampton CCG,10X,Total primary care (all BNF),Net Ingredient Cost (£),37706868.26
2016/17,Southampton CCG,10X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,176038.00
2016/17,Southampton CCG,10X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4104169.23
2016/17,Southampton CCG,10X,Insulins (BNF 6.1.1) ,Prescription Items,30424.00
2016/17,Southampton CCG,10X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1605581.77
2016/17,Southampton CCG,10X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8802.00
2016/17,Southampton CCG,10X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),439331.00
2016/17,Southampton CCG,10X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21622.00
2016/17,Southampton CCG,10X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1166250.77
2016/17,Southampton CCG,10X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,115025.00
2016/17,Southampton CCG,10X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1736456.43
2016/17,Southampton CCG,10X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23254.00
2016/17,Southampton CCG,10X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),138664.14
2016/17,Southampton CCG,10X,Biguanides (BNF 6.1.2.2) ,Prescription Items,68693.00
2016/17,Southampton CCG,10X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),362039.28
2016/17,Southampton CCG,10X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,23078.00
2016/17,Southampton CCG,10X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1235753.01
2016/17,Southampton CCG,10X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,29133.00
2016/17,Southampton CCG,10X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),743240.49
2016/17,Southampton CCG,10X,Human analogue insulins ,Prescription Items,22764.00
2016/17,Southampton CCG,10X,Human analogue insulins ,Net Ingredient Cost (£),1323456.11
2016/17,Southampton CCG,10X,Other insulins ,Prescription Items,7660.00
2016/17,Southampton CCG,10X,Other insulins ,Net Ingredient Cost (£),282125.66
2016/17,Southend CCG,99G,Total primary care (all BNF),Prescription Items,2960792.00
2016/17,Southend CCG,99G,Total primary care (all BNF),Net Ingredient Cost (£),28618348.38
2016/17,Southend CCG,99G,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,135386.00
2016/17,Southend CCG,99G,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3012078.40
2016/17,Southend CCG,99G,Insulins (BNF 6.1.1) ,Prescription Items,22117.00
2016/17,Southend CCG,99G,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1148065.89
2016/17,Southend CCG,99G,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6998.00
2016/17,Southend CCG,99G,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),339595.53
2016/17,Southend CCG,99G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15119.00
2016/17,Southend CCG,99G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),808470.36
2016/17,Southend CCG,99G,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,92006.00
2016/17,Southend CCG,99G,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1296567.14
2016/17,Southend CCG,99G,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,21120.00
2016/17,Southend CCG,99G,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),96323.94
2016/17,Southend CCG,99G,Biguanides (BNF 6.1.2.2) ,Prescription Items,52011.00
2016/17,Southend CCG,99G,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),305802.64
2016/17,Southend CCG,99G,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,18875.00
2016/17,Southend CCG,99G,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),894440.56
2016/17,Southend CCG,99G,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,20361.00
2016/17,Southend CCG,99G,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),556690.68
2016/17,Southend CCG,99G,Human analogue insulins ,Prescription Items,17044.00
2016/17,Southend CCG,99G,Human analogue insulins ,Net Ingredient Cost (£),960429.00
2016/17,Southend CCG,99G,Other insulins ,Prescription Items,5073.00
2016/17,Southend CCG,99G,Other insulins ,Net Ingredient Cost (£),187636.89
2016/17,Southern Derbyshire CCG,04R,Total primary care (all BNF),Prescription Items,8795297.00
2016/17,Southern Derbyshire CCG,04R,Total primary care (all BNF),Net Ingredient Cost (£),78576972.18
2016/17,Southern Derbyshire CCG,04R,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,377319.00
2016/17,Southern Derbyshire CCG,04R,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),7799022.54
2016/17,Southern Derbyshire CCG,04R,Insulins (BNF 6.1.1) ,Prescription Items,63581.00
2016/17,Southern Derbyshire CCG,04R,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3069801.70
2016/17,Southern Derbyshire CCG,04R,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,21295.00
2016/17,Southern Derbyshire CCG,04R,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),1053833.63
2016/17,Southern Derbyshire CCG,04R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,42286.00
2016/17,Southern Derbyshire CCG,04R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2015968.07
2016/17,Southern Derbyshire CCG,04R,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,246303.00
2016/17,Southern Derbyshire CCG,04R,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2671754.98
2016/17,Southern Derbyshire CCG,04R,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,62658.00
2016/17,Southern Derbyshire CCG,04R,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),243599.43
2016/17,Southern Derbyshire CCG,04R,Biguanides (BNF 6.1.2.2) ,Prescription Items,151591.00
2016/17,Southern Derbyshire CCG,04R,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),844056.02
2016/17,Southern Derbyshire CCG,04R,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,32054.00
2016/17,Southern Derbyshire CCG,04R,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1584099.53
2016/17,Southern Derbyshire CCG,04R,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,64225.00
2016/17,Southern Derbyshire CCG,04R,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),2016560.95
2016/17,Southern Derbyshire CCG,04R,Human analogue insulins ,Prescription Items,48591.00
2016/17,Southern Derbyshire CCG,04R,Human analogue insulins ,Net Ingredient Cost (£),2572914.74
2016/17,Southern Derbyshire CCG,04R,Other insulins ,Prescription Items,14990.00
2016/17,Southern Derbyshire CCG,04R,Other insulins ,Net Ingredient Cost (£),496886.96
2016/17,Southport and Formby CCG,01V,Total primary care (all BNF),Prescription Items,2991305.00
2016/17,Southport and Formby CCG,01V,Total primary care (all BNF),Net Ingredient Cost (£),23556520.66
2016/17,Southport and Formby CCG,01V,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,117862.00
2016/17,Southport and Formby CCG,01V,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2251384.33
2016/17,Southport and Formby CCG,01V,Insulins (BNF 6.1.1) ,Prescription Items,16774.00
2016/17,Southport and Formby CCG,01V,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),809382.14
2016/17,Southport and Formby CCG,01V,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6063.00
2016/17,Southport and Formby CCG,01V,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),270570.03
2016/17,Southport and Formby CCG,01V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,10711.00
2016/17,Southport and Formby CCG,01V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),538812.11
2016/17,Southport and Formby CCG,01V,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,85013.00
2016/17,Southport and Formby CCG,01V,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),980845.65
2016/17,Southport and Formby CCG,01V,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,17488.00
2016/17,Southport and Formby CCG,01V,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),47912.57
2016/17,Southport and Formby CCG,01V,Biguanides (BNF 6.1.2.2) ,Prescription Items,47694.00
2016/17,Southport and Formby CCG,01V,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),190662.77
2016/17,Southport and Formby CCG,01V,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,19831.00
2016/17,Southport and Formby CCG,01V,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),742270.31
2016/17,Southport and Formby CCG,01V,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,15543.00
2016/17,Southport and Formby CCG,01V,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),455229.65
2016/17,Southport and Formby CCG,01V,Human analogue insulins ,Prescription Items,15436.00
2016/17,Southport and Formby CCG,01V,Human analogue insulins ,Net Ingredient Cost (£),760036.26
2016/17,Southport and Formby CCG,01V,Other insulins ,Prescription Items,1338.00
2016/17,Southport and Formby CCG,01V,Other insulins ,Net Ingredient Cost (£),49345.88
2016/17,Southwark CCG,08Q,Total primary care (all BNF),Prescription Items,4051840.00
2016/17,Southwark CCG,08Q,Total primary care (all BNF),Net Ingredient Cost (£),32838154.32
2016/17,Southwark CCG,08Q,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,254361.00
2016/17,Southwark CCG,08Q,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4195856.98
2016/17,Southwark CCG,08Q,Insulins (BNF 6.1.1) ,Prescription Items,27616.00
2016/17,Southwark CCG,08Q,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1431424.23
2016/17,Southwark CCG,08Q,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,8012.00
2016/17,Southwark CCG,08Q,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),402775.88
2016/17,Southwark CCG,08Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19604.00
2016/17,Southwark CCG,08Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1028648.35
2016/17,Southwark CCG,08Q,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,197841.00
2016/17,Southwark CCG,08Q,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1969247.91
2016/17,Southwark CCG,08Q,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,52842.00
2016/17,Southwark CCG,08Q,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),162580.77
2016/17,Southwark CCG,08Q,Biguanides (BNF 6.1.2.2) ,Prescription Items,110931.00
2016/17,Southwark CCG,08Q,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),467736.76
2016/17,Southwark CCG,08Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,34068.00
2016/17,Southwark CCG,08Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1338930.38
2016/17,Southwark CCG,08Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,28143.00
2016/17,Southwark CCG,08Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),785974.24
2016/17,Southwark CCG,08Q,Human analogue insulins ,Prescription Items,21423.00
2016/17,Southwark CCG,08Q,Human analogue insulins ,Net Ingredient Cost (£),1223803.96
2016/17,Southwark CCG,08Q,Other insulins ,Prescription Items,6193.00
2016/17,Southwark CCG,08Q,Other insulins ,Net Ingredient Cost (£),207620.27
2016/17,St Helens CCG,01X,Total primary care (all BNF),Prescription Items,4997405.00
2016/17,St Helens CCG,01X,Total primary care (all BNF),Net Ingredient Cost (£),40966394.78
2016/17,St Helens CCG,01X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,195473.00
2016/17,St Helens CCG,01X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3815106.16
2016/17,St Helens CCG,01X,Insulins (BNF 6.1.1) ,Prescription Items,28674.00
2016/17,St Helens CCG,01X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1516886.80
2016/17,St Helens CCG,01X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9524.00
2016/17,St Helens CCG,01X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),427201.76
2016/17,St Helens CCG,01X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19150.00
2016/17,St Helens CCG,01X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1089685.04
2016/17,St Helens CCG,01X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,135107.00
2016/17,St Helens CCG,01X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1495881.30
2016/17,St Helens CCG,01X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,29751.00
2016/17,St Helens CCG,01X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),95209.80
2016/17,St Helens CCG,01X,Biguanides (BNF 6.1.2.2) ,Prescription Items,81510.00
2016/17,St Helens CCG,01X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),418083.46
2016/17,St Helens CCG,01X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,23846.00
2016/17,St Helens CCG,01X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),982588.04
2016/17,St Helens CCG,01X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,28899.00
2016/17,St Helens CCG,01X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),775341.15
2016/17,St Helens CCG,01X,Human analogue insulins ,Prescription Items,26224.00
2016/17,St Helens CCG,01X,Human analogue insulins ,Net Ingredient Cost (£),1410601.68
2016/17,St Helens CCG,01X,Other insulins ,Prescription Items,2450.00
2016/17,St Helens CCG,01X,Other insulins ,Net Ingredient Cost (£),106285.12
2016/17,Stafford and Surrounds CCG,05V,Total primary care (all BNF),Prescription Items,3004363.00
2016/17,Stafford and Surrounds CCG,05V,Total primary care (all BNF),Net Ingredient Cost (£),26378075.92
2016/17,Stafford and Surrounds CCG,05V,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,127923.00
2016/17,Stafford and Surrounds CCG,05V,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2691422.00
2016/17,Stafford and Surrounds CCG,05V,Insulins (BNF 6.1.1) ,Prescription Items,20237.00
2016/17,Stafford and Surrounds CCG,05V,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),993920.50
2016/17,Stafford and Surrounds CCG,05V,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6309.00
2016/17,Stafford and Surrounds CCG,05V,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),284864.25
2016/17,Stafford and Surrounds CCG,05V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13928.00
2016/17,Stafford and Surrounds CCG,05V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),709056.25
2016/17,Stafford and Surrounds CCG,05V,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,86453.00
2016/17,Stafford and Surrounds CCG,05V,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1202550.53
2016/17,Stafford and Surrounds CCG,05V,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,16493.00
2016/17,Stafford and Surrounds CCG,05V,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),55743.03
2016/17,Stafford and Surrounds CCG,05V,Biguanides (BNF 6.1.2.2) ,Prescription Items,50288.00
2016/17,Stafford and Surrounds CCG,05V,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),278430.16
2016/17,Stafford and Surrounds CCG,05V,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,19672.00
2016/17,Stafford and Surrounds CCG,05V,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),868377.34
2016/17,Stafford and Surrounds CCG,05V,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,20367.00
2016/17,Stafford and Surrounds CCG,05V,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),473012.53
2016/17,Stafford and Surrounds CCG,05V,Human analogue insulins ,Prescription Items,16284.00
2016/17,Stafford and Surrounds CCG,05V,Human analogue insulins ,Net Ingredient Cost (£),854103.29
2016/17,Stafford and Surrounds CCG,05V,Other insulins ,Prescription Items,3953.00
2016/17,Stafford and Surrounds CCG,05V,Other insulins ,Net Ingredient Cost (£),139817.21
2016/17,Stockport CCG,01W,Total primary care (all BNF),Prescription Items,6642453.00
2016/17,Stockport CCG,01W,Total primary care (all BNF),Net Ingredient Cost (£),50955017.30
2016/17,Stockport CCG,01W,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,285809.00
2016/17,Stockport CCG,01W,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5194568.80
2016/17,Stockport CCG,01W,Insulins (BNF 6.1.1) ,Prescription Items,36468.00
2016/17,Stockport CCG,01W,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1720834.40
2016/17,Stockport CCG,01W,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12958.00
2016/17,Stockport CCG,01W,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),605416.93
2016/17,Stockport CCG,01W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,23510.00
2016/17,Stockport CCG,01W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1115417.47
2016/17,Stockport CCG,01W,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,210159.00
2016/17,Stockport CCG,01W,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2316936.45
2016/17,Stockport CCG,01W,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,45214.00
2016/17,Stockport CCG,01W,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),106052.83
2016/17,Stockport CCG,01W,Biguanides (BNF 6.1.2.2) ,Prescription Items,116506.00
2016/17,Stockport CCG,01W,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),466525.12
2016/17,Stockport CCG,01W,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,48439.00
2016/17,Stockport CCG,01W,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1744358.50
2016/17,Stockport CCG,01W,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,37392.00
2016/17,Stockport CCG,01W,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1133233.58
2016/17,Stockport CCG,01W,Human analogue insulins ,Prescription Items,26660.00
2016/17,Stockport CCG,01W,Human analogue insulins ,Net Ingredient Cost (£),1403956.81
2016/17,Stockport CCG,01W,Other insulins ,Prescription Items,9808.00
2016/17,Stockport CCG,01W,Other insulins ,Net Ingredient Cost (£),316877.59
2016/17,Stoke On Trent CCG,05W,Total primary care (all BNF),Prescription Items,6571801.00
2016/17,Stoke On Trent CCG,05W,Total primary care (all BNF),Net Ingredient Cost (£),52106837.88
2016/17,Stoke On Trent CCG,05W,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,348843.00
2016/17,Stoke On Trent CCG,05W,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5598343.78
2016/17,Stoke On Trent CCG,05W,Insulins (BNF 6.1.1) ,Prescription Items,39027.00
2016/17,Stoke On Trent CCG,05W,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1841823.47
2016/17,Stoke On Trent CCG,05W,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12343.00
2016/17,Stoke On Trent CCG,05W,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),522507.79
2016/17,Stoke On Trent CCG,05W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,26684.00
2016/17,Stoke On Trent CCG,05W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1319315.68
2016/17,Stoke On Trent CCG,05W,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,265780.00
2016/17,Stoke On Trent CCG,05W,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2858558.51
2016/17,Stoke On Trent CCG,05W,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,67123.00
2016/17,Stoke On Trent CCG,05W,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),223883.40
2016/17,Stoke On Trent CCG,05W,Biguanides (BNF 6.1.2.2) ,Prescription Items,146310.00
2016/17,Stoke On Trent CCG,05W,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),628179.23
2016/17,Stoke On Trent CCG,05W,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,52347.00
2016/17,Stoke On Trent CCG,05W,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2006495.88
2016/17,Stoke On Trent CCG,05W,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,42137.00
2016/17,Stoke On Trent CCG,05W,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),878212.56
2016/17,Stoke On Trent CCG,05W,Human analogue insulins ,Prescription Items,35452.00
2016/17,Stoke On Trent CCG,05W,Human analogue insulins ,Net Ingredient Cost (£),1731080.17
2016/17,Stoke On Trent CCG,05W,Other insulins ,Prescription Items,3575.00
2016/17,Stoke On Trent CCG,05W,Other insulins ,Net Ingredient Cost (£),110743.30
2016/17,Sunderland CCG,00P,Total primary care (all BNF),Prescription Items,8519713.00
2016/17,Sunderland CCG,00P,Total primary care (all BNF),Net Ingredient Cost (£),54148975.15
2016/17,Sunderland CCG,00P,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,346013.00
2016/17,Sunderland CCG,00P,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5076972.74
2016/17,Sunderland CCG,00P,Insulins (BNF 6.1.1) ,Prescription Items,41284.00
2016/17,Sunderland CCG,00P,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2010655.67
2016/17,Sunderland CCG,00P,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,12484.00
2016/17,Sunderland CCG,00P,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),588431.58
2016/17,Sunderland CCG,00P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,28800.00
2016/17,Sunderland CCG,00P,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1422224.09
2016/17,Sunderland CCG,00P,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,267021.00
2016/17,Sunderland CCG,00P,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2045869.54
2016/17,Sunderland CCG,00P,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,66151.00
2016/17,Sunderland CCG,00P,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),138482.37
2016/17,Sunderland CCG,00P,Biguanides (BNF 6.1.2.2) ,Prescription Items,153312.00
2016/17,Sunderland CCG,00P,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),515390.30
2016/17,Sunderland CCG,00P,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,47558.00
2016/17,Sunderland CCG,00P,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1391996.87
2016/17,Sunderland CCG,00P,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,35871.00
2016/17,Sunderland CCG,00P,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),999083.93
2016/17,Sunderland CCG,00P,Human analogue insulins ,Prescription Items,31757.00
2016/17,Sunderland CCG,00P,Human analogue insulins ,Net Ingredient Cost (£),1699907.07
2016/17,Sunderland CCG,00P,Other insulins ,Prescription Items,9527.00
2016/17,Sunderland CCG,00P,Other insulins ,Net Ingredient Cost (£),310748.60
2016/17,Surrey Downs CCG,99H,Total primary care (all BNF),Prescription Items,4242796.00
2016/17,Surrey Downs CCG,99H,Total primary care (all BNF),Net Ingredient Cost (£),41587092.31
2016/17,Surrey Downs CCG,99H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,178416.00
2016/17,Surrey Downs CCG,99H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4370316.71
2016/17,Surrey Downs CCG,99H,Insulins (BNF 6.1.1) ,Prescription Items,26935.00
2016/17,Surrey Downs CCG,99H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1428339.81
2016/17,Surrey Downs CCG,99H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10253.00
2016/17,Surrey Downs CCG,99H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),513698.44
2016/17,Surrey Downs CCG,99H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,16682.00
2016/17,Surrey Downs CCG,99H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),914641.37
2016/17,Surrey Downs CCG,99H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,120736.00
2016/17,Surrey Downs CCG,99H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2081444.75
2016/17,Surrey Downs CCG,99H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,22027.00
2016/17,Surrey Downs CCG,99H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),92132.31
2016/17,Surrey Downs CCG,99H,Biguanides (BNF 6.1.2.2) ,Prescription Items,69551.00
2016/17,Surrey Downs CCG,99H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),407108.06
2016/17,Surrey Downs CCG,99H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,29158.00
2016/17,Surrey Downs CCG,99H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1582204.38
2016/17,Surrey Downs CCG,99H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,29805.00
2016/17,Surrey Downs CCG,99H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),848673.04
2016/17,Surrey Downs CCG,99H,Human analogue insulins ,Prescription Items,24352.00
2016/17,Surrey Downs CCG,99H,Human analogue insulins ,Net Ingredient Cost (£),1343645.90
2016/17,Surrey Downs CCG,99H,Other insulins ,Prescription Items,2583.00
2016/17,Surrey Downs CCG,99H,Other insulins ,Net Ingredient Cost (£),84693.91
2016/17,Surrey Heath CCG,10C,Total primary care (all BNF),Prescription Items,1413248.00
2016/17,Surrey Heath CCG,10C,Total primary care (all BNF),Net Ingredient Cost (£),13349519.88
2016/17,Surrey Heath CCG,10C,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,65290.00
2016/17,Surrey Heath CCG,10C,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1688096.87
2016/17,Surrey Heath CCG,10C,Insulins (BNF 6.1.1) ,Prescription Items,10293.00
2016/17,Surrey Heath CCG,10C,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),576711.05
2016/17,Surrey Heath CCG,10C,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,3832.00
2016/17,Surrey Heath CCG,10C,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),192471.29
2016/17,Surrey Heath CCG,10C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,6461.00
2016/17,Surrey Heath CCG,10C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),384239.76
2016/17,Surrey Heath CCG,10C,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,45194.00
2016/17,Surrey Heath CCG,10C,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),825757.01
2016/17,Surrey Heath CCG,10C,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,7567.00
2016/17,Surrey Heath CCG,10C,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),34626.66
2016/17,Surrey Heath CCG,10C,Biguanides (BNF 6.1.2.2) ,Prescription Items,25206.00
2016/17,Surrey Heath CCG,10C,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),155094.77
2016/17,Surrey Heath CCG,10C,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,12421.00
2016/17,Surrey Heath CCG,10C,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),636035.58
2016/17,Surrey Heath CCG,10C,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,9346.00
2016/17,Surrey Heath CCG,10C,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),280267.36
2016/17,Surrey Heath CCG,10C,Human analogue insulins ,Prescription Items,9731.00
2016/17,Surrey Heath CCG,10C,Human analogue insulins ,Net Ingredient Cost (£),559320.12
2016/17,Surrey Heath CCG,10C,Other insulins ,Prescription Items,562.00
2016/17,Surrey Heath CCG,10C,Other insulins ,Net Ingredient Cost (£),17390.93
2016/17,Sutton CCG,08T,Total primary care (all BNF),Prescription Items,3228886.00
2016/17,Sutton CCG,08T,Total primary care (all BNF),Net Ingredient Cost (£),24761532.14
2016/17,Sutton CCG,08T,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,169431.00
2016/17,Sutton CCG,08T,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3184356.17
2016/17,Sutton CCG,08T,Insulins (BNF 6.1.1) ,Prescription Items,20509.00
2016/17,Sutton CCG,08T,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1098520.43
2016/17,Sutton CCG,08T,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7293.00
2016/17,Sutton CCG,08T,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),340695.96
2016/17,Sutton CCG,08T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,13216.00
2016/17,Sutton CCG,08T,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),757824.47
2016/17,Sutton CCG,08T,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,125995.00
2016/17,Sutton CCG,08T,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1504847.54
2016/17,Sutton CCG,08T,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23420.00
2016/17,Sutton CCG,08T,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),68352.58
2016/17,Sutton CCG,08T,Biguanides (BNF 6.1.2.2) ,Prescription Items,73065.00
2016/17,Sutton CCG,08T,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),297715.14
2016/17,Sutton CCG,08T,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,29510.00
2016/17,Sutton CCG,08T,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1138779.82
2016/17,Sutton CCG,08T,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,22174.00
2016/17,Sutton CCG,08T,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),571206.02
2016/17,Sutton CCG,08T,Human analogue insulins ,Prescription Items,19016.00
2016/17,Sutton CCG,08T,Human analogue insulins ,Net Ingredient Cost (£),1052467.46
2016/17,Sutton CCG,08T,Other insulins ,Prescription Items,1493.00
2016/17,Sutton CCG,08T,Other insulins ,Net Ingredient Cost (£),46052.97
2016/17,Swale CCG,10D,Total primary care (all BNF),Prescription Items,1987902.00
2016/17,Swale CCG,10D,Total primary care (all BNF),Net Ingredient Cost (£),19700420.79
2016/17,Swale CCG,10D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,103909.00
2016/17,Swale CCG,10D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2606065.98
2016/17,Swale CCG,10D,Insulins (BNF 6.1.1) ,Prescription Items,13887.00
2016/17,Swale CCG,10D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),732401.81
2016/17,Swale CCG,10D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,4672.00
2016/17,Swale CCG,10D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),237959.27
2016/17,Swale CCG,10D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,9215.00
2016/17,Swale CCG,10D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),494442.54
2016/17,Swale CCG,10D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,75262.00
2016/17,Swale CCG,10D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1465980.47
2016/17,Swale CCG,10D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,12840.00
2016/17,Swale CCG,10D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),50775.28
2016/17,Swale CCG,10D,Biguanides (BNF 6.1.2.2) ,Prescription Items,37936.00
2016/17,Swale CCG,10D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),230844.23
2016/17,Swale CCG,10D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,24486.00
2016/17,Swale CCG,10D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1184360.96
2016/17,Swale CCG,10D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,14112.00
2016/17,Swale CCG,10D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),367898.16
2016/17,Swale CCG,10D,Human analogue insulins ,Prescription Items,12640.00
2016/17,Swale CCG,10D,Human analogue insulins ,Net Ingredient Cost (£),691911.61
2016/17,Swale CCG,10D,Other insulins ,Prescription Items,1247.00
2016/17,Swale CCG,10D,Other insulins ,Net Ingredient Cost (£),40490.20
2016/17,Swindon CCG,12D,Total primary care (all BNF),Prescription Items,4546132.00
2016/17,Swindon CCG,12D,Total primary care (all BNF),Net Ingredient Cost (£),34262894.09
2016/17,Swindon CCG,12D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,249986.00
2016/17,Swindon CCG,12D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4225038.12
2016/17,Swindon CCG,12D,Insulins (BNF 6.1.1) ,Prescription Items,29679.00
2016/17,Swindon CCG,12D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1488977.94
2016/17,Swindon CCG,12D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9506.00
2016/17,Swindon CCG,12D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),444370.76
2016/17,Swindon CCG,12D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,20173.00
2016/17,Swindon CCG,12D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1044607.18
2016/17,Swindon CCG,12D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,187435.00
2016/17,Swindon CCG,12D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1881962.07
2016/17,Swindon CCG,12D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,46111.00
2016/17,Swindon CCG,12D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),134664.06
2016/17,Swindon CCG,12D,Biguanides (BNF 6.1.2.2) ,Prescription Items,102066.00
2016/17,Swindon CCG,12D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),394414.68
2016/17,Swindon CCG,12D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,39258.00
2016/17,Swindon CCG,12D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1352883.33
2016/17,Swindon CCG,12D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,31910.00
2016/17,Swindon CCG,12D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),842187.42
2016/17,Swindon CCG,12D,Human analogue insulins ,Prescription Items,24137.00
2016/17,Swindon CCG,12D,Human analogue insulins ,Net Ingredient Cost (£),1311497.42
2016/17,Swindon CCG,12D,Other insulins ,Prescription Items,5542.00
2016/17,Swindon CCG,12D,Other insulins ,Net Ingredient Cost (£),177480.52
2016/17,Tameside and Glossop CCG,01Y,Total primary care (all BNF),Prescription Items,5606149.00
2016/17,Tameside and Glossop CCG,01Y,Total primary care (all BNF),Net Ingredient Cost (£),45672810.84
2016/17,Tameside and Glossop CCG,01Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,254300.00
2016/17,Tameside and Glossop CCG,01Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5028535.65
2016/17,Tameside and Glossop CCG,01Y,Insulins (BNF 6.1.1) ,Prescription Items,36006.00
2016/17,Tameside and Glossop CCG,01Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1778396.73
2016/17,Tameside and Glossop CCG,01Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,13342.00
2016/17,Tameside and Glossop CCG,01Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),595309.64
2016/17,Tameside and Glossop CCG,01Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,22664.00
2016/17,Tameside and Glossop CCG,01Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1183087.09
2016/17,Tameside and Glossop CCG,01Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,185270.00
2016/17,Tameside and Glossop CCG,01Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2356659.60
2016/17,Tameside and Glossop CCG,01Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,34813.00
2016/17,Tameside and Glossop CCG,01Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),108720.14
2016/17,Tameside and Glossop CCG,01Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,106544.00
2016/17,Tameside and Glossop CCG,01Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),530372.75
2016/17,Tameside and Glossop CCG,01Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,43913.00
2016/17,Tameside and Glossop CCG,01Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1717566.71
2016/17,Tameside and Glossop CCG,01Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,32007.00
2016/17,Tameside and Glossop CCG,01Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),878186.56
2016/17,Tameside and Glossop CCG,01Y,Human analogue insulins ,Prescription Items,33730.00
2016/17,Tameside and Glossop CCG,01Y,Human analogue insulins ,Net Ingredient Cost (£),1700744.18
2016/17,Tameside and Glossop CCG,01Y,Other insulins ,Prescription Items,2276.00
2016/17,Tameside and Glossop CCG,01Y,Other insulins ,Net Ingredient Cost (£),77652.55
2016/17,Telford & Wrekin CCG,05X,Total primary care (all BNF),Prescription Items,2986596.00
2016/17,Telford & Wrekin CCG,05X,Total primary care (all BNF),Net Ingredient Cost (£),30449723.63
2016/17,Telford & Wrekin CCG,05X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,147477.00
2016/17,Telford & Wrekin CCG,05X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3381442.81
2016/17,Telford & Wrekin CCG,05X,Insulins (BNF 6.1.1) ,Prescription Items,21858.00
2016/17,Telford & Wrekin CCG,05X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1226255.27
2016/17,Telford & Wrekin CCG,05X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6354.00
2016/17,Telford & Wrekin CCG,05X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),324416.83
2016/17,Telford & Wrekin CCG,05X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,15504.00
2016/17,Telford & Wrekin CCG,05X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),901838.44
2016/17,Telford & Wrekin CCG,05X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,100824.00
2016/17,Telford & Wrekin CCG,05X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1469658.46
2016/17,Telford & Wrekin CCG,05X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,24323.00
2016/17,Telford & Wrekin CCG,05X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),101196.14
2016/17,Telford & Wrekin CCG,05X,Biguanides (BNF 6.1.2.2) ,Prescription Items,54889.00
2016/17,Telford & Wrekin CCG,05X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),330707.06
2016/17,Telford & Wrekin CCG,05X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,21612.00
2016/17,Telford & Wrekin CCG,05X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1037755.26
2016/17,Telford & Wrekin CCG,05X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,23488.00
2016/17,Telford & Wrekin CCG,05X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),669464.97
2016/17,Telford & Wrekin CCG,05X,Human analogue insulins ,Prescription Items,18693.00
2016/17,Telford & Wrekin CCG,05X,Human analogue insulins ,Net Ingredient Cost (£),1114390.78
2016/17,Telford & Wrekin CCG,05X,Other insulins ,Prescription Items,3165.00
2016/17,Telford & Wrekin CCG,05X,Other insulins ,Net Ingredient Cost (£),111864.49
2016/17,Thanet CCG,10E,Total primary care (all BNF),Prescription Items,3143077.00
2016/17,Thanet CCG,10E,Total primary care (all BNF),Net Ingredient Cost (£),27716287.11
2016/17,Thanet CCG,10E,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,142273.00
2016/17,Thanet CCG,10E,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3092908.78
2016/17,Thanet CCG,10E,Insulins (BNF 6.1.1) ,Prescription Items,21909.00
2016/17,Thanet CCG,10E,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1149914.73
2016/17,Thanet CCG,10E,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7320.00
2016/17,Thanet CCG,10E,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),379130.54
2016/17,Thanet CCG,10E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,14589.00
2016/17,Thanet CCG,10E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),770784.19
2016/17,Thanet CCG,10E,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,99791.00
2016/17,Thanet CCG,10E,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1428447.27
2016/17,Thanet CCG,10E,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,19643.00
2016/17,Thanet CCG,10E,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),71862.23
2016/17,Thanet CCG,10E,Biguanides (BNF 6.1.2.2) ,Prescription Items,54690.00
2016/17,Thanet CCG,10E,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),282122.95
2016/17,Thanet CCG,10E,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,25458.00
2016/17,Thanet CCG,10E,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1074462.09
2016/17,Thanet CCG,10E,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,19393.00
2016/17,Thanet CCG,10E,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),477178.83
2016/17,Thanet CCG,10E,Human analogue insulins ,Prescription Items,18289.00
2016/17,Thanet CCG,10E,Human analogue insulins ,Net Ingredient Cost (£),1031639.13
2016/17,Thanet CCG,10E,Other insulins ,Prescription Items,3620.00
2016/17,Thanet CCG,10E,Other insulins ,Net Ingredient Cost (£),118275.60
2016/17,Thurrock CCG,07G,Total primary care (all BNF),Prescription Items,3083198.00
2016/17,Thurrock CCG,07G,Total primary care (all BNF),Net Ingredient Cost (£),23523085.86
2016/17,Thurrock CCG,07G,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,178604.00
2016/17,Thurrock CCG,07G,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3082963.65
2016/17,Thurrock CCG,07G,Insulins (BNF 6.1.1) ,Prescription Items,23603.00
2016/17,Thurrock CCG,07G,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1104469.81
2016/17,Thurrock CCG,07G,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6694.00
2016/17,Thurrock CCG,07G,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),295330.20
2016/17,Thurrock CCG,07G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,16909.00
2016/17,Thurrock CCG,07G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),809139.61
2016/17,Thurrock CCG,07G,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,132791.00
2016/17,Thurrock CCG,07G,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1491289.17
2016/17,Thurrock CCG,07G,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,28081.00
2016/17,Thurrock CCG,07G,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),87821.09
2016/17,Thurrock CCG,07G,Biguanides (BNF 6.1.2.2) ,Prescription Items,72162.00
2016/17,Thurrock CCG,07G,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),281263.12
2016/17,Thurrock CCG,07G,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,32548.00
2016/17,Thurrock CCG,07G,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1122204.96
2016/17,Thurrock CCG,07G,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,21243.00
2016/17,Thurrock CCG,07G,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),475303.14
2016/17,Thurrock CCG,07G,Human analogue insulins ,Prescription Items,17731.00
2016/17,Thurrock CCG,07G,Human analogue insulins ,Net Ingredient Cost (£),924337.17
2016/17,Thurrock CCG,07G,Other insulins ,Prescription Items,5872.00
2016/17,Thurrock CCG,07G,Other insulins ,Net Ingredient Cost (£),180132.64
2016/17,Tower Hamlets CCG,08V,Total primary care (all BNF),Prescription Items,5012650.00
2016/17,Tower Hamlets CCG,08V,Total primary care (all BNF),Net Ingredient Cost (£),32028357.30
2016/17,Tower Hamlets CCG,08V,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,389139.00
2016/17,Tower Hamlets CCG,08V,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4402453.02
2016/17,Tower Hamlets CCG,08V,Insulins (BNF 6.1.1) ,Prescription Items,29518.00
2016/17,Tower Hamlets CCG,08V,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1573456.41
2016/17,Tower Hamlets CCG,08V,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7902.00
2016/17,Tower Hamlets CCG,08V,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),428617.77
2016/17,Tower Hamlets CCG,08V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,21616.00
2016/17,Tower Hamlets CCG,08V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1144838.64
2016/17,Tower Hamlets CCG,08V,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,333304.00
2016/17,Tower Hamlets CCG,08V,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2154545.09
2016/17,Tower Hamlets CCG,08V,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,81736.00
2016/17,Tower Hamlets CCG,08V,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),183366.95
2016/17,Tower Hamlets CCG,08V,Biguanides (BNF 6.1.2.2) ,Prescription Items,190721.00
2016/17,Tower Hamlets CCG,08V,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),505159.16
2016/17,Tower Hamlets CCG,08V,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,60847.00
2016/17,Tower Hamlets CCG,08V,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1466018.98
2016/17,Tower Hamlets CCG,08V,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,25410.00
2016/17,Tower Hamlets CCG,08V,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),660333.48
2016/17,Tower Hamlets CCG,08V,Human analogue insulins ,Prescription Items,21000.00
2016/17,Tower Hamlets CCG,08V,Human analogue insulins ,Net Ingredient Cost (£),1275631.35
2016/17,Tower Hamlets CCG,08V,Other insulins ,Prescription Items,8518.00
2016/17,Tower Hamlets CCG,08V,Other insulins ,Net Ingredient Cost (£),297825.06
2016/17,Trafford CCG,02A,Total primary care (all BNF),Prescription Items,5043717.00
2016/17,Trafford CCG,02A,Total primary care (all BNF),Net Ingredient Cost (£),41208461.60
2016/17,Trafford CCG,02A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,226221.00
2016/17,Trafford CCG,02A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4603489.27
2016/17,Trafford CCG,02A,Insulins (BNF 6.1.1) ,Prescription Items,27674.00
2016/17,Trafford CCG,02A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1380988.70
2016/17,Trafford CCG,02A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10106.00
2016/17,Trafford CCG,02A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),472106.22
2016/17,Trafford CCG,02A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,17568.00
2016/17,Trafford CCG,02A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),908882.48
2016/17,Trafford CCG,02A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,171130.00
2016/17,Trafford CCG,02A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2381257.33
2016/17,Trafford CCG,02A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,32916.00
2016/17,Trafford CCG,02A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),81195.10
2016/17,Trafford CCG,02A,Biguanides (BNF 6.1.2.2) ,Prescription Items,85968.00
2016/17,Trafford CCG,02A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),400939.69
2016/17,Trafford CCG,02A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,52246.00
2016/17,Trafford CCG,02A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1899122.54
2016/17,Trafford CCG,02A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,26668.00
2016/17,Trafford CCG,02A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),831723.04
2016/17,Trafford CCG,02A,Human analogue insulins ,Prescription Items,26117.00
2016/17,Trafford CCG,02A,Human analogue insulins ,Net Ingredient Cost (£),1328783.75
2016/17,Trafford CCG,02A,Other insulins ,Prescription Items,1557.00
2016/17,Trafford CCG,02A,Other insulins ,Net Ingredient Cost (£),52204.95
2016/17,Vale of York CCG,03Q,Total primary care (all BNF),Prescription Items,6314739.00
2016/17,Vale of York CCG,03Q,Total primary care (all BNF),Net Ingredient Cost (£),53122978.18
2016/17,Vale of York CCG,03Q,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,244586.00
2016/17,Vale of York CCG,03Q,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4761409.40
2016/17,Vale of York CCG,03Q,Insulins (BNF 6.1.1) ,Prescription Items,36027.00
2016/17,Vale of York CCG,03Q,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1725040.23
2016/17,Vale of York CCG,03Q,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,11666.00
2016/17,Vale of York CCG,03Q,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),556665.06
2016/17,Vale of York CCG,03Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,24361.00
2016/17,Vale of York CCG,03Q,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1168375.17
2016/17,Vale of York CCG,03Q,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,169063.00
2016/17,Vale of York CCG,03Q,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1964744.31
2016/17,Vale of York CCG,03Q,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,39979.00
2016/17,Vale of York CCG,03Q,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),118616.85
2016/17,Vale of York CCG,03Q,Biguanides (BNF 6.1.2.2) ,Prescription Items,95558.00
2016/17,Vale of York CCG,03Q,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),444991.11
2016/17,Vale of York CCG,03Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,33526.00
2016/17,Vale of York CCG,03Q,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1401136.35
2016/17,Vale of York CCG,03Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,37921.00
2016/17,Vale of York CCG,03Q,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1053332.78
2016/17,Vale of York CCG,03Q,Human analogue insulins ,Prescription Items,28914.00
2016/17,Vale of York CCG,03Q,Human analogue insulins ,Net Ingredient Cost (£),1487886.37
2016/17,Vale of York CCG,03Q,Other insulins ,Prescription Items,7113.00
2016/17,Vale of York CCG,03Q,Other insulins ,Net Ingredient Cost (£),237153.86
2016/17,Vale Royal CCG,02D,Total primary care (all BNF),Prescription Items,2511538.00
2016/17,Vale Royal CCG,02D,Total primary care (all BNF),Net Ingredient Cost (£),17527131.21
2016/17,Vale Royal CCG,02D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,113507.00
2016/17,Vale Royal CCG,02D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2001645.44
2016/17,Vale Royal CCG,02D,Insulins (BNF 6.1.1) ,Prescription Items,16455.00
2016/17,Vale Royal CCG,02D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),803305.17
2016/17,Vale Royal CCG,02D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,6169.00
2016/17,Vale Royal CCG,02D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),281797.64
2016/17,Vale Royal CCG,02D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,10286.00
2016/17,Vale Royal CCG,02D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),521507.53
2016/17,Vale Royal CCG,02D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,81089.00
2016/17,Vale Royal CCG,02D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),838544.45
2016/17,Vale Royal CCG,02D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,18445.00
2016/17,Vale Royal CCG,02D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),50249.85
2016/17,Vale Royal CCG,02D,Biguanides (BNF 6.1.2.2) ,Prescription Items,45091.00
2016/17,Vale Royal CCG,02D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),194959.99
2016/17,Vale Royal CCG,02D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,17553.00
2016/17,Vale Royal CCG,02D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),593334.61
2016/17,Vale Royal CCG,02D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,15264.00
2016/17,Vale Royal CCG,02D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),352612.85
2016/17,Vale Royal CCG,02D,Human analogue insulins ,Prescription Items,13625.00
2016/17,Vale Royal CCG,02D,Human analogue insulins ,Net Ingredient Cost (£),708586.81
2016/17,Vale Royal CCG,02D,Other insulins ,Prescription Items,2830.00
2016/17,Vale Royal CCG,02D,Other insulins ,Net Ingredient Cost (£),94718.36
2016/17,Wakefield CCG,03R,Total primary care (all BNF),Prescription Items,7939893.00
2016/17,Wakefield CCG,03R,Total primary care (all BNF),Net Ingredient Cost (£),65221363.85
2016/17,Wakefield CCG,03R,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,353210.00
2016/17,Wakefield CCG,03R,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6975509.25
2016/17,Wakefield CCG,03R,Insulins (BNF 6.1.1) ,Prescription Items,51543.00
2016/17,Wakefield CCG,03R,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2542115.03
2016/17,Wakefield CCG,03R,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,15629.00
2016/17,Wakefield CCG,03R,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),708621.63
2016/17,Wakefield CCG,03R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,35914.00
2016/17,Wakefield CCG,03R,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1833493.40
2016/17,Wakefield CCG,03R,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,247156.00
2016/17,Wakefield CCG,03R,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3190419.60
2016/17,Wakefield CCG,03R,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,55613.00
2016/17,Wakefield CCG,03R,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),184237.84
2016/17,Wakefield CCG,03R,Biguanides (BNF 6.1.2.2) ,Prescription Items,136359.00
2016/17,Wakefield CCG,03R,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),651320.49
2016/17,Wakefield CCG,03R,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,55184.00
2016/17,Wakefield CCG,03R,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2354861.27
2016/17,Wakefield CCG,03R,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,52058.00
2016/17,Wakefield CCG,03R,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1216260.63
2016/17,Wakefield CCG,03R,Human analogue insulins ,Prescription Items,37456.00
2016/17,Wakefield CCG,03R,Human analogue insulins ,Net Ingredient Cost (£),2049387.43
2016/17,Wakefield CCG,03R,Other insulins ,Prescription Items,14087.00
2016/17,Wakefield CCG,03R,Other insulins ,Net Ingredient Cost (£),492727.60
2016/17,Walsall CCG,05Y,Total primary care (all BNF),Prescription Items,5604445.00
2016/17,Walsall CCG,05Y,Total primary care (all BNF),Net Ingredient Cost (£),52896377.13
2016/17,Walsall CCG,05Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,270896.00
2016/17,Walsall CCG,05Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5852617.69
2016/17,Walsall CCG,05Y,Insulins (BNF 6.1.1) ,Prescription Items,45365.00
2016/17,Walsall CCG,05Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2342291.43
2016/17,Walsall CCG,05Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10966.00
2016/17,Walsall CCG,05Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),537426.83
2016/17,Walsall CCG,05Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,34399.00
2016/17,Walsall CCG,05Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1804864.60
2016/17,Walsall CCG,05Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,180321.00
2016/17,Walsall CCG,05Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2567980.12
2016/17,Walsall CCG,05Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,37445.00
2016/17,Walsall CCG,05Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),133435.66
2016/17,Walsall CCG,05Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,105580.00
2016/17,Walsall CCG,05Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),523680.88
2016/17,Walsall CCG,05Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,37296.00
2016/17,Walsall CCG,05Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1910863.58
2016/17,Walsall CCG,05Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,44104.00
2016/17,Walsall CCG,05Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),927152.08
2016/17,Walsall CCG,05Y,Human analogue insulins ,Prescription Items,37884.00
2016/17,Walsall CCG,05Y,Human analogue insulins ,Net Ingredient Cost (£),2087625.49
2016/17,Walsall CCG,05Y,Other insulins ,Prescription Items,7481.00
2016/17,Walsall CCG,05Y,Other insulins ,Net Ingredient Cost (£),254665.94
2016/17,Waltham Forest CCG,08W,Total primary care (all BNF),Prescription Items,3676673.00
2016/17,Waltham Forest CCG,08W,Total primary care (all BNF),Net Ingredient Cost (£),34900743.67
2016/17,Waltham Forest CCG,08W,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,238087.00
2016/17,Waltham Forest CCG,08W,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5031299.71
2016/17,Waltham Forest CCG,08W,Insulins (BNF 6.1.1) ,Prescription Items,27348.00
2016/17,Waltham Forest CCG,08W,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1382291.60
2016/17,Waltham Forest CCG,08W,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7791.00
2016/17,Waltham Forest CCG,08W,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),381171.09
2016/17,Waltham Forest CCG,08W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19557.00
2016/17,Waltham Forest CCG,08W,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1001120.51
2016/17,Waltham Forest CCG,08W,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,179705.00
2016/17,Waltham Forest CCG,08W,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2926034.97
2016/17,Waltham Forest CCG,08W,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,40572.00
2016/17,Waltham Forest CCG,08W,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),178985.72
2016/17,Waltham Forest CCG,08W,Biguanides (BNF 6.1.2.2) ,Prescription Items,93843.00
2016/17,Waltham Forest CCG,08W,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),510185.27
2016/17,Waltham Forest CCG,08W,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,45290.00
2016/17,Waltham Forest CCG,08W,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2236863.98
2016/17,Waltham Forest CCG,08W,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,30113.00
2016/17,Waltham Forest CCG,08W,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),708103.60
2016/17,Waltham Forest CCG,08W,Human analogue insulins ,Prescription Items,22712.00
2016/17,Waltham Forest CCG,08W,Human analogue insulins ,Net Ingredient Cost (£),1230106.44
2016/17,Waltham Forest CCG,08W,Other insulins ,Prescription Items,4636.00
2016/17,Waltham Forest CCG,08W,Other insulins ,Net Ingredient Cost (£),152185.16
2016/17,Wandsworth CCG,08X,Total primary care (all BNF),Prescription Items,4876822.00
2016/17,Wandsworth CCG,08X,Total primary care (all BNF),Net Ingredient Cost (£),38846212.83
2016/17,Wandsworth CCG,08X,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,281620.00
2016/17,Wandsworth CCG,08X,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4416178.29
2016/17,Wandsworth CCG,08X,Insulins (BNF 6.1.1) ,Prescription Items,29671.00
2016/17,Wandsworth CCG,08X,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1522650.15
2016/17,Wandsworth CCG,08X,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9831.00
2016/17,Wandsworth CCG,08X,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),476136.21
2016/17,Wandsworth CCG,08X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,19840.00
2016/17,Wandsworth CCG,08X,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1046513.94
2016/17,Wandsworth CCG,08X,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,219508.00
2016/17,Wandsworth CCG,08X,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2030854.12
2016/17,Wandsworth CCG,08X,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,52970.00
2016/17,Wandsworth CCG,08X,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),139075.16
2016/17,Wandsworth CCG,08X,Biguanides (BNF 6.1.2.2) ,Prescription Items,122210.00
2016/17,Wandsworth CCG,08X,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),449942.35
2016/17,Wandsworth CCG,08X,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,44328.00
2016/17,Wandsworth CCG,08X,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1441836.61
2016/17,Wandsworth CCG,08X,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,31483.00
2016/17,Wandsworth CCG,08X,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),848384.12
2016/17,Wandsworth CCG,08X,Human analogue insulins ,Prescription Items,25412.00
2016/17,Wandsworth CCG,08X,Human analogue insulins ,Net Ingredient Cost (£),1389013.94
2016/17,Wandsworth CCG,08X,Other insulins ,Prescription Items,4259.00
2016/17,Wandsworth CCG,08X,Other insulins ,Net Ingredient Cost (£),133636.21
2016/17,Warrington CCG,02E,Total primary care (all BNF),Prescription Items,3851723.00
2016/17,Warrington CCG,02E,Total primary care (all BNF),Net Ingredient Cost (£),34776597.64
2016/17,Warrington CCG,02E,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,177385.00
2016/17,Warrington CCG,02E,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3873006.39
2016/17,Warrington CCG,02E,Insulins (BNF 6.1.1) ,Prescription Items,24283.00
2016/17,Warrington CCG,02E,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1234913.18
2016/17,Warrington CCG,02E,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7920.00
2016/17,Warrington CCG,02E,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),388746.50
2016/17,Warrington CCG,02E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,16363.00
2016/17,Warrington CCG,02E,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),846166.68
2016/17,Warrington CCG,02E,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,123208.00
2016/17,Warrington CCG,02E,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1807993.39
2016/17,Warrington CCG,02E,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,23958.00
2016/17,Warrington CCG,02E,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),85893.55
2016/17,Warrington CCG,02E,Biguanides (BNF 6.1.2.2) ,Prescription Items,70076.00
2016/17,Warrington CCG,02E,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),361922.43
2016/17,Warrington CCG,02E,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,29174.00
2016/17,Warrington CCG,02E,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1360177.41
2016/17,Warrington CCG,02E,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,28864.00
2016/17,Warrington CCG,02E,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),819249.05
2016/17,Warrington CCG,02E,Human analogue insulins ,Prescription Items,20948.00
2016/17,Warrington CCG,02E,Human analogue insulins ,Net Ingredient Cost (£),1112223.04
2016/17,Warrington CCG,02E,Other insulins ,Prescription Items,3335.00
2016/17,Warrington CCG,02E,Other insulins ,Net Ingredient Cost (£),122690.14
2016/17,Warwickshire North CCG,05H,Total primary care (all BNF),Prescription Items,4425110.00
2016/17,Warwickshire North CCG,05H,Total primary care (all BNF),Net Ingredient Cost (£),32153176.17
2016/17,Warwickshire North CCG,05H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,239422.00
2016/17,Warwickshire North CCG,05H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4506578.97
2016/17,Warwickshire North CCG,05H,Insulins (BNF 6.1.1) ,Prescription Items,33177.00
2016/17,Warwickshire North CCG,05H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1676019.72
2016/17,Warwickshire North CCG,05H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10714.00
2016/17,Warwickshire North CCG,05H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),477737.21
2016/17,Warwickshire North CCG,05H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,22463.00
2016/17,Warwickshire North CCG,05H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1198282.51
2016/17,Warwickshire North CCG,05H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,172627.00
2016/17,Warwickshire North CCG,05H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2022570.06
2016/17,Warwickshire North CCG,05H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,36667.00
2016/17,Warwickshire North CCG,05H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),102741.23
2016/17,Warwickshire North CCG,05H,Biguanides (BNF 6.1.2.2) ,Prescription Items,91062.00
2016/17,Warwickshire North CCG,05H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),331582.86
2016/17,Warwickshire North CCG,05H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,44898.00
2016/17,Warwickshire North CCG,05H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1588245.97
2016/17,Warwickshire North CCG,05H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,31831.00
2016/17,Warwickshire North CCG,05H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),789686.10
2016/17,Warwickshire North CCG,05H,Human analogue insulins ,Prescription Items,31335.00
2016/17,Warwickshire North CCG,05H,Human analogue insulins ,Net Ingredient Cost (£),1612281.90
2016/17,Warwickshire North CCG,05H,Other insulins ,Prescription Items,1842.00
2016/17,Warwickshire North CCG,05H,Other insulins ,Net Ingredient Cost (£),63737.82
2016/17,West Cheshire CCG,02F,Total primary care (all BNF),Prescription Items,4933398.00
2016/17,West Cheshire CCG,02F,Total primary care (all BNF),Net Ingredient Cost (£),43188233.92
2016/17,West Cheshire CCG,02F,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,202360.00
2016/17,West Cheshire CCG,02F,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4278480.54
2016/17,West Cheshire CCG,02F,Insulins (BNF 6.1.1) ,Prescription Items,27758.00
2016/17,West Cheshire CCG,02F,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1412232.71
2016/17,West Cheshire CCG,02F,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10445.00
2016/17,West Cheshire CCG,02F,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),512556.57
2016/17,West Cheshire CCG,02F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,17313.00
2016/17,West Cheshire CCG,02F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),899676.14
2016/17,West Cheshire CCG,02F,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,143303.00
2016/17,West Cheshire CCG,02F,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1989886.42
2016/17,West Cheshire CCG,02F,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,28773.00
2016/17,West Cheshire CCG,02F,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),115374.60
2016/17,West Cheshire CCG,02F,Biguanides (BNF 6.1.2.2) ,Prescription Items,80556.00
2016/17,West Cheshire CCG,02F,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),439199.29
2016/17,West Cheshire CCG,02F,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,33974.00
2016/17,West Cheshire CCG,02F,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1435312.53
2016/17,West Cheshire CCG,02F,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,30236.00
2016/17,West Cheshire CCG,02F,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),852722.72
2016/17,West Cheshire CCG,02F,Human analogue insulins ,Prescription Items,24851.00
2016/17,West Cheshire CCG,02F,Human analogue insulins ,Net Ingredient Cost (£),1324192.47
2016/17,West Cheshire CCG,02F,Other insulins ,Prescription Items,2907.00
2016/17,West Cheshire CCG,02F,Other insulins ,Net Ingredient Cost (£),88040.24
2016/17,West Essex CCG,07H,Total primary care (all BNF),Prescription Items,5756003.00
2016/17,West Essex CCG,07H,Total primary care (all BNF),Net Ingredient Cost (£),45185426.54
2016/17,West Essex CCG,07H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,259000.00
2016/17,West Essex CCG,07H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4550315.76
2016/17,West Essex CCG,07H,Insulins (BNF 6.1.1) ,Prescription Items,37161.00
2016/17,West Essex CCG,07H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1757144.99
2016/17,West Essex CCG,07H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,13775.00
2016/17,West Essex CCG,07H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),613648.50
2016/17,West Essex CCG,07H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,23386.00
2016/17,West Essex CCG,07H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1143496.49
2016/17,West Essex CCG,07H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,181493.00
2016/17,West Essex CCG,07H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1778528.29
2016/17,West Essex CCG,07H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,44677.00
2016/17,West Essex CCG,07H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),155503.55
2016/17,West Essex CCG,07H,Biguanides (BNF 6.1.2.2) ,Prescription Items,103530.00
2016/17,West Essex CCG,07H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),419921.56
2016/17,West Essex CCG,07H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,33286.00
2016/17,West Essex CCG,07H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1203103.18
2016/17,West Essex CCG,07H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,37695.00
2016/17,West Essex CCG,07H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),988418.33
2016/17,West Essex CCG,07H,Human analogue insulins ,Prescription Items,31782.00
2016/17,West Essex CCG,07H,Human analogue insulins ,Net Ingredient Cost (£),1588366.35
2016/17,West Essex CCG,07H,Other insulins ,Prescription Items,5379.00
2016/17,West Essex CCG,07H,Other insulins ,Net Ingredient Cost (£),168778.64
2016/17,West Hampshire CCG,11A,Total primary care (all BNF),Prescription Items,9453645.00
2016/17,West Hampshire CCG,11A,Total primary care (all BNF),Net Ingredient Cost (£),92679538.52
2016/17,West Hampshire CCG,11A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,372018.00
2016/17,West Hampshire CCG,11A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),8864830.66
2016/17,West Hampshire CCG,11A,Insulins (BNF 6.1.1) ,Prescription Items,57958.00
2016/17,West Hampshire CCG,11A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),3100972.71
2016/17,West Hampshire CCG,11A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,19475.00
2016/17,West Hampshire CCG,11A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),974277.36
2016/17,West Hampshire CCG,11A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,38483.00
2016/17,West Hampshire CCG,11A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2126695.35
2016/17,West Hampshire CCG,11A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,248884.00
2016/17,West Hampshire CCG,11A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3965871.70
2016/17,West Hampshire CCG,11A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,54466.00
2016/17,West Hampshire CCG,11A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),246443.03
2016/17,West Hampshire CCG,11A,Biguanides (BNF 6.1.2.2) ,Prescription Items,136709.00
2016/17,West Hampshire CCG,11A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),766417.22
2016/17,West Hampshire CCG,11A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,57709.00
2016/17,West Hampshire CCG,11A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2953011.45
2016/17,West Hampshire CCG,11A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,62133.00
2016/17,West Hampshire CCG,11A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1759024.64
2016/17,West Hampshire CCG,11A,Human analogue insulins ,Prescription Items,46890.00
2016/17,West Hampshire CCG,11A,Human analogue insulins ,Net Ingredient Cost (£),2732021.24
2016/17,West Hampshire CCG,11A,Other insulins ,Prescription Items,11068.00
2016/17,West Hampshire CCG,11A,Other insulins ,Net Ingredient Cost (£),368951.47
2016/17,West Kent CCG,99J,Total primary care (all BNF),Prescription Items,9331019.00
2016/17,West Kent CCG,99J,Total primary care (all BNF),Net Ingredient Cost (£),75931976.58
2016/17,West Kent CCG,99J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,429494.00
2016/17,West Kent CCG,99J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),8154018.30
2016/17,West Kent CCG,99J,Insulins (BNF 6.1.1) ,Prescription Items,58136.00
2016/17,West Kent CCG,99J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2705915.75
2016/17,West Kent CCG,99J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,21165.00
2016/17,West Kent CCG,99J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),946688.35
2016/17,West Kent CCG,99J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,36971.00
2016/17,West Kent CCG,99J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1759227.40
2016/17,West Kent CCG,99J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,309038.00
2016/17,West Kent CCG,99J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3672941.69
2016/17,West Kent CCG,99J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,70487.00
2016/17,West Kent CCG,99J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),212229.00
2016/17,West Kent CCG,99J,Biguanides (BNF 6.1.2.2) ,Prescription Items,165036.00
2016/17,West Kent CCG,99J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),774626.91
2016/17,West Kent CCG,99J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,73515.00
2016/17,West Kent CCG,99J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2686085.78
2016/17,West Kent CCG,99J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,59152.00
2016/17,West Kent CCG,99J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1714773.40
2016/17,West Kent CCG,99J,Human analogue insulins ,Prescription Items,49899.00
2016/17,West Kent CCG,99J,Human analogue insulins ,Net Ingredient Cost (£),2451518.13
2016/17,West Kent CCG,99J,Other insulins ,Prescription Items,8237.00
2016/17,West Kent CCG,99J,Other insulins ,Net Ingredient Cost (£),254397.62
2016/17,West Lancashire CCG,02G,Total primary care (all BNF),Prescription Items,2299312.00
2016/17,West Lancashire CCG,02G,Total primary care (all BNF),Net Ingredient Cost (£),20334064.94
2016/17,West Lancashire CCG,02G,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,105385.00
2016/17,West Lancashire CCG,02G,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2133911.96
2016/17,West Lancashire CCG,02G,Insulins (BNF 6.1.1) ,Prescription Items,12590.00
2016/17,West Lancashire CCG,02G,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),652635.42
2016/17,West Lancashire CCG,02G,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,4597.00
2016/17,West Lancashire CCG,02G,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),225267.82
2016/17,West Lancashire CCG,02G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,7993.00
2016/17,West Lancashire CCG,02G,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),427367.60
2016/17,West Lancashire CCG,02G,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,79310.00
2016/17,West Lancashire CCG,02G,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1101964.35
2016/17,West Lancashire CCG,02G,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,18808.00
2016/17,West Lancashire CCG,02G,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),66627.81
2016/17,West Lancashire CCG,02G,Biguanides (BNF 6.1.2.2) ,Prescription Items,40303.00
2016/17,West Lancashire CCG,02G,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),175383.21
2016/17,West Lancashire CCG,02G,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,20199.00
2016/17,West Lancashire CCG,02G,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),859953.33
2016/17,West Lancashire CCG,02G,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,13079.00
2016/17,West Lancashire CCG,02G,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),373534.34
2016/17,West Lancashire CCG,02G,Human analogue insulins ,Prescription Items,11733.00
2016/17,West Lancashire CCG,02G,Human analogue insulins ,Net Ingredient Cost (£),621212.94
2016/17,West Lancashire CCG,02G,Other insulins ,Prescription Items,857.00
2016/17,West Lancashire CCG,02G,Other insulins ,Net Ingredient Cost (£),31422.48
2016/17,West Leicestershire CCG,04V,Total primary care (all BNF),Prescription Items,7330741.00
2016/17,West Leicestershire CCG,04V,Total primary care (all BNF),Net Ingredient Cost (£),56676762.12
2016/17,West Leicestershire CCG,04V,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,342550.00
2016/17,West Leicestershire CCG,04V,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6639522.91
2016/17,West Leicestershire CCG,04V,Insulins (BNF 6.1.1) ,Prescription Items,55557.00
2016/17,West Leicestershire CCG,04V,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2917481.41
2016/17,West Leicestershire CCG,04V,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,17107.00
2016/17,West Leicestershire CCG,04V,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),821255.98
2016/17,West Leicestershire CCG,04V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,38450.00
2016/17,West Leicestershire CCG,04V,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),2096225.43
2016/17,West Leicestershire CCG,04V,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,231960.00
2016/17,West Leicestershire CCG,04V,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2371242.00
2016/17,West Leicestershire CCG,04V,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,56263.00
2016/17,West Leicestershire CCG,04V,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),174864.55
2016/17,West Leicestershire CCG,04V,Biguanides (BNF 6.1.2.2) ,Prescription Items,134770.00
2016/17,West Leicestershire CCG,04V,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),553124.63
2016/17,West Leicestershire CCG,04V,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,40927.00
2016/17,West Leicestershire CCG,04V,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1643252.82
2016/17,West Leicestershire CCG,04V,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,52713.00
2016/17,West Leicestershire CCG,04V,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1327652.71
2016/17,West Leicestershire CCG,04V,Human analogue insulins ,Prescription Items,43135.00
2016/17,West Leicestershire CCG,04V,Human analogue insulins ,Net Ingredient Cost (£),2444039.23
2016/17,West Leicestershire CCG,04V,Other insulins ,Prescription Items,12422.00
2016/17,West Leicestershire CCG,04V,Other insulins ,Net Ingredient Cost (£),473442.18
2016/17,West London (K&C & QPP) CCG,08Y,Total primary care (all BNF),Prescription Items,2678163.00
2016/17,West London (K&C & QPP) CCG,08Y,Total primary care (all BNF),Net Ingredient Cost (£),25443853.50
2016/17,West London (K&C & QPP) CCG,08Y,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,152865.00
2016/17,West London (K&C & QPP) CCG,08Y,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),3171403.72
2016/17,West London (K&C & QPP) CCG,08Y,Insulins (BNF 6.1.1) ,Prescription Items,18253.00
2016/17,West London (K&C & QPP) CCG,08Y,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1001465.36
2016/17,West London (K&C & QPP) CCG,08Y,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,5336.00
2016/17,West London (K&C & QPP) CCG,08Y,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),287608.13
2016/17,West London (K&C & QPP) CCG,08Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,12917.00
2016/17,West London (K&C & QPP) CCG,08Y,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),713857.23
2016/17,West London (K&C & QPP) CCG,08Y,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,113682.00
2016/17,West London (K&C & QPP) CCG,08Y,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1638759.82
2016/17,West London (K&C & QPP) CCG,08Y,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,27557.00
2016/17,West London (K&C & QPP) CCG,08Y,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),93642.76
2016/17,West London (K&C & QPP) CCG,08Y,Biguanides (BNF 6.1.2.2) ,Prescription Items,61016.00
2016/17,West London (K&C & QPP) CCG,08Y,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),311924.24
2016/17,West London (K&C & QPP) CCG,08Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,25109.00
2016/17,West London (K&C & QPP) CCG,08Y,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1233192.82
2016/17,West London (K&C & QPP) CCG,08Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,20241.00
2016/17,West London (K&C & QPP) CCG,08Y,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),522364.56
2016/17,West London (K&C & QPP) CCG,08Y,Human analogue insulins ,Prescription Items,15141.00
2016/17,West London (K&C & QPP) CCG,08Y,Human analogue insulins ,Net Ingredient Cost (£),899599.90
2016/17,West London (K&C & QPP) CCG,08Y,Other insulins ,Prescription Items,3112.00
2016/17,West London (K&C & QPP) CCG,08Y,Other insulins ,Net Ingredient Cost (£),101865.46
2016/17,West Norfolk CCG,07J,Total primary care (all BNF),Prescription Items,4769155.00
2016/17,West Norfolk CCG,07J,Total primary care (all BNF),Net Ingredient Cost (£),35688188.97
2016/17,West Norfolk CCG,07J,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,222005.00
2016/17,West Norfolk CCG,07J,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),4026637.84
2016/17,West Norfolk CCG,07J,Insulins (BNF 6.1.1) ,Prescription Items,31734.00
2016/17,West Norfolk CCG,07J,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1544210.61
2016/17,West Norfolk CCG,07J,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,9355.00
2016/17,West Norfolk CCG,07J,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),445035.45
2016/17,West Norfolk CCG,07J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,22379.00
2016/17,West Norfolk CCG,07J,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1099175.16
2016/17,West Norfolk CCG,07J,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,154851.00
2016/17,West Norfolk CCG,07J,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1645994.31
2016/17,West Norfolk CCG,07J,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,33389.00
2016/17,West Norfolk CCG,07J,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),96213.44
2016/17,West Norfolk CCG,07J,Biguanides (BNF 6.1.2.2) ,Prescription Items,87147.00
2016/17,West Norfolk CCG,07J,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),350461.42
2016/17,West Norfolk CCG,07J,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,34315.00
2016/17,West Norfolk CCG,07J,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1199319.45
2016/17,West Norfolk CCG,07J,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,33008.00
2016/17,West Norfolk CCG,07J,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),815075.60
2016/17,West Norfolk CCG,07J,Human analogue insulins ,Prescription Items,23006.00
2016/17,West Norfolk CCG,07J,Human analogue insulins ,Net Ingredient Cost (£),1266750.97
2016/17,West Norfolk CCG,07J,Other insulins ,Prescription Items,8728.00
2016/17,West Norfolk CCG,07J,Other insulins ,Net Ingredient Cost (£),277459.64
2016/17,West Suffolk CCG,07K,Total primary care (all BNF),Prescription Items,5636628.00
2016/17,West Suffolk CCG,07K,Total primary care (all BNF),Net Ingredient Cost (£),43023529.71
2016/17,West Suffolk CCG,07K,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,253082.00
2016/17,West Suffolk CCG,07K,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),5030815.33
2016/17,West Suffolk CCG,07K,Insulins (BNF 6.1.1) ,Prescription Items,34397.00
2016/17,West Suffolk CCG,07K,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),1659119.71
2016/17,West Suffolk CCG,07K,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,10914.00
2016/17,West Suffolk CCG,07K,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),517274.68
2016/17,West Suffolk CCG,07K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,23483.00
2016/17,West Suffolk CCG,07K,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1141845.03
2016/17,West Suffolk CCG,07K,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,179015.00
2016/17,West Suffolk CCG,07K,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2252246.24
2016/17,West Suffolk CCG,07K,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,34691.00
2016/17,West Suffolk CCG,07K,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),121988.97
2016/17,West Suffolk CCG,07K,Biguanides (BNF 6.1.2.2) ,Prescription Items,97502.00
2016/17,West Suffolk CCG,07K,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),377968.10
2016/17,West Suffolk CCG,07K,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,46822.00
2016/17,West Suffolk CCG,07K,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),1752289.17
2016/17,West Suffolk CCG,07K,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,38112.00
2016/17,West Suffolk CCG,07K,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1103401.05
2016/17,West Suffolk CCG,07K,Human analogue insulins ,Prescription Items,29645.00
2016/17,West Suffolk CCG,07K,Human analogue insulins ,Net Ingredient Cost (£),1513394.15
2016/17,West Suffolk CCG,07K,Other insulins ,Prescription Items,4752.00
2016/17,West Suffolk CCG,07K,Other insulins ,Net Ingredient Cost (£),145725.56
2016/17,Wigan Borough CCG,02H,Total primary care (all BNF),Prescription Items,6775183.00
2016/17,Wigan Borough CCG,02H,Total primary care (all BNF),Net Ingredient Cost (£),63526914.53
2016/17,Wigan Borough CCG,02H,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,279449.00
2016/17,Wigan Borough CCG,02H,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6111987.75
2016/17,Wigan Borough CCG,02H,Insulins (BNF 6.1.1) ,Prescription Items,42594.00
2016/17,Wigan Borough CCG,02H,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2184871.42
2016/17,Wigan Borough CCG,02H,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,16413.00
2016/17,Wigan Borough CCG,02H,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),769526.26
2016/17,Wigan Borough CCG,02H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,26181.00
2016/17,Wigan Borough CCG,02H,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1415345.16
2016/17,Wigan Borough CCG,02H,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,194221.00
2016/17,Wigan Borough CCG,02H,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2853477.60
2016/17,Wigan Borough CCG,02H,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,42173.00
2016/17,Wigan Borough CCG,02H,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),151162.48
2016/17,Wigan Borough CCG,02H,Biguanides (BNF 6.1.2.2) ,Prescription Items,103603.00
2016/17,Wigan Borough CCG,02H,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),515676.53
2016/17,Wigan Borough CCG,02H,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,48445.00
2016/17,Wigan Borough CCG,02H,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2186638.59
2016/17,Wigan Borough CCG,02H,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,40613.00
2016/17,Wigan Borough CCG,02H,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1051255.92
2016/17,Wigan Borough CCG,02H,Human analogue insulins ,Prescription Items,41077.00
2016/17,Wigan Borough CCG,02H,Human analogue insulins ,Net Ingredient Cost (£),2119231.01
2016/17,Wigan Borough CCG,02H,Other insulins ,Prescription Items,1517.00
2016/17,Wigan Borough CCG,02H,Other insulins ,Net Ingredient Cost (£),65640.41
2016/17,Wiltshire CCG,99N,Total primary care (all BNF),Prescription Items,9222879.00
2016/17,Wiltshire CCG,99N,Total primary care (all BNF),Net Ingredient Cost (£),73064360.93
2016/17,Wiltshire CCG,99N,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,397329.00
2016/17,Wiltshire CCG,99N,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),8277116.55
2016/17,Wiltshire CCG,99N,Insulins (BNF 6.1.1) ,Prescription Items,58125.00
2016/17,Wiltshire CCG,99N,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2930646.97
2016/17,Wiltshire CCG,99N,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,20826.00
2016/17,Wiltshire CCG,99N,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),997143.85
2016/17,Wiltshire CCG,99N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,37299.00
2016/17,Wiltshire CCG,99N,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1933503.12
2016/17,Wiltshire CCG,99N,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,273185.00
2016/17,Wiltshire CCG,99N,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3488380.54
2016/17,Wiltshire CCG,99N,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,66620.00
2016/17,Wiltshire CCG,99N,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),226326.03
2016/17,Wiltshire CCG,99N,Biguanides (BNF 6.1.2.2) ,Prescription Items,145685.00
2016/17,Wiltshire CCG,99N,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),700486.85
2016/17,Wiltshire CCG,99N,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,60880.00
2016/17,Wiltshire CCG,99N,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2561567.66
2016/17,Wiltshire CCG,99N,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,62753.00
2016/17,Wiltshire CCG,99N,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),1820900.76
2016/17,Wiltshire CCG,99N,Human analogue insulins ,Prescription Items,43810.00
2016/17,Wiltshire CCG,99N,Human analogue insulins ,Net Ingredient Cost (£),2411014.35
2016/17,Wiltshire CCG,99N,Other insulins ,Prescription Items,14315.00
2016/17,Wiltshire CCG,99N,Other insulins ,Net Ingredient Cost (£),519632.62
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Total primary care (all BNF),Prescription Items,1993877.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Total primary care (all BNF),Net Ingredient Cost (£),17798946.55
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,94440.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1960568.43
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Insulins (BNF 6.1.1) ,Prescription Items,13241.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),654837.79
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,4243.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),201987.16
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,8998.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),452850.63
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,66902.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),925731.57
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,17032.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),74726.96
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Biguanides (BNF 6.1.2.2) ,Prescription Items,35869.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),205413.17
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,14001.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),645591.44
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,13825.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),374863.71
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Human analogue insulins ,Prescription Items,10297.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Human analogue insulins ,Net Ingredient Cost (£),557244.33
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Other insulins ,Prescription Items,2944.00
2016/17,"Windsor, Ascot and Maidenhead CCG",11C,Other insulins ,Net Ingredient Cost (£),97593.46
2016/17,Wirral CCG,12F,Total primary care (all BNF),Prescription Items,7585008.00
2016/17,Wirral CCG,12F,Total primary care (all BNF),Net Ingredient Cost (£),63049020.44
2016/17,Wirral CCG,12F,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,298384.00
2016/17,Wirral CCG,12F,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6039035.21
2016/17,Wirral CCG,12F,Insulins (BNF 6.1.1) ,Prescription Items,42568.00
2016/17,Wirral CCG,12F,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2046167.80
2016/17,Wirral CCG,12F,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,13842.00
2016/17,Wirral CCG,12F,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),595106.00
2016/17,Wirral CCG,12F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,28726.00
2016/17,Wirral CCG,12F,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1451061.80
2016/17,Wirral CCG,12F,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,212523.00
2016/17,Wirral CCG,12F,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),2994199.99
2016/17,Wirral CCG,12F,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,37431.00
2016/17,Wirral CCG,12F,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),116054.43
2016/17,Wirral CCG,12F,Biguanides (BNF 6.1.2.2) ,Prescription Items,119254.00
2016/17,Wirral CCG,12F,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),555896.04
2016/17,Wirral CCG,12F,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,55838.00
2016/17,Wirral CCG,12F,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),2322249.52
2016/17,Wirral CCG,12F,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,41107.00
2016/17,Wirral CCG,12F,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),971521.15
2016/17,Wirral CCG,12F,Human analogue insulins ,Prescription Items,41440.00
2016/17,Wirral CCG,12F,Human analogue insulins ,Net Ingredient Cost (£),2005669.22
2016/17,Wirral CCG,12F,Other insulins ,Prescription Items,1128.00
2016/17,Wirral CCG,12F,Other insulins ,Net Ingredient Cost (£),40498.58
2016/17,Wokingham CCG,11D,Total primary care (all BNF),Prescription Items,2249461.00
2016/17,Wokingham CCG,11D,Total primary care (all BNF),Net Ingredient Cost (£),21662892.73
2016/17,Wokingham CCG,11D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,92815.00
2016/17,Wokingham CCG,11D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1972954.72
2016/17,Wokingham CCG,11D,Insulins (BNF 6.1.1) ,Prescription Items,14246.00
2016/17,Wokingham CCG,11D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),703438.75
2016/17,Wokingham CCG,11D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,4479.00
2016/17,Wokingham CCG,11D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),225831.09
2016/17,Wokingham CCG,11D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,9767.00
2016/17,Wokingham CCG,11D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),477607.66
2016/17,Wokingham CCG,11D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,62805.00
2016/17,Wokingham CCG,11D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),809806.37
2016/17,Wokingham CCG,11D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,13584.00
2016/17,Wokingham CCG,11D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),50713.52
2016/17,Wokingham CCG,11D,Biguanides (BNF 6.1.2.2) ,Prescription Items,36231.00
2016/17,Wokingham CCG,11D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),190696.59
2016/17,Wokingham CCG,11D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,12990.00
2016/17,Wokingham CCG,11D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),568396.26
2016/17,Wokingham CCG,11D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,15095.00
2016/17,Wokingham CCG,11D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),451473.95
2016/17,Wokingham CCG,11D,Human analogue insulins ,Prescription Items,9908.00
2016/17,Wokingham CCG,11D,Human analogue insulins ,Net Ingredient Cost (£),542252.61
2016/17,Wokingham CCG,11D,Other insulins ,Prescription Items,4338.00
2016/17,Wokingham CCG,11D,Other insulins ,Net Ingredient Cost (£),161186.14
2016/17,Wolverhampton CCG,06A,Total primary care (all BNF),Prescription Items,5545481.00
2016/17,Wolverhampton CCG,06A,Total primary care (all BNF),Net Ingredient Cost (£),47673162.07
2016/17,Wolverhampton CCG,06A,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,308731.00
2016/17,Wolverhampton CCG,06A,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),6640460.11
2016/17,Wolverhampton CCG,06A,Insulins (BNF 6.1.1) ,Prescription Items,36309.00
2016/17,Wolverhampton CCG,06A,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),2005836.52
2016/17,Wolverhampton CCG,06A,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,7046.00
2016/17,Wolverhampton CCG,06A,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),339168.12
2016/17,Wolverhampton CCG,06A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,29263.00
2016/17,Wolverhampton CCG,06A,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),1666668.40
2016/17,Wolverhampton CCG,06A,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,226677.00
2016/17,Wolverhampton CCG,06A,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),3630259.44
2016/17,Wolverhampton CCG,06A,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,39549.00
2016/17,Wolverhampton CCG,06A,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),86036.77
2016/17,Wolverhampton CCG,06A,Biguanides (BNF 6.1.2.2) ,Prescription Items,121603.00
2016/17,Wolverhampton CCG,06A,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),504373.28
2016/17,Wolverhampton CCG,06A,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,65525.00
2016/17,Wolverhampton CCG,06A,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),3039849.39
2016/17,Wolverhampton CCG,06A,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,44478.00
2016/17,Wolverhampton CCG,06A,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),990572.64
2016/17,Wolverhampton CCG,06A,Human analogue insulins ,Prescription Items,28188.00
2016/17,Wolverhampton CCG,06A,Human analogue insulins ,Net Ingredient Cost (£),1664207.45
2016/17,Wolverhampton CCG,06A,Other insulins ,Prescription Items,8121.00
2016/17,Wolverhampton CCG,06A,Other insulins ,Net Ingredient Cost (£),341629.07
2016/17,Wyre Forest CCG,06D,Total primary care (all BNF),Prescription Items,2195286.00
2016/17,Wyre Forest CCG,06D,Total primary care (all BNF),Net Ingredient Cost (£),19554413.74
2016/17,Wyre Forest CCG,06D,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,92150.00
2016/17,Wyre Forest CCG,06D,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),2404132.47
2016/17,Wyre Forest CCG,06D,Insulins (BNF 6.1.1) ,Prescription Items,16537.00
2016/17,Wyre Forest CCG,06D,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),940288.36
2016/17,Wyre Forest CCG,06D,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,4597.00
2016/17,Wyre Forest CCG,06D,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),216919.55
2016/17,Wyre Forest CCG,06D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,11940.00
2016/17,Wyre Forest CCG,06D,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),723368.81
2016/17,Wyre Forest CCG,06D,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,58214.00
2016/17,Wyre Forest CCG,06D,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),1064395.63
2016/17,Wyre Forest CCG,06D,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,8251.00
2016/17,Wyre Forest CCG,06D,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),34144.29
2016/17,Wyre Forest CCG,06D,Biguanides (BNF 6.1.2.2) ,Prescription Items,33888.00
2016/17,Wyre Forest CCG,06D,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),192423.55
2016/17,Wyre Forest CCG,06D,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,16075.00
2016/17,Wyre Forest CCG,06D,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),837827.79
2016/17,Wyre Forest CCG,06D,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,16622.00
2016/17,Wyre Forest CCG,06D,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),391995.71
2016/17,Wyre Forest CCG,06D,Human analogue insulins ,Prescription Items,14691.00
2016/17,Wyre Forest CCG,06D,Human analogue insulins ,Net Ingredient Cost (£),879233.36
2016/17,Wyre Forest CCG,06D,Other insulins ,Prescription Items,1846.00
2016/17,Wyre Forest CCG,06D,Other insulins ,Net Ingredient Cost (£),61055.00
2016/17,Non-CCG,non-ccg,Total primary care (all BNF),Prescription Items,3623654.00
2016/17,Non-CCG,non-ccg,Total primary care (all BNF),Net Ingredient Cost (£),45419235.98
2016/17,Non-CCG,non-ccg,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,23773.00
2016/17,Non-CCG,non-ccg,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),639258.60
2016/17,Non-CCG,non-ccg,Insulins (BNF 6.1.1) ,Prescription Items,8293.00
2016/17,Non-CCG,non-ccg,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),275368.36
2016/17,Non-CCG,non-ccg,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,2163.00
2016/17,Non-CCG,non-ccg,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),64636.05
2016/17,Non-CCG,non-ccg,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,6130.00
2016/17,Non-CCG,non-ccg,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),210732.31
2016/17,Non-CCG,non-ccg,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,9580.00
2016/17,Non-CCG,non-ccg,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),239684.93
2016/17,Non-CCG,non-ccg,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,1700.00
2016/17,Non-CCG,non-ccg,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),4308.80
2016/17,Non-CCG,non-ccg,Biguanides (BNF 6.1.2.2) ,Prescription Items,3584.00
2016/17,Non-CCG,non-ccg,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),10799.23
2016/17,Non-CCG,non-ccg,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,4296.00
2016/17,Non-CCG,non-ccg,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),224576.90
2016/17,Non-CCG,non-ccg,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,5639.00
2016/17,Non-CCG,non-ccg,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),120873.65
2016/17,Non-CCG,non-ccg,Human analogue insulins ,Prescription Items,5795.00
2016/17,Non-CCG,non-ccg,Human analogue insulins ,Net Ingredient Cost (£),214417.41
2016/17,Non-CCG,non-ccg,Other insulins ,Prescription Items,2498.00
2016/17,Non-CCG,non-ccg,Other insulins ,Net Ingredient Cost (£),60950.95
2016/17,unidentified,unidentified,Total primary care (all BNF),Prescription Items,1557610.00
2016/17,unidentified,unidentified,Total primary care (all BNF),Net Ingredient Cost (£),16415382.17
2016/17,unidentified,unidentified,Drugs used for Diabetes (BNF 6.1) ,Prescription Items,66451.00
2016/17,unidentified,unidentified,Drugs used for Diabetes (BNF 6.1) ,Net Ingredient Cost (£),1177004.83
2016/17,unidentified,unidentified,Insulins (BNF 6.1.1) ,Prescription Items,9133.00
2016/17,unidentified,unidentified,Insulins (BNF 6.1.1) ,Net Ingredient Cost (£),426587.64
2016/17,unidentified,unidentified,Short-acting insulins (BNF 6.1.1.1) ,Prescription Items,2772.00
2016/17,unidentified,unidentified,Short-acting insulins (BNF 6.1.1.1) ,Net Ingredient Cost (£),121357.07
2016/17,unidentified,unidentified,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Prescription Items,6361.00
2016/17,unidentified,unidentified,Intermediate and long-acting insulins (BNF 6.1.1.2) ,Net Ingredient Cost (£),305230.57
2016/17,unidentified,unidentified,Antidiabetic drugs (BNF 6.1.2) ,Prescription Items,47582.00
2016/17,unidentified,unidentified,Antidiabetic drugs (BNF 6.1.2) ,Net Ingredient Cost (£),519167.14
2016/17,unidentified,unidentified,Sulfonylureas (BNF 6.1.2.1) ,Prescription Items,10520.00
2016/17,unidentified,unidentified,Sulfonylureas (BNF 6.1.2.1) ,Net Ingredient Cost (£),28883.54
2016/17,unidentified,unidentified,Biguanides (BNF 6.1.2.2) ,Prescription Items,26258.00
2016/17,unidentified,unidentified,Biguanides (BNF 6.1.2.2) ,Net Ingredient Cost (£),117066.12
2016/17,unidentified,unidentified,Other antidiabetic drugs (BNF 6.1.2.3) ,Prescription Items,10804.00
2016/17,unidentified,unidentified,Other antidiabetic drugs (BNF 6.1.2.3) ,Net Ingredient Cost (£),373217.48
2016/17,unidentified,unidentified,Diagnostic and monitoring devices (BNF 6.1.6) ,Prescription Items,9310.00
2016/17,unidentified,unidentified,Diagnostic and monitoring devices (BNF 6.1.6) ,Net Ingredient Cost (£),226541.26
2016/17,unidentified,unidentified,Human analogue insulins ,Prescription Items,7342.00
2016/17,unidentified,unidentified,Human analogue insulins ,Net Ingredient Cost (£),371182.87
2016/17,unidentified,unidentified,Other insulins ,Prescription Items,1791.00
2016/17,unidentified,unidentified,Other insulins ,Net Ingredient Cost (£),55404.77
